Antibiotics — MCQs

Q: A 57-year-old woman returns to her primary care provider complaining of fever, skin rash, and flank pain. She had just visited her PCP 2 weeks ago complaining of a sore throat and was diagnosed with pharyngitis. She was then given a 10 day prescription for phenoxymethylpenicillin. Today she is on day 6 of her prescription. Her symptoms started yesterday. Past medical history is significant for type 2 diabetes mellitus, essential hypertension, and has gastroesophageal reflux disease. Her medications include metformin, captopril, hydrochlorothiazide, and pantoprazole and a multivitamin that she takes daily. Today her temperature is 38.0°C (100.4°F), the blood pressure is 147/95 mm Hg, and the pulse is 82/min. Physical examination shows a sparse maculopapular rash over her upper trunk. Laboratory results are shown: CBC with Diff Leukocyte count 9,500/mm3 Segmented neutrophils 54% Bands 4% Eosinophils 8% Basophils 0.5% Lymphocytes 30% Monocytes 4% Blood urea nitrogen 25 mg/dL Serum creatinine 2 mg/dL Urinalysis 27 white blood cells/ high powered field 5 red blood cells/high powered field Urine culture No growth after 72 hours A urine cytospin with stained with Wright’s stain shows 4.5% eosinophils. Which of the following is the best initial step in the management of this patient condition?

Discontinue the triggering medication(s). ***Discontinue the triggering medication(s)*** - This patient presents with symptoms highly suggestive of **acute interstitial nephritis (AIN)**, including fever, rash, flank pain, new-onset **eosinophilia** (peripheral and urine), and acute kidney injury (elevated BUN and creatinine) following recent antibiotic use. - The most crucial initial step in managing drug-induced AIN is the immediate cessation of the suspected **causative agent**, which in this case is **phenoxymethylpenicillin**. *Renal biopsy* - While a **renal biopsy** can definitively diagnose AIN, it is an **invasive procedure** and not the initial management step. - It is typically considered if the diagnosis remains uncertain after discontinuing the suspected drug or if there is no improvement. *Supportive dialysis* - **Supportive dialysis** is indicated for severe **acute kidney injury (AKI)** complications like refractory hyperkalemia, severe metabolic acidosis, or fluid overload. - Although the patient has AKI, there's no evidence presented to suggest these urgent indications for dialysis. *Short course of prednisolone* - A short course of **corticosteroids** like prednisolone may be considered for AIN, especially if renal function does not improve after discontinuing the offending drug. - However, the **initial and most critical step** is to remove the inciting agent. *Empiric oral fluoroquinolones* - The **urine culture** showing no growth after 72 hours makes a **bacterial urinary tract infection (UTI)** unlikely, ruling out the need for empiric antibiotics like fluoroquinolones. - The patient's symptoms are more consistent with a drug reaction leading to AIN rather than an untreated infection.

Q: A 28-year-old man presents with a complaint of penile discharge. He says that he noticed a yellowish watery discharge from his penis since last week. He adds that he has painful urination only in the mornings, but he sometimes feels a lingering pain in his genital region throughout the day. He denies any fever, body aches, or joint pains. No significant past medical history or current medications. When asked about his social history, he mentions that he has regular intercourse with women he meets in bars, however, he doesn’t always remember to use a condom. Physical examination is unremarkable. The penile discharge is collected and sent for analysis. Ceftriaxone IM is administered, after which the patient is sent home with a prescription for an oral medication. Which of the following oral drugs was most likely prescribed to this patient?

Doxycycline. ***Doxycycline*** - The patient's symptoms (penile discharge, painful urination) after unprotected sex suggest **gonorrhea** and/or **chlamydia** infection. - While ceftriaxone treats gonorrhea, doxycycline is typically co-prescribed to cover potential **concurrent chlamydia infection**, which often presents similarly. *Ampicillin* - **Ampicillin** is a penicillin antibiotic **not effective** against typical causes of urethritis like *Neisseria gonorrhoeae* or *Chlamydia trachomatis*. - It would not be used as a primary or adjunctive treatment for this presentation. *Gentamicin* - **Gentamicin** is an aminoglycoside antibiotic, usually reserved for **severe gram-negative bacterial infections**, and is administered intravenously or intramuscularly. - It is **not the standard oral treatment** for uncomplicated urethritis or co-treatment with ceftriaxone. *Clindamycin* - **Clindamycin** is primarily effective against **anaerobic bacteria** and some gram-positive cocci. - It is **not effective** against *Neisseria gonorrhoeae* or *Chlamydia trachomatis* and is not part of the recommended treatment regimen for suspected STIs in this context. *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily used for **tuberculosis** and severe bacterial infections. - It is **not indicated** for the treatment of uncomplicated urethritis or sexually transmitted infections like gonorrhea and chlamydia.

Q: A 5-year-old girl presents to the emergency room due to difficulty walking. According to her parents, she has been complaining of pain in her right leg for the last few days. Her neighbor’s cat bit her last week and her parents attributed the pain to her healing bite. At the time of the bite they cleaned the wound and irrigated it with sterile saline water from a first aid kit. She has no past medical history and has never been hospitalized. On physical examination her temperature is 102.2°F (39°C), blood pressure is 118/78 mmHg, pulse is 90/min, respirations are 21/min, and pulse oximetry is 99% on room air. The open wound remains present on the thigh with surrounding erythema and edema. MRI is consistent with osteomyelitis. Which of the following is the most appropriate next step in management?

Ampicillin and sulbactam. ***Ampicillin and sulbactam*** - This combination provides broad-spectrum coverage, including activity against **Pasteurella multocida** (common in cat bites) and **Staphylococcus aureus**, which are frequent causes of osteomyelitis from animal bites. - **Sulbactam** is a beta-lactamase inhibitor, crucial for overcoming resistance in many common bacterial pathogens, especially in mixed infections. *Vancomycin* - Primarily used for covering **methicillin-resistant Staphylococcus aureus (MRSA)**. While *S. aureus* can cause osteomyelitis, this patient's history of a cat bite makes polymicrobial infection with Pasteurella and other oral flora highly likely, for which vancomycin alone would be insufficient. - It does not cover gram-negative bacteria or anaerobes commonly involved in animal bite infections. *Amoxicillin* - While active against some common bacteria, **amoxicillin alone lacks coverage for beta-lactamase-producing bacteria**, including many strains of *S. aureus* and gram-negative organisms like *Pasteurella*, which are prevalent in animal bite infections. - This monotherapy would be inadequate for the likely causative pathogens and the severity of osteomyelitis. *Fluconazole* - **Fluconazole is an antifungal medication** and has no antibacterial activity. - The patient's symptoms and MRI findings are consistent with a bacterial osteomyelitis, not a fungal infection. *Doxycycline* - **Doxycycline** has a broad spectrum of activity but is **generally not recommended as a first-line agent for acute osteomyelitis in children** due to concerns about tooth discoloration and bone development. - While it has some activity against *Pasteurella*, its coverage against typical osteomyelitis pathogens like *S. aureus* may be insufficient or less effective than beta-lactam/beta-lactamase inhibitor combinations.

Q: A 50-year-old man with acute myeloid leukemia undergoes multiple chemotherapeutic regimens but does not enter remission. His oncologist suggests that he enroll in a trial for a new medication that causes DNA strand breaks and is particularly effective during the G2 phase of the cell cycle. Which of the following anti-cancer agents is this new agent most similar to?

Bleomycin. ***Bleomycin*** - **Bleomycin** induces **DNA strand breaks** through free radical formation, making it particularly effective during the **G2 phase** of the cell cycle. - Its mechanism of action aligns with the description of the new investigational drug. *Cisplatin* - **Cisplatin** is an **alkylating-like agent** that forms DNA cross-links, preventing DNA replication and repair. - While it causes DNA damage, its primary mechanism is not typically characterized by an enhanced G2 phase specificity like bleomycin. *Vincristine* - **Vincristine** is a **microtubule inhibitor** that prevents microtubule assembly, thereby disrupting spindle formation during the M phase of the cell cycle. - It does not primarily act by causing DNA strand breaks or having G2 phase specificity. *Paclitaxel* - **Paclitaxel** is another **microtubule inhibitor** that stabilizes microtubules, preventing their disassembly and thus arresting the cell in the M phase. - Its mechanism differs significantly from causing DNA strand breaks during G2. *5-Fluorouracil* - **5-Fluorouracil (5-FU)** is an **antimetabolite** that inhibits thymidylate synthase, interfering with DNA synthesis, primarily during the S phase. - It does not directly cause DNA strand breaks and is active in a different phase of the cell cycle.

Q: A 35-year-old man comes to the physician because of an ulcer on his penis that he first noticed 4 days ago. He is currently sexually active with multiple male partners and uses condoms inconsistently. Genital examination shows a shallow, nontender ulcer with a smooth base and indurated border along the shaft of the penis. There is bilateral inguinal lymphadenopathy. Darkfield microscopy of a sample from the lesion shows gram-negative, spiral-shaped bacteria. A drug that acts by inhibition of which of the following is the most appropriate treatment for this patient?

Transpeptidase. ***Transpeptidase*** - The patient presents with a **painless chancre** and **bilateral inguinal lymphadenopathy**, pathognomonic for **primary syphilis** caused by *Treponema pallidum*. - The drug of choice for syphilis is **penicillin G**, which inhibits **transpeptidase** (penicillin-binding proteins) involved in bacterial cell wall synthesis. *Dihydropteroate synthase* - This enzyme is targeted by **sulfonamide antibiotics**, which inhibit **folic acid synthesis** in bacteria by competing with PABA. - Sulfonamides are not the primary treatment for syphilis. *Aminoacyl-tRNA binding* - This process is inhibited by **tetracyclines** and **macrolides**, which bind to the **30S** or **50S ribosomal subunit**, respectively, to prevent protein synthesis. - While tetracyclines (e.g., doxycycline) can be used for syphilis in penicillin-allergic patients, they are not the first-line treatment. *Topoisomerase II and IV* - These enzymes are responsible for DNA supercoiling and uncoiling and are inhibited by **fluoroquinolone antibiotics**, like ciprofloxacin. - Fluoroquinolones are not used for the treatment of syphilis. *Dihydrofolate reductase* - This enzyme is part of the **folic acid synthesis pathway** and is inhibited by **trimethoprim**. - Trimethoprim is often used in combination with sulfamethoxazole (e.g., TMP-SMX) but is not effective against *Treponema pallidum*.

Q: A 33-year-old man is admitted to hospital with a 1-week history of productive bloody cough, weight loss, and nocturnal sweats. He is of a lower socioeconomic status and has a history of alcohol and drug abuse. On physical examination his vital signs are as follows: blood pressure is 130/70 mm Hg, heart rate is 89/min, respiratory rate is 18/min, and temperature is 37.9℃ (100.2℉). Physical examination is remarkable for a unilateral left-sided focus of diminished vesicular respiration and rales. X-ray shows a focus of infiltration in the upper portion of the left lung that is 2 cm in diameter with signs of cavitation. A nucleic acid amplification test is positive for M. tuberculosis. The patient is prescribed an anti-tuberculosis (TB) regimen that includes rifampin. Which target will be inhibited by rifampin, and which process will be disrupted?

DNA-dependent RNA polymerase, transcription. ***DNA-dependent RNA polymerase, transcription*** - **Rifampin** primarily functions by inhibiting **bacterial DNA-dependent RNA polymerase**. - This inhibition directly blocks the process of **transcription**, preventing the synthesis of mRNA from a DNA template. - This is the classic mechanism of action for rifampin against *M. tuberculosis*. *DNA-dependent RNA polymerase, splicing* - While rifampin targets bacterial **DNA-dependent RNA polymerase**, it does so to inhibit transcription, not splicing. - **Splicing** is a post-transcriptional modification primarily occurring in eukaryotes and is not directly affected by rifampin's mechanism of action in bacteria. *RNA-dependent RNA polymerase, translation* - Rifampin does not target an **RNA-dependent RNA polymerase**; this enzyme is typically found in certain viruses. - Inhibition of bacterial **translation** (protein synthesis) is the target of other antibiotic classes (e.g., aminoglycosides, tetracyclines, macrolides), not rifampin. *DNA-dependent DNA polymerase, DNA replication* - Rifampin's target is **DNA-dependent RNA polymerase**, not **DNA-dependent DNA polymerase**. - Inhibiting **DNA replication** would be the mechanism of action for antimicrobials like fluoroquinolones, which target bacterial DNA gyrase or topoisomerase IV. *RNA-dependent RNA polymerase, transcription* - Rifampin does not target an **RNA-dependent RNA polymerase**; while it inhibits transcription, the enzyme involved is **DNA-dependent RNA polymerase**. - **RNA-dependent RNA polymerase** is characteristic of RNA viruses, not bacteria like *M. tuberculosis*.

A 57-year-old woman returns to her primary care provider complaining of fever, skin rash, and flank pain. She had just visited her PCP 2 weeks ago complaining of a sore throat and was diagnosed with pharyngitis. She was then given a 10 day prescription for phenoxymethylpenicillin. Today she is on day 6 of her prescription. Her symptoms started yesterday. Past medical history is significant for type 2 diabetes mellitus, essential hypertension, and has gastroesophageal reflux disease. Her medications include metformin, captopril, hydrochlorothiazide, and pantoprazole and a multivitamin that she takes daily. Today her temperature is 38.0°C (100.4°F), the blood pressure is 147/95 mm Hg, and the pulse is 82/min. Physical examination shows a sparse maculopapular rash over her upper trunk. Laboratory results are shown: CBC with Diff Leukocyte count 9,500/mm3 Segmented neutrophils 54% Bands 4% Eosinophils 8% Basophils 0.5% Lymphocytes 30% Monocytes 4% Blood urea nitrogen 25 mg/dL Serum creatinine 2 mg/dL Urinalysis 27 white blood cells/ high powered field 5 red blood cells/high powered field Urine culture No growth after 72 hours A urine cytospin with stained with Wright’s stain shows 4.5% eosinophils. Which of the following is the best initial step in the management of this patient condition?

An 81-year-old man is brought to the emergency department by staff of an assisted living facility where he resides with fever and a cough that produces yellow-green sputum. His temperature is 39.1°C (102.3°F). Physical examination shows diffuse crackles over the right lung fields. An x-ray of the chest shows consolidation in the right lower lobe. Sputum cultures grow an organism that produces blue-green pigments and smells of sweet grapes. Treatment with piperacillin and a second agent is begun. Which of the following is the most likely mechanism of action of the second agent?

A 28-year-old man presents with a complaint of penile discharge. He says that he noticed a yellowish watery discharge from his penis since last week. He adds that he has painful urination only in the mornings, but he sometimes feels a lingering pain in his genital region throughout the day. He denies any fever, body aches, or joint pains. No significant past medical history or current medications. When asked about his social history, he mentions that he has regular intercourse with women he meets in bars, however, he doesn’t always remember to use a condom. Physical examination is unremarkable. The penile discharge is collected and sent for analysis. Ceftriaxone IM is administered, after which the patient is sent home with a prescription for an oral medication. Which of the following oral drugs was most likely prescribed to this patient?

A 45-year-old male presents to the emergency room following a seizure. The patient suffered from an upper respiratory infection complicated by sinusitis two weeks ago. The patient's past medical history is remarkable for hypertension for which he takes hydrochlorathiazide. Temperature is 39.5C, blood pressure is 120/60 mmHg, pulse is 85/min, and respiratory rate is 20/min. Upon interview, the patient appears confused and exhibits photophobia. CSF cultures are obtained. Which of the following is the most appropriate next step in the management of this patient?

A 32-year-old man presents with a fever that has persisted for 3 days. He says that the fever was initially low at around 37.8°C (100.0°F), but, for the past 2 days, it has been around 38.9°C (102.0°F), regardless of his attempts to bring it down. He has also noticed some bumps on his neck. On further questioning, he mentions that he was recently out rabbit hunting with his friends. He is prescribed an antibiotic and requested to follow-up in 2 weeks. On follow-up, the patient seems better, however, he says he now has a slight hearing difficulty. What is the mechanism of action of the drug that was prescribed to this patient?

A 5-year-old girl presents to the emergency room due to difficulty walking. According to her parents, she has been complaining of pain in her right leg for the last few days. Her neighbor’s cat bit her last week and her parents attributed the pain to her healing bite. At the time of the bite they cleaned the wound and irrigated it with sterile saline water from a first aid kit. She has no past medical history and has never been hospitalized. On physical examination her temperature is 102.2°F (39°C), blood pressure is 118/78 mmHg, pulse is 90/min, respirations are 21/min, and pulse oximetry is 99% on room air. The open wound remains present on the thigh with surrounding erythema and edema. MRI is consistent with osteomyelitis. Which of the following is the most appropriate next step in management?

A 66-year-old woman with type 2 diabetes mellitus comes to the physician because of a severely painful right ear with discharge for 10 days. The ear pain was acute in onset and is constant. She has been using over-the-counter eardrops but her symptoms have worsened. Her only medication is insulin, which she uses inconsistently. Her temperature is 39°C (102.2°F), pulse is 108/min, and blood pressure is 130/90 mm Hg. Examination of the right ear shows a swollen pinna and lobule and malodorous purulent discharge; the ear is tender to touch. Posterior auricular lymphadenopathy is present. There is mild hearing loss of the right ear. Otoscopic examination shows a swollen ear canal with granulation tissue. Laboratory studies show: Hemoglobin 13.3 g/dL Hemoglobin A1c 12.2% Leukocyte count 18,300/mm3 Segmented neutrophils 76% Eosinophils 1% Lymphocytes 20% Monocytes 3% Serum Glucose 212 mg/dL Creatinine 1.7 mg/dL A CT scan of the head shows severe thickening and enhancing of the soft tissue of the external auditory canal with patchy destruction of the mastoid process. Culture results of the ear drainage are pending. Which of the following is the most appropriate pharmacotherapy?

A 50-year-old man with acute myeloid leukemia undergoes multiple chemotherapeutic regimens but does not enter remission. His oncologist suggests that he enroll in a trial for a new medication that causes DNA strand breaks and is particularly effective during the G2 phase of the cell cycle. Which of the following anti-cancer agents is this new agent most similar to?

A 35-year-old man comes to the physician because of an ulcer on his penis that he first noticed 4 days ago. He is currently sexually active with multiple male partners and uses condoms inconsistently. Genital examination shows a shallow, nontender ulcer with a smooth base and indurated border along the shaft of the penis. There is bilateral inguinal lymphadenopathy. Darkfield microscopy of a sample from the lesion shows gram-negative, spiral-shaped bacteria. A drug that acts by inhibition of which of the following is the most appropriate treatment for this patient?

Q10

A 33-year-old man is admitted to hospital with a 1-week history of productive bloody cough, weight loss, and nocturnal sweats. He is of a lower socioeconomic status and has a history of alcohol and drug abuse. On physical examination his vital signs are as follows: blood pressure is 130/70 mm Hg, heart rate is 89/min, respiratory rate is 18/min, and temperature is 37.9℃ (100.2℉). Physical examination is remarkable for a unilateral left-sided focus of diminished vesicular respiration and rales. X-ray shows a focus of infiltration in the upper portion of the left lung that is 2 cm in diameter with signs of cavitation. A nucleic acid amplification test is positive for M. tuberculosis. The patient is prescribed an anti-tuberculosis (TB) regimen that includes rifampin. Which target will be inhibited by rifampin, and which process will be disrupted?

Antibiotics US Medical PG Practice Questions and MCQs

Question 1: A 57-year-old woman returns to her primary care provider complaining of fever, skin rash, and flank pain. She had just visited her PCP 2 weeks ago complaining of a sore throat and was diagnosed with pharyngitis. She was then given a 10 day prescription for phenoxymethylpenicillin. Today she is on day 6 of her prescription. Her symptoms started yesterday. Past medical history is significant for type 2 diabetes mellitus, essential hypertension, and has gastroesophageal reflux disease. Her medications include metformin, captopril, hydrochlorothiazide, and pantoprazole and a multivitamin that she takes daily. Today her temperature is 38.0°C (100.4°F), the blood pressure is 147/95 mm Hg, and the pulse is 82/min. Physical examination shows a sparse maculopapular rash over her upper trunk. Laboratory results are shown: CBC with Diff Leukocyte count 9,500/mm3 Segmented neutrophils 54% Bands 4% Eosinophils 8% Basophils 0.5% Lymphocytes 30% Monocytes 4% Blood urea nitrogen 25 mg/dL Serum creatinine 2 mg/dL Urinalysis 27 white blood cells/ high powered field 5 red blood cells/high powered field Urine culture No growth after 72 hours A urine cytospin with stained with Wright’s stain shows 4.5% eosinophils. Which of the following is the best initial step in the management of this patient condition?

A. Discontinue the triggering medication(s) (Correct Answer)
B. Renal biopsy
C. Supportive dialysis
D. Short course of prednisolone
E. Empiric oral fluoroquinolones

Explanation: ***Discontinue the triggering medication(s)*** - This patient presents with symptoms highly suggestive of **acute interstitial nephritis (AIN)**, including fever, rash, flank pain, new-onset **eosinophilia** (peripheral and urine), and acute kidney injury (elevated BUN and creatinine) following recent antibiotic use. - The most crucial initial step in managing drug-induced AIN is the immediate cessation of the suspected **causative agent**, which in this case is **phenoxymethylpenicillin**. *Renal biopsy* - While a **renal biopsy** can definitively diagnose AIN, it is an **invasive procedure** and not the initial management step. - It is typically considered if the diagnosis remains uncertain after discontinuing the suspected drug or if there is no improvement. *Supportive dialysis* - **Supportive dialysis** is indicated for severe **acute kidney injury (AKI)** complications like refractory hyperkalemia, severe metabolic acidosis, or fluid overload. - Although the patient has AKI, there's no evidence presented to suggest these urgent indications for dialysis. *Short course of prednisolone* - A short course of **corticosteroids** like prednisolone may be considered for AIN, especially if renal function does not improve after discontinuing the offending drug. - However, the **initial and most critical step** is to remove the inciting agent. *Empiric oral fluoroquinolones* - The **urine culture** showing no growth after 72 hours makes a **bacterial urinary tract infection (UTI)** unlikely, ruling out the need for empiric antibiotics like fluoroquinolones. - The patient's symptoms are more consistent with a drug reaction leading to AIN rather than an untreated infection.

Question 2: An 81-year-old man is brought to the emergency department by staff of an assisted living facility where he resides with fever and a cough that produces yellow-green sputum. His temperature is 39.1°C (102.3°F). Physical examination shows diffuse crackles over the right lung fields. An x-ray of the chest shows consolidation in the right lower lobe. Sputum cultures grow an organism that produces blue-green pigments and smells of sweet grapes. Treatment with piperacillin and a second agent is begun. Which of the following is the most likely mechanism of action of the second agent?

A. Impairs bacterial degradation of piperacillin (Correct Answer)
B. Inhibits bacterial synthesis of folate
C. Increases the potency of piperacillin
D. Inhibits bacterial DNA gyrase
E. Inhibits the bacterial 50S ribosomal subunit

Explanation: ***Impairs bacterial degradation of piperacillin*** - The combination therapy with **piperacillin** (β-lactam antibiotic) and a second agent suggests the second agent is a **β-lactamase inhibitor** (e.g., tazobactam), which prevents bacterial enzymes from inactivating piperacillin. - This organism's growth of blue-green pigments and sweet grape smell is characteristic of **Pseudomonas aeruginosa**, a bacterium known for producing β-lactamase enzymes. *Inhibits bacterial synthesis of folate* - This mechanism describes **sulfonamides** or **trimethoprim**, which would not be the primary co-treatment for a suspected *Pseudomonas* infection alongside piperacillin. - Folate synthesis inhibitors are rarely used in combination with β-lactam antibiotics for empiric treatment of severe pneumonia caused by organisms like *Pseudomonas*. *Increases the potency of piperacillin* - While β-lactamase inhibitors effectively *restore* the potency of piperacillin against resistant bacteria, saying they "increase" its potency is less precise than describing their role in **preventing degradation**. - The core action is to overcome resistance, not directly make the antibiotic intrinsically more powerful against susceptible strains. *Inhibits bacterial DNA gyrase* - This mechanism describes **fluoroquinolones** (e.g., ciprofloxacin, levofloxacin), which target bacterial DNA replication. - While fluoroquinolones have anti-pseudomonal activity and could be used in combination therapy, the question specifically asks about the agent combined with piperacillin, which is typically a **β-lactamase inhibitor** like tazobactam. *Inhibits the bacterial 50S ribosomal subunit* - Antibiotics like **macrolides** (e.g., azithromycin) or **clindamycin** act on the 50S ribosomal subunit. - These agents are not typically combined with piperacillin specifically to treat *Pseudomonas aeruginosa* pneumonia, as *Pseudomonas* is usually resistant to these classes.

Question 3: A 28-year-old man presents with a complaint of penile discharge. He says that he noticed a yellowish watery discharge from his penis since last week. He adds that he has painful urination only in the mornings, but he sometimes feels a lingering pain in his genital region throughout the day. He denies any fever, body aches, or joint pains. No significant past medical history or current medications. When asked about his social history, he mentions that he has regular intercourse with women he meets in bars, however, he doesn’t always remember to use a condom. Physical examination is unremarkable. The penile discharge is collected and sent for analysis. Ceftriaxone IM is administered, after which the patient is sent home with a prescription for an oral medication. Which of the following oral drugs was most likely prescribed to this patient?

A. Ampicillin
B. Gentamicin
C. Doxycycline (Correct Answer)
D. Clindamycin
E. Streptomycin

Explanation: ***Doxycycline*** - The patient's symptoms (penile discharge, painful urination) after unprotected sex suggest **gonorrhea** and/or **chlamydia** infection. - While ceftriaxone treats gonorrhea, doxycycline is typically co-prescribed to cover potential **concurrent chlamydia infection**, which often presents similarly. *Ampicillin* - **Ampicillin** is a penicillin antibiotic **not effective** against typical causes of urethritis like *Neisseria gonorrhoeae* or *Chlamydia trachomatis*. - It would not be used as a primary or adjunctive treatment for this presentation. *Gentamicin* - **Gentamicin** is an aminoglycoside antibiotic, usually reserved for **severe gram-negative bacterial infections**, and is administered intravenously or intramuscularly. - It is **not the standard oral treatment** for uncomplicated urethritis or co-treatment with ceftriaxone. *Clindamycin* - **Clindamycin** is primarily effective against **anaerobic bacteria** and some gram-positive cocci. - It is **not effective** against *Neisseria gonorrhoeae* or *Chlamydia trachomatis* and is not part of the recommended treatment regimen for suspected STIs in this context. *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily used for **tuberculosis** and severe bacterial infections. - It is **not indicated** for the treatment of uncomplicated urethritis or sexually transmitted infections like gonorrhea and chlamydia.

Question 4: A 45-year-old male presents to the emergency room following a seizure. The patient suffered from an upper respiratory infection complicated by sinusitis two weeks ago. The patient's past medical history is remarkable for hypertension for which he takes hydrochlorathiazide. Temperature is 39.5C, blood pressure is 120/60 mmHg, pulse is 85/min, and respiratory rate is 20/min. Upon interview, the patient appears confused and exhibits photophobia. CSF cultures are obtained. Which of the following is the most appropriate next step in the management of this patient?

A. Head CT
B. MRI of the head
C. Ceftriaxone
D. Ceftriaxone and vancomycin (Correct Answer)
E. Ceftriaxone, vancomycin and ampicillin

Explanation: ***Ceftriaxone and vancomycin*** - This patient presents with symptoms highly suggestive of **bacterial meningitis**, including **fever, seizure, confusion, and photophobia**, following a recent infection. **Empiric broad-spectrum antibiotic coverage** is critical and should be initiated immediately after CSF cultures are drawn, even before imaging results are available. - **Ceftriaxone** provides excellent coverage for common bacterial meningitis pathogens like *Streptococcus pneumoniae* and *Neisseria meningitidis*, while **vancomycin** addresses potential penicillin-resistant and cephalosporin-resistant strains of *S. pneumoniae*. - This combination is the **standard empiric therapy** for community-acquired bacterial meningitis in immunocompetent adults aged 18-50 years. *Head CT* - While a head CT is often indicated before a **lumbar puncture** if there are signs of increased intracranial pressure (e.g., focal neurological deficits, papilledema, altered mental status with concern for mass effect), the key principle is that **antibiotics should never be delayed** for imaging in suspected bacterial meningitis. - In this case, CSF cultures have already been obtained, and empiric antibiotics should be started immediately. If imaging is needed, it can be performed after antibiotic administration without compromising diagnostic accuracy of cultures already drawn. *MRI of the head* - An MRI provides more detailed imaging of the brain than a CT but is typically **not immediately available** in an emergency setting and is usually reserved for further evaluation after stabilization or when CT findings are non-diagnostic. - Delaying antibiotic administration for an MRI in a patient with suspected bacterial meningitis could have **severe consequences** due to the rapid progression of the infection, with potential for irreversible neurological damage or death. *Ceftriaxone* - Administering only ceftriaxone would provide partial coverage. While effective against many common meningitis pathogens, it leaves the patient vulnerable to **penicillin-resistant and cephalosporin-resistant *Streptococcus pneumoniae***, which is increasingly prevalent. - **Empiric treatment** for bacterial meningitis should include agents that cover the most likely pathogens and their resistance patterns, making monotherapy with ceftriaxone insufficient in critically ill patients. *Ceftriaxone, vancomycin and ampicillin* - Adding **ampicillin** to this regimen is typically indicated for patients at higher risk for *Listeria monocytogenes* infection, specifically those **>50 years of age**, neonates, immunocompromised patients, or pregnant women. - This **45-year-old immunocompetent patient** does not meet criteria for *Listeria* coverage based on current IDSA guidelines, making ampicillin unnecessary and contributing to broader antibiotic exposure without clear benefit.

Question 5: A 32-year-old man presents with a fever that has persisted for 3 days. He says that the fever was initially low at around 37.8°C (100.0°F), but, for the past 2 days, it has been around 38.9°C (102.0°F), regardless of his attempts to bring it down. He has also noticed some bumps on his neck. On further questioning, he mentions that he was recently out rabbit hunting with his friends. He is prescribed an antibiotic and requested to follow-up in 2 weeks. On follow-up, the patient seems better, however, he says he now has a slight hearing difficulty. What is the mechanism of action of the drug that was prescribed to this patient?

A. It binds to the 30S subunit and prevents amino acid incorporation
B. It binds to the 30S subunit and prevents the formation of the initiation complex (Correct Answer)
C. It binds to the 50S subunit and prevents the formation of the initiation complex
D. It binds to the 50S subunit and prevents translocation
E. It binds to the 50S subunit and prevents the formation of the peptide bond

Explanation: ***It binds to the 30S subunit and prevents the formation of the initiation complex*** - The patient's history of **rabbit hunting**, fever, and **lymphadenopathy** (bumps on his neck) is highly suggestive of **tularemia**. - **Streptomycin**, an **aminoglycoside**, is a first-line treatment for tularemia, and its mechanism involves binding to the bacterial **30S ribosomal subunit** to prevent the formation of the initiation complex, thereby inhibiting protein synthesis. *It binds to the 30S subunit and prevents amino acid incorporation* - This mechanism is characteristic of **tetracyclines**, which, while bacteristatic and sometimes used in tularemia, are not the preferred first-line therapy, which is typically an aminoglycoside. - Tetracyclines prevent the binding of **aminoacyl-tRNA** to the A-site of the ribosome, thus blocking polypeptide chain elongation. *It binds to the 50S subunit and prevents the formation of the initiation complex* - While some antibiotics target the 50S subunit, this specific mechanism of preventing the initiation complex formation is not characteristic of the agents typically used for tularemia. - This mechanism is more typically associated with **linezolid**, which targets the 50S subunit but is not used to treat tularemia. *It binds to the 50S subunit and prevents translocation* - This is the mechanism of action for **macrolides** (e.g., erythromycin) and **clindamycin**. - Macrolides are not the first-line treatment for tularemia, and they act by blocking ribosome translocation during protein synthesis. *It binds to the 50S subunit and prevents the formation of the peptide bond* - This mechanism is characteristic of **chloramphenicol**, an antibiotic that inhibits the **peptidyl transferase** activity of the 50S ribosomal subunit. - While effective against some bacteria, it is not the primary treatment for tularemia and carries a risk of severe side effects like bone marrow suppression.

Question 6: A 5-year-old girl presents to the emergency room due to difficulty walking. According to her parents, she has been complaining of pain in her right leg for the last few days. Her neighbor’s cat bit her last week and her parents attributed the pain to her healing bite. At the time of the bite they cleaned the wound and irrigated it with sterile saline water from a first aid kit. She has no past medical history and has never been hospitalized. On physical examination her temperature is 102.2°F (39°C), blood pressure is 118/78 mmHg, pulse is 90/min, respirations are 21/min, and pulse oximetry is 99% on room air. The open wound remains present on the thigh with surrounding erythema and edema. MRI is consistent with osteomyelitis. Which of the following is the most appropriate next step in management?

A. Ampicillin and sulbactam (Correct Answer)
B. Vancomycin
C. Amoxicillin
D. Fluconazole
E. Doxycycline

Explanation: ***Ampicillin and sulbactam*** - This combination provides broad-spectrum coverage, including activity against **Pasteurella multocida** (common in cat bites) and **Staphylococcus aureus**, which are frequent causes of osteomyelitis from animal bites. - **Sulbactam** is a beta-lactamase inhibitor, crucial for overcoming resistance in many common bacterial pathogens, especially in mixed infections. *Vancomycin* - Primarily used for covering **methicillin-resistant Staphylococcus aureus (MRSA)**. While *S. aureus* can cause osteomyelitis, this patient's history of a cat bite makes polymicrobial infection with Pasteurella and other oral flora highly likely, for which vancomycin alone would be insufficient. - It does not cover gram-negative bacteria or anaerobes commonly involved in animal bite infections. *Amoxicillin* - While active against some common bacteria, **amoxicillin alone lacks coverage for beta-lactamase-producing bacteria**, including many strains of *S. aureus* and gram-negative organisms like *Pasteurella*, which are prevalent in animal bite infections. - This monotherapy would be inadequate for the likely causative pathogens and the severity of osteomyelitis. *Fluconazole* - **Fluconazole is an antifungal medication** and has no antibacterial activity. - The patient's symptoms and MRI findings are consistent with a bacterial osteomyelitis, not a fungal infection. *Doxycycline* - **Doxycycline** has a broad spectrum of activity but is **generally not recommended as a first-line agent for acute osteomyelitis in children** due to concerns about tooth discoloration and bone development. - While it has some activity against *Pasteurella*, its coverage against typical osteomyelitis pathogens like *S. aureus* may be insufficient or less effective than beta-lactam/beta-lactamase inhibitor combinations.

Question 7: A 66-year-old woman with type 2 diabetes mellitus comes to the physician because of a severely painful right ear with discharge for 10 days. The ear pain was acute in onset and is constant. She has been using over-the-counter eardrops but her symptoms have worsened. Her only medication is insulin, which she uses inconsistently. Her temperature is 39°C (102.2°F), pulse is 108/min, and blood pressure is 130/90 mm Hg. Examination of the right ear shows a swollen pinna and lobule and malodorous purulent discharge; the ear is tender to touch. Posterior auricular lymphadenopathy is present. There is mild hearing loss of the right ear. Otoscopic examination shows a swollen ear canal with granulation tissue. Laboratory studies show: Hemoglobin 13.3 g/dL Hemoglobin A1c 12.2% Leukocyte count 18,300/mm3 Segmented neutrophils 76% Eosinophils 1% Lymphocytes 20% Monocytes 3% Serum Glucose 212 mg/dL Creatinine 1.7 mg/dL A CT scan of the head shows severe thickening and enhancing of the soft tissue of the external auditory canal with patchy destruction of the mastoid process. Culture results of the ear drainage are pending. Which of the following is the most appropriate pharmacotherapy?

A. Topical ciprofloxacin-hydrocortisone
B. Intravenous ciprofloxacin (Correct Answer)
C. Topical clotrimazole
D. Oral clarithromycin
E. Intravenous trimethoprim-sulfamethoxazole

Explanation: ***Intravenous ciprofloxacin*** - The patient's presentation with **painful ear discharge**, **granulation tissue** in the ear canal, **fever**, **leukocytosis**, and a **CT scan showing bone erosion (mastoiditis)** in a diabetic patient is highly suggestive of **necrotizing (malignant) otitis externa**. - **Pseudomonas aeruginosa** is the most common pathogen, and **intravenous ciprofloxacin** is the drug of choice due to its excellent antipseudomonal activity and ability to penetrate bone. *Topical ciprofloxacin-hydrocortisone* - This treatment is appropriate for **mild otitis externa** without signs of invasive infection or bone involvement. - The patient's severe symptoms, systemic involvement (fever, leukocytosis), and evidence of **osteomyelitis** on CT scan indicate a more serious infection requiring systemic therapy. *Topical clotrimazole* - **Topical clotrimazole** is an antifungal agent used for treating **fungal otitis externa**. - While fungal infections can occur, the clinical picture (granulation tissue, bone erosion, fever, and commonality in diabetes) points more strongly to a severe bacterial infection, most commonly *Pseudomonas*. *Oral clarithromycin* - **Clarithromycin** is a macrolide antibiotic effective against *Streptococcus pneumoniae* and *Haemophilus influenzae*, common causes of **otitis media**. - It has **poor activity against *Pseudomonas aeruginosa*** and would be ineffective for necrotizing otitis externa, especially with bone involvement. *Intravenous trimethoprim-sulfamethoxazole* - While **trimethoprim-sulfamethoxazole** can be used as an alternative agent for some *Pseudomonas* infections, **ciprofloxacin** is generally preferred as the first-line intravenous therapy for **necrotizing otitis externa** due to superior efficacy and established guidelines. - The patient's **elevated creatinine (1.7 mg/dL)** also requires careful consideration with trimethoprim-sulfamethoxazole due to potential for worsening renal function and hyperkalemia.

Question 8: A 50-year-old man with acute myeloid leukemia undergoes multiple chemotherapeutic regimens but does not enter remission. His oncologist suggests that he enroll in a trial for a new medication that causes DNA strand breaks and is particularly effective during the G2 phase of the cell cycle. Which of the following anti-cancer agents is this new agent most similar to?

A. Cisplatin
B. Vincristine
C. Bleomycin (Correct Answer)
D. Paclitaxel
E. 5-Fluorouracil

Explanation: ***Bleomycin*** - **Bleomycin** induces **DNA strand breaks** through free radical formation, making it particularly effective during the **G2 phase** of the cell cycle. - Its mechanism of action aligns with the description of the new investigational drug. *Cisplatin* - **Cisplatin** is an **alkylating-like agent** that forms DNA cross-links, preventing DNA replication and repair. - While it causes DNA damage, its primary mechanism is not typically characterized by an enhanced G2 phase specificity like bleomycin. *Vincristine* - **Vincristine** is a **microtubule inhibitor** that prevents microtubule assembly, thereby disrupting spindle formation during the M phase of the cell cycle. - It does not primarily act by causing DNA strand breaks or having G2 phase specificity. *Paclitaxel* - **Paclitaxel** is another **microtubule inhibitor** that stabilizes microtubules, preventing their disassembly and thus arresting the cell in the M phase. - Its mechanism differs significantly from causing DNA strand breaks during G2. *5-Fluorouracil* - **5-Fluorouracil (5-FU)** is an **antimetabolite** that inhibits thymidylate synthase, interfering with DNA synthesis, primarily during the S phase. - It does not directly cause DNA strand breaks and is active in a different phase of the cell cycle.

Question 9: A 35-year-old man comes to the physician because of an ulcer on his penis that he first noticed 4 days ago. He is currently sexually active with multiple male partners and uses condoms inconsistently. Genital examination shows a shallow, nontender ulcer with a smooth base and indurated border along the shaft of the penis. There is bilateral inguinal lymphadenopathy. Darkfield microscopy of a sample from the lesion shows gram-negative, spiral-shaped bacteria. A drug that acts by inhibition of which of the following is the most appropriate treatment for this patient?

A. Dihydropteroate synthase
B. Aminoacyl-tRNA binding
C. Topoisomerase II and IV
D. Transpeptidase (Correct Answer)
E. Dihydrofolate reductase

Explanation: ***Transpeptidase*** - The patient presents with a **painless chancre** and **bilateral inguinal lymphadenopathy**, pathognomonic for **primary syphilis** caused by *Treponema pallidum*. - The drug of choice for syphilis is **penicillin G**, which inhibits **transpeptidase** (penicillin-binding proteins) involved in bacterial cell wall synthesis. *Dihydropteroate synthase* - This enzyme is targeted by **sulfonamide antibiotics**, which inhibit **folic acid synthesis** in bacteria by competing with PABA. - Sulfonamides are not the primary treatment for syphilis. *Aminoacyl-tRNA binding* - This process is inhibited by **tetracyclines** and **macrolides**, which bind to the **30S** or **50S ribosomal subunit**, respectively, to prevent protein synthesis. - While tetracyclines (e.g., doxycycline) can be used for syphilis in penicillin-allergic patients, they are not the first-line treatment. *Topoisomerase II and IV* - These enzymes are responsible for DNA supercoiling and uncoiling and are inhibited by **fluoroquinolone antibiotics**, like ciprofloxacin. - Fluoroquinolones are not used for the treatment of syphilis. *Dihydrofolate reductase* - This enzyme is part of the **folic acid synthesis pathway** and is inhibited by **trimethoprim**. - Trimethoprim is often used in combination with sulfamethoxazole (e.g., TMP-SMX) but is not effective against *Treponema pallidum*.

Question 10: A 33-year-old man is admitted to hospital with a 1-week history of productive bloody cough, weight loss, and nocturnal sweats. He is of a lower socioeconomic status and has a history of alcohol and drug abuse. On physical examination his vital signs are as follows: blood pressure is 130/70 mm Hg, heart rate is 89/min, respiratory rate is 18/min, and temperature is 37.9℃ (100.2℉). Physical examination is remarkable for a unilateral left-sided focus of diminished vesicular respiration and rales. X-ray shows a focus of infiltration in the upper portion of the left lung that is 2 cm in diameter with signs of cavitation. A nucleic acid amplification test is positive for M. tuberculosis. The patient is prescribed an anti-tuberculosis (TB) regimen that includes rifampin. Which target will be inhibited by rifampin, and which process will be disrupted?

A. DNA-dependent RNA polymerase, transcription (Correct Answer)
B. DNA-dependent RNA polymerase, splicing
C. RNA-dependent RNA polymerase, translation
D. DNA-dependent DNA polymerase, DNA replication
E. RNA-dependent RNA polymerase, transcription

Explanation: ***DNA-dependent RNA polymerase, transcription*** - **Rifampin** primarily functions by inhibiting **bacterial DNA-dependent RNA polymerase**. - This inhibition directly blocks the process of **transcription**, preventing the synthesis of mRNA from a DNA template. - This is the classic mechanism of action for rifampin against *M. tuberculosis*. *DNA-dependent RNA polymerase, splicing* - While rifampin targets bacterial **DNA-dependent RNA polymerase**, it does so to inhibit transcription, not splicing. - **Splicing** is a post-transcriptional modification primarily occurring in eukaryotes and is not directly affected by rifampin's mechanism of action in bacteria. *RNA-dependent RNA polymerase, translation* - Rifampin does not target an **RNA-dependent RNA polymerase**; this enzyme is typically found in certain viruses. - Inhibition of bacterial **translation** (protein synthesis) is the target of other antibiotic classes (e.g., aminoglycosides, tetracyclines, macrolides), not rifampin. *DNA-dependent DNA polymerase, DNA replication* - Rifampin's target is **DNA-dependent RNA polymerase**, not **DNA-dependent DNA polymerase**. - Inhibiting **DNA replication** would be the mechanism of action for antimicrobials like fluoroquinolones, which target bacterial DNA gyrase or topoisomerase IV. *RNA-dependent RNA polymerase, transcription* - Rifampin does not target an **RNA-dependent RNA polymerase**; while it inhibits transcription, the enzyme involved is **DNA-dependent RNA polymerase**. - **RNA-dependent RNA polymerase** is characteristic of RNA viruses, not bacteria like *M. tuberculosis*.

Question 11: A 6-year-old boy is brought to the pediatric emergency department after having an accident at school. According to his parents, he punched a student in the mouth, which caused a deep laceration to his hand. The child’s past medical history is unremarkable and all of his vaccines are current. A physical examination is significant for stable vital signs and lacerations over the 3rd and 4th metacarpophalangeal joints of his dominant hand. Which of the following antibiotic regimens is best for this type of injury?

A. Amoxicillin-clavulanate (Correct Answer)
B. Clindamycin
C. Cephalexin
D. Metronidazole
E. Dicloxacillin

Explanation: ***Amoxicillin-clavulanate*** - This is the optimal choice for a **fight bite** due to its broad spectrum against **oral flora**, including both aerobic (e.g., *Staphylococcus species*, *Streptococcus species*) and anaerobic bacteria (e.g., *Eikenella corrodens*). - The clavulanate component provides **beta-lactamase inhibition**, crucial for treating infections caused by penicillin-resistant strains commonly found in human bites. *Clindamycin* - While clindamycin is effective against **anaerobic bacteria**, it has limited activity against some common aerobic pathogens found in human bite wounds, such as *Eikenella corrodens*. - It is often considered for patients with **penicillin allergies** but is not the first-line choice when amoxicillin-clavulanate can be used. *Cephalexin* - Cephalexin is a first-generation cephalosporin primarily active against **Gram-positive cocci** like staphylococci and streptococci. - It lacks sufficient coverage for the broad range of aerobic and anaerobic bacteria, especially **Gram-negative rods** and **anaerobes**, typically involved in human bite infections. *Metronidazole* - Metronidazole provides excellent coverage against **anaerobic bacteria** but has poor activity against aerobic and facultative anaerobic organisms common in human bite wounds. - It would need to be combined with another antibiotic to provide adequate empirical coverage for a fight bite. *Dicloxacillin* - Dicloxacillin is a penicillinase-resistant penicillin primarily effective against **methicillin-sensitive *Staphylococcus aureus* (MSSA)** and streptococci. - It does not cover **Gram-negative bacteria** or the broad range of anaerobic bacteria, especially *Eikenella corrodens*, which are key pathogens in human bite infections.

Question 12: A 47–year-old man presents to the emergency department with worsening weakness in the setting of persistent abdominal pain. The man arrived to the United States 6 months ago and has been working in a restaurant as a cook. His abdominal pain started 4 months ago, but he could not find time away from work to see a doctor. He reports nausea but denies any vomiting. His temperature is 98.6°F (37°C), blood pressure is 98/61 mmHg, pulse is 110/min, and respirations are 18/min. He has no cardiac murmurs but does have tenderness in his epigastric region. His heme-occult test is positive. His laboratory workup notes the following: Hemoglobin: 7.2 g/dL Hematocrit: 23% Leukocyte count: 11,000/mm^3 with normal differential Platelet count: 470,000/mm^3 Serum: Na+: 137 mEq/L Cl-: 109 mEq/L K+: 3.1 mEq/L HCO3-: 23 mEq/L BUN: 52 mg/dL Glucose: 89 mg/dL Creatinine: 0.9 mg/dL An esophagogastroduodenoscopy reveals the presence of a mass surrounded by bleeding ulcers. On initial shave biopsy, the preliminary diagnosis is mucosa-associated lymphatic tissue lymphoma (MALToma). What is the best next step in management?

A. Hospice care
B. Partial gastrectomy
C. Cyclophosphamide, doxorubicin, vincristine, and prednisone
D. Full thickness biopsy
E. Amoxicillin, clarithromycin, and pantoprazole (Correct Answer)

Explanation: ***Amoxicillin, clarithromycin, and pantoprazole*** - This regimen is **triple therapy for *Helicobacter pylori***. MALT lymphoma (MALToma) of the stomach is strongly associated with *H. pylori* infection, and eradication of the bacterium often leads to remission of the lymphoma. - Given the preliminary diagnosis of **MALToma**, treatment of the underlying *H. pylori* infection with antibiotics and a proton pump inhibitor is the initial and often curative step. *Hospice care* - **MALT lymphoma** is typically an indolent, slow-growing lymphoma, and initial treatment is often very effective, leading to remission. - Recommending hospice care at this stage, without attempting definitive treatment, would be premature and inappropriate for a treatable condition. *Partial gastrectomy* - **Surgical resection** is generally reserved for MALToma cases that are refractory to *H. pylori* eradication or chemotherapy, or if there are complications like obstruction or perforation, which are not described here. - Initial management focuses on **non-invasive strategies** due to the high rate of response to *H. pylori* eradication. *Cyclophosphamide, doxorubicin, vincristine, and prednisone* - This chemotherapy regimen (CHOP) is typically used for more **aggressive non-Hodgkin lymphomas** or for MALTomas that have progressed to a higher grade or stage, or are refractory to *H. pylori* eradication. - MALToma is generally an **indolent lymphoma**, and initial treatment with *H. pylori* eradication is preferred due to its efficacy and lower toxicity compared to systemic chemotherapy. *Full thickness biopsy* - While a **full-thickness biopsy** might provide more tissue for definitive staging and grading, the initial shave biopsy has already provided a preliminary diagnosis of MALToma. - Given the strong association with *H. pylori*, the immediate next step leans towards **therapeutic intervention** for the infection rather than another diagnostic procedure, especially since *H. pylori* eradication is often curative for low-grade MALTomas.

Question 13: A 12-year-old boy is brought to the emergency department by his parents after he was bitten by a friend's cat while playing at their house. The patient reports moderate pain of the right hand and wrist but has full range of motion and strength. He is up to date on his vaccinations and is generally healthy. His vitals are unremarkable. Physical exam reveals a deep puncture wound that is actively bleeding. The wound is irrigated and a dressing is applied. Which of the following is appropriate management of this patient?

A. Ampicillin-sulbactam and surgical debridement
B. Amoxicillin-clavulanate (Correct Answer)
C. Amoxicillin-clavulanate and laceration closure
D. Ampicillin-sulbactam, surgical debridement, and laceration closure
E. Laceration closure

Explanation: ***Amoxicillin-clavulanate*** - This is the **first-line antibiotic** for **cat bites**, offering broad-spectrum coverage against common pathogens like *Pasteurella multocida* and anaerobes. - Due to the high risk of infection associated with puncture wounds from animal bites, **prophylactic antibiotics** are highly recommended. *Ampicillin-sulbactam and surgical debridement* - **Ampicillin-sulbactam** is a suitable alternative if amoxicillin-clavulanate cannot be used, but it's not the primary choice in this scenario. - **Surgical debridement** is generally reserved for bites with significant tissue damage or established infection, which is not indicated for a simple puncture wound with active bleeding in an otherwise healthy patient. *Amoxicillin-clavulanate and laceration closure* - While **amoxicillin-clavulanate** is appropriate, **closing a puncture wound** from an animal bite is generally contraindicated. - **Closing these wounds increases the risk of infection** by trapping bacteria within the tissues; such wounds are typically left open to drain. *Ampicillin-sulbactam, surgical debridement, and laceration closure* - This option combines an appropriate antibiotic (though not first-line) with two inappropriate interventions for this specific bite. - Neither **surgical debridement** nor **laceration closure** is indicated for a clean, actively bleeding puncture wound without signs of extensive damage or infection. *Laceration closure* - **Closing a puncture wound** from an animal bite is an absolute contraindication due to the **high risk of infection**. - These wounds are best left open to allow for drainage and reduce bacterial inoculum.

Question 14: A 31-year-old woman is brought to the emergency department because of a severe right-sided temporal headache with conjunctival swelling and anterior bulging of the left eye for 1 hour. The patient has had right-sided purulent nasal discharge and nasal congestion for the past 2 days. There is no personal or family history of serious illness. The patient does not smoke or drink alcohol. She takes no medications. She appears to be in acute distress. Her temperature is 40°C (104°F), pulse is 105/min, and blood pressure is 125/80 mm Hg. Examination shows bilateral ptosis. The pupils are equal and reactive to light; lateral gaze of the left eye is limited. Ophthalmic examination shows periorbital edema and chemosis of the left eye. The remainder of the examination shows no abnormalities. The patient most likely requires treatment with which of the following?

A. Oral warfarin
B. Intravenous vancomycin, ceftriaxone, and metronidazole (Correct Answer)
C. Intranasal sumatriptan
D. Surgical debridement
E. Intravenous dihydroergotamine

Explanation: ***Intravenous vancomycin, ceftriaxone, and metronidazole*** - This patient presents with signs highly suggestive of **cavernous sinus thrombosis (CST)** secondary to an infection, likely a nasal sinus infection, given the **purulent nasal discharge, fever, severe headache, ptosis, limited extraocular movements (left lateral gaze), proptosis, and periorbital edema/chemosis**. - **Broad-spectrum intravenous antibiotics** are essential to cover the common pathogens associated with CST, including *Staphylococcus aureus* (covered by vancomycin), streptococci (covered by ceftriaxone), and anaerobic bacteria (covered by metronidazole) that often originate from sinonasal infections. *Oral warfarin* - While **anticoagulation (heparin followed by warfarin)** is often considered in CST to prevent propagation of the thrombus, it is typically initiated after starting appropriate antibiotic therapy or in conjunction with it. - The immediate priority in this acute, febrile presentation with severe infection is the eradication of the underlying bacterial cause; anticoagulation alone without antibiotics would be insufficient and potentially dangerous. *Intranasal sumatriptan* - **Sumatriptan** is a triptan used for the abortive treatment of **migraine headaches** and **cluster headaches** by causing vasoconstriction. - The patient's headache is part of a severe infectious process with neurological compromise (cranial nerve palsies, proptosis, fever), making a migraine diagnosis highly unlikely and sumatriptan completely ineffective and inappropriate. *Surgical debridement* - **Surgical debridement** might be considered in cases of extensive and refractory sinusitis or epidural/subdural empyema, or for drainage of abscesses *secondary* to the spread of infection from the sinuses. - However, in the acute management of CST, **antibiotic therapy** is the primary treatment; surgery is not typically the first-line intervention for CST itself unless there is an undrainable abscess or bone involvement requiring debridement as part of a more complex intervention. *Intravenous dihydroergotamine* - **Dihydroergotamine** is an ergot alkaloid used for the acute treatment of **severe migraine** and **cluster headaches**, similar to triptans, by acting as a vasoconstrictor. - This patient's symptoms are clearly indicative of a severe bacterial infection leading to complications like CST, not a primary headache disorder, rendering dihydroergotamine inappropriate and ineffective.

Question 15: A 42-year-old woman comes to the physician because of pain in her left ankle for 2 days. The pain is worse at night and with exercise. Five days ago, the patient was diagnosed with Salmonella gastroenteritis and started on ciprofloxacin. She has ulcerative colitis, hypertension, and hypercholesterolemia. She has smoked two packs of cigarettes daily for 25 years and drinks 2–3 beers daily. Current medications include mesalamine, hydrochlorothiazide, and simvastatin. She is 158 cm (5 ft 2 in) tall and weighs 74 kg (164 lb); BMI is 30 kg/m2. Her temperature is 36.7°C (98°F), pulse is 75/min, and blood pressure is 138/85 mm Hg. There is tenderness above the left posterior calcaneus and mild swelling. There is normal range of motion of the left ankle with both active and passive movement. Calf squeeze does not elicit plantar flexion. Which of the following is the most likely underlying mechanism for this patient's symptoms?

A. Recent bacterial gastroenteritis
B. Crystal formation within the joint
C. Adverse medication effect (Correct Answer)
D. Underlying inflammatory bowel disease
E. Bacterial seeding of the joint

Explanation: ***Adverse medication effect*** - The patient was recently started on **ciprofloxacin**, which is known to cause **tendinopathy** and tendon rupture, particularly in the Achilles tendon, making it a strong suspect for her ankle pain. - The **negative calf squeeze test** (Thompson test) indicates **Achilles tendon rupture or severe tendinopathy**, which is a well-documented adverse effect of fluoroquinolone antibiotics. - Key clinical features supporting this diagnosis: tenderness **above the posterior calcaneus** (Achilles tendon insertion site), pain worse with exercise, and temporal relationship to ciprofloxacin initiation. - Risk factors for fluoroquinolone-induced tendinopathy include older age (>60), corticosteroid use, renal failure, and pre-existing tendon issues, though tendon complications can occur even without all risk factors. *Recent bacterial gastroenteritis* - While **Salmonella gastroenteritis** can precede **reactive arthritis** (part of the seronegative spondyloarthropathies), which affects joints, the description of tenderness specifically above the posterior calcaneus points more towards **Achilles tendinopathy** rather than a joint effusion or diffuse arthritis. - Reactive arthritis typically presents with **inflammatory arthritis**, often affecting multiple joints, conjunctivitis, urethritis (classic triad), or presenting as a sausage digit, rather than isolated tendon pain with a negative Thompson test. *Crystal formation within the joint* - **Gout** or **pseudogout**, caused by crystal deposition, typically presents with **acute, severe pain**, redness, swelling, and warmth in a single joint, often the great toe (first metatarsophalangeal joint) for gout. - The symptoms described (tenderness above the calcaneus, normal range of motion, negative calf squeeze test) are more consistent with **tendon pathology** than an intra-articular crystal-induced arthritis. *Underlying inflammatory bowel disease* - **Ulcerative colitis** can be associated with **spondyloarthritis** or **peripheral arthritis** (enteropathic arthritis), which occurs in up to 20% of IBD patients. - However, the localized tenderness to the Achilles tendon insertion area, rather than widespread joint pain or specific inflammatory back pain, makes a direct manifestation of IBD less likely as the primary mechanism for these specific symptoms. - The temporal relationship to ciprofloxacin initiation and the tendon-specific findings point away from IBD-related arthropathy. *Bacterial seeding of the joint* - **Septic arthritis** typically presents with severe pain, swelling, redness, warmth, and **restricted range of motion** of the affected joint, often with systemic signs of infection (fever, elevated WBC). - The patient's normal temperature, good range of motion, and localized tenderness to the **tendon** (not the joint) make **bacterial seeding of the joint** unlikely as the cause of her ankle pain.

Question 16: A 5-year-old girl is brought to the physician because of a 2-day history of redness and foreign body sensation in both eyes. She has not had vision loss. Her mother reports that she has also had violent coughing spells followed by a high-pitched inspiratory sound during this time. For the past week, she has had low-grade fevers and a runny nose. Her only vaccinations were received at birth. Her temperature is 37.7°C (99.9°F). Examination shows conjunctival hemorrhage and petechiae. Oropharyngeal examination shows no abnormalities. Which of the following is the most appropriate pharmacotherapy?

A. Artificial tears
B. Oral azithromycin (Correct Answer)
C. Topical tobramycin
D. Intramuscular ceftriaxone
E. Topical azithromycin

Explanation: ***Oral azithromycin*** - This patient's symptoms (violent coughing spells with a high-pitched inspiratory sound, conjunctival hemorrhage, and petechiae, along with an incomplete vaccination history) are highly suggestive of **pertussis** (*whooping cough*). - Oral azithromycin is the **recommended treatment** for pertussis, as it can reduce the duration and severity of symptoms and prevent transmission, especially if administered early in the course of the disease. *Artificial tears* - While the patient has foreign body sensation and redness in her eyes, these are likely due to the **conjunctival hemorrhages** and **petechiae** resulting from severe coughing. - Artificial tears offer symptomatic relief for dry eyes or mild irritation but would not address the underlying infectious cause or the systemic manifestations. *Topical tobramycin* - Topical tobramycin is an **aminoglycoside antibiotic** used to treat **bacterial conjunctivitis**. - While the patient has eye symptoms, the broader clinical picture points to a systemic infection (pertussis) with ocular manifestations rather than a primary bacterial eye infection. *Intramuscular ceftriaxone* - Ceftriaxone is a **cephalosporin antibiotic** typically used for a wide range of bacterial infections, including **meningitis**, **gonorrhea**, and **severe community-acquired pneumonia**. - It is not the drug of choice for pertussis, for which macrolides like azithromycin are preferred. *Topical azithromycin* - Topical azithromycin is used for **bacterial conjunctivitis** but would not be effective against the systemic infection causing pertussis. - Although the patient has eye symptoms, the primary issue is a systemic respiratory infection that requires oral or systemic therapy.

Question 17: You are a resident in the surgical ICU. One of the patients you are covering is a 35-year-old pregnant G1P0 in her first trimester admitted for complicated appendicitis and awaiting appendectomy. Your attending surgeon would like you to start the patient on moxifloxacin IV preoperatively. You remember from your obstetrics clerkship, however, that moxifloxacin is Pregnancy Category C, and animal studies have shown that immature animals exposed to fluoroquinolones like moxifloxacin may experience cartilage damage. You know that there are potentially safer antibiotics, such as piperacillin/tazobactam, which is in Pregnancy Category B. What should you do?

A. Administer moxifloxacin since it is only Pregnancy Category C and, although studies may have revealed adverse effects in animals, there is no definite evidence that it causes risk in humans.
B. Administer piperacillin/tazobactam instead of moxifloxacin without discussing with the attending since your obligation is to "first, do no harm" and both are acceptable antibiotics for complicated appendicitis.
C. Discuss the adverse effects of each antibiotic with the patient, and then let the patient decide which antibiotic she would prefer.
D. Wait to administer any antibiotics until you discuss your safety concerns with your attending. (Correct Answer)
E. Administer moxifloxacin since the attending is the executive decision maker and had to know the patient was pregnant when deciding on an antibiotic.

Explanation: **Wait to administer any antibiotics until you discuss your safety concerns with your attending.** - As a resident, you have a **professional and ethical obligation** to voice concerns about patient safety, especially regarding medication choices in vulnerable populations like pregnant women. - Discussing your concerns with the attending physician allows for a **re-evaluation of the treatment plan** based on current evidence and patient-specific factors, ensuring the safest care. *Administer moxifloxacin since it is only Pregnancy Category C and, although studies may have revealed adverse effects in animals, there is no definite evidence that it causes risk in humans.* - While Category C means risk cannot be ruled out and benefits *may* outweigh risks, the presence of **known adverse effects in animal studies** and the availability of a safer alternative warrant reconsideration. - Administering a drug with known potential harm without discussing alternatives or concerns goes against the principle of **prudence and patient safety**. *Administer piperacillin/tazobactam instead of moxifloxacin without discussing with the attending since your obligation is to "first, do no harm" and both are acceptable antibiotics for complicated appendicitis.* - While "first, do no harm" is paramount, **unilaterally changing a treatment plan** ordered by an attending physician is inappropriate and breaches professional hierarchy and communication protocols. - The correct approach is to **communicate concerns** to the attending, allowing for a collaborative decision, rather than making independent substitutions. *Discuss the adverse effects of each antibiotic with the patient, and then let the patient decide which antibiotic she would prefer.* - While patient autonomy and informed consent are crucial, decisions about specific antibiotic choices, especially for a complicated condition like appendicitis, require **medical expertise**. - As a resident, it is your role to present information but not to delegate such complex medical decisions to a patient, particularly when you yourself have **unresolved concerns** with the attending's order. *Administer moxifloxacin since the attending is the executive decision maker and had to know the patient was pregnant when deciding on an antibiotic.* - While the attending is the senior decision-maker, it is possible for **oversights or errors to occur**, even with experienced physicians. - Assuming the attending "had to know" and therefore dismissing your own clinical judgment and knowledge of potential harm is **irresponsible** and compromises patient safety.

Question 18: A 2-year-old boy is brought to the office by his mother due to the recent onset of fever and ear pain. He began tugging on his ear and complaining of pain 3 days ago. The mother reports a temperature of 37.8°C (100.0°F) this morning, with decreased appetite. The current temperature is 38.6ºC (101.4ºF). Ear, nose, and throat (ENT) examination shows erythema and decreased mobility of the right tympanic membrane. Which is the most appropriate pharmacological agent for the management of this patient?

A. Amoxicillin (Correct Answer)
B. Azithromycin
C. Ciprofloxacin
D. Piperacillin
E. Ceftriaxone

Explanation: ***Amoxicillin*** - This patient presents with symptoms and signs consistent with **acute otitis media** (AOM), including fever, ear pain, and an erythematous, bulging tympanic membrane with decreased mobility. - **Amoxicillin** is the first-line antibiotic for AOM in children, due to its **efficacy**, safety profile, and narrow spectrum against common AOM pathogens. *Azithromycin* - **Azithromycin** is a macrolide antibiotic typically reserved for patients with severe **penicillin allergies** or for AOM caused by atypical organisms. - It is not considered first-line for uncomplicated AOM due to concerns about increasing **antibiotic resistance** and its broader spectrum compared to amoxicillin. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone antibiotic primarily used for resistant infections, **otitis externa**, or in specific cases of perforated tympanic membranes. - It is generally not recommended for AOM in young children due to potential side effects and is not effective against the most common AOM pathogens as a first-line agent. *Piperacillin* - **Piperacillin** is a broad-spectrum penicillin, often combined with a beta-lactamase inhibitor (e.g., tazobactam), used for severe bacterial infections, usually in hospitalized patients. - It is far **too broad-spectrum** and unnecessary for typical uncomplicated acute otitis media in an outpatient setting. *Ceftriaxone* - **Ceftriaxone** is a third-generation cephalosporin that is typically used for AOM when there is **treatment failure with amoxicillin** or for patients who are unable to tolerate oral antibiotics. - While effective, it is administered parenterally and is not the initial antimicrobial of choice for uncomplicated AOM.

Question 19: A 24-year-old man presents to the physician because of headache, malaise, fatigue, aching pain in the bones, and a non-itchy skin rash for the past week. He reports that he had developed a single, raised, red-colored eruption over the glans penis 2 months ago, which had healed spontaneously 1 month ago. Physical examination shows bilaterally symmetric, discrete, round, pale-red-colored, 5–10 mm-sized macules on his trunk and extremities, including over the palms and soles. His genital examination shows reddish-brown plaques on the penis. Venereal disease research laboratory test is positive and high-sensitivity enzyme-linked immunosorbent assay for HIV is negative. Fluorescent treponemal antibody-absorption test is positive. Eight hours after the administration of intramuscular benzathine penicillin, the patient presents to the emergency department with complaints of fever with chills, worsening headache, muscle pains, and worsening of his pre-existing skin lesions for the past 4 hours. There is no history of itching. His temperature is 38.5°C (101.3°F), heart rate is 108/min, respiratory rate is 24/min, and blood pressure is 104/76 mm Hg. There is no bronchospasm. His complete blood count shows leukocytosis with lymphopenia. What is the most appropriate next step in management?

A. Administer intramuscular epinephrine
B. Administer intravenous diphenhydramine
C. Prescribe an antipyretic and an analgesic for symptom relief (Correct Answer)
D. Prescribe doxycycline for 28 days
E. Prescribe oral prednisone for 5 days

Explanation: ***Prescribe an antipyretic and an analgesic for symptom relief*** - The patient is experiencing symptoms consistent with a **Jarisch-Herxheimer reaction**, which is an acute febrile reaction seen after the initiation of antibiotic treatment for spirochetal infections like **syphilis**. This reaction is self-limiting and resolved with supportive care. - Management involves supportive care with **antipyretics** (e.g., ibuprofen, acetaminophen) and **analgesics** to alleviate fever, headache, muscle pains, and malaise. *Administer intramuscular epinephrine* - **Epinephrine** is indicated for **anaphylaxis** or severe allergic reactions, which typically involve **bronchospasm**, angioedema, or severe hypotension. The patient's symptoms (fever, chills, muscle pains, worsening rash) are not indicative of anaphylaxis. - The absence of **bronchospasm** and the presence of symptoms 8 hours post-antibiotic are inconsistent with an immediate hypersensitivity reaction. *Administer intravenous diphenhydramine* - **Diphenhydramine**, an antihistamine, is primarily used for **allergic reactions** with prominent **urticaria** or **angioedema**. While it can mitigate some inflammatory responses, it is not the primary treatment for Jarisch-Herxheimer reaction. - The patient's rash is described as non-itchy **macules** and **plaques**, not urticaria, making antihistamine less effective. *Prescribe doxycycline for 28 days* - **Doxycycline** is an alternative antibiotic for syphilis, especially in penicillin-allergic patients. However, the patient has already received **benzathine penicillin**, which is the gold standard for syphilis treatment, and the current symptoms are a reaction to this treatment, not inadequate treatment itself. - Switching antibiotics or extending treatment with an alternative at this point would not address the acute Jarisch-Herxheimer reaction and is not indicated. *Prescribe oral prednisone for 5 days* - **Prednisone**, a corticosteroid, could be considered in severe cases of Jarisch-Herxheimer reaction, particularly if there is central nervous system or ophthalmic involvement, to reduce inflammation. However, for typical, self-limiting reactions, it is not routinely recommended and is generally reserved for severe or persistent symptoms. - The current symptoms, while uncomfortable, are classic for a Jarisch-Herxheimer reaction and respond well to symptomatic management without corticosteroids.

Question 20: A 33-year-old man presents to the emergency department complaining of weakness and fatigue. He states that his symptoms have worsened over the past day. He has a past medical history of IV drug abuse and alcoholism and he currently smells of alcohol. His temperature is 102°F (38.9°C), blood pressure is 111/68 mmHg, pulse is 110/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for focal tenderness over the lumbar spine. Initial lab values and blood cultures are drawn and are notable for leukocytosis and an elevated C-reactive protein (CRP). Which of the following is the best treatment for this patient?

A. Nafcillin
B. Ceftriaxone
C. Piperacillin-tazobactam
D. Vancomycin (Correct Answer)
E. Ibuprofen and warm compresses

Explanation: ***Vancomycin*** - The patient's history of **IV drug abuse**, fever, leukocytosis, elevated CRP, and focal lumbar tenderness is highly suggestive of **vertebral osteomyelitis** or **discitis**, often caused by methicillin-resistant *Staphylococcus aureus* (MRSA). - **Vancomycin** is the appropriate empiric treatment for suspected severe *S. aureus* infections in patients with risk factors for MRSA until culture and sensitivity results are available. *Nafcillin* - **Nafcillin** is effective against **methicillin-sensitive *Staphylococcus aureus* (MSSA)**. - Given the patient's history of IV drug abuse, there's a high likelihood of MRSA, making nafcillin an inadequate empiric choice. *Ceftriaxone* - **Ceftriaxone** is a broad-spectrum cephalosporin effective against many gram-negative and some gram-positive bacteria, but it has **poor coverage against *Staphylococcus aureus***, particularly MRSA. - It would be ineffective as a monotherapy for the suspected staphylococcal infection. *Piperacillin-tazobactam* - This combination provides broad-spectrum coverage, including **Pseudomonas** and many gram-negative and anaerobic bacteria, but its coverage for **MRSA is limited**. - It would not be the first-line empiric choice for a suspected MRSA infection in this setting. *Ibuprofen and warm compresses* - This treatment addresses pain and inflammation but does not treat the underlying **infectious process**. - Overlooking the infection would lead to significant morbidity and potential mortality, making this an inappropriate primary treatment.

Question 21: A 39-year-old man presents to his primary care physician with a high fever, cough, and malaise. One week ago, he returned from a vacation to Hawaii where he went waterskiing with his family. Three days before presentation, he started experiencing intermittent abdominal pain, which was followed by flu-like symptoms, itchiness in his eyes, and photosensitivity. On presentation, his temperature is 103°F (39.4°C), blood pressure is 114/72 mmHg, pulse is 105/min, and respirations are 18/min. Physical exam reveals conjunctivitis and mild jaundice. Which of the following treatments could be used to treat this patient's condition?

A. Ganciclovir
B. Metronidazole
C. Doxycycline (Correct Answer)
D. Vancomycin
E. Azithromycin

Explanation: ***Doxycycline*** - The patient's symptoms (fever, cough, malaise, abdominal pain, **conjunctival suffusion** presenting as conjunctivitis, jaundice) after waterskiing in Hawaii are highly suggestive of **leptospirosis**, an infection caused by *Leptospira* bacteria. - **Doxycycline** is the recommended treatment for mild to moderate leptospirosis, while severe cases (Weil's disease with jaundice) may require intravenous penicillin G or ceftriaxone. - The biphasic illness pattern and water exposure history are classic features of this spirochete infection. *Ganciclovir* - **Ganciclovir** is an antiviral medication primarily used to treat **cytomegalovirus (CMV)** infections, especially in immunocompromised patients. - The clinical picture presented does not align with typical CMV infection, which is often asymptomatic or causes mono-like symptoms without the water exposure history. *Metronidazole* - **Metronidazole** is an antibiotic effective against **anaerobic bacteria** and certain parasites (e.g., *Giardia*, *Trichomonas*). - It is not indicated for the treatment of leptospirosis, which is caused by a spirochete requiring tetracyclines or beta-lactams. *Vancomycin* - **Vancomycin** is an antibiotic used for treating serious infections caused by **Gram-positive bacteria**, particularly **methicillin-resistant *Staphylococcus aureus* (MRSA)** or *Clostridioides difficile*. - It is not effective against *Leptospira* species, which are spirochetes. *Azithromycin* - **Azithromycin** is a macrolide antibiotic effective against a range of bacterial infections, including **atypical pneumonia** and some sexually transmitted infections. - While azithromycin has some activity against leptospirosis, **doxycycline** or penicillin-based antibiotics are strongly preferred as first-line treatment with better evidence base.

Question 22: A 19-year-old woman presents to the family medicine clinic after noticing swelling of her right index finger a few hours ago. She has no past medical history and takes no prescription medications. She takes ibuprofen occasionally, as needed. She says that she has smoked a few cigarettes a day for the last year. On further questioning, the patient says that she has a dog and a cat at home. Her blood pressure is 108/67 mm Hg, heart rate is 94/min, respiratory rate is 12/min, and temperature is 37.8°C (100.1°F). On physical examination, the physician notices 2 clean puncture wounds with localized erythema and induration on the dorsum of the right second digit. Capillary refill is 2 seconds. Sensory and motor function are intact bilaterally. Which of the following is the most appropriate treatment choice for this patient?

A. Doxycycline
B. Amoxicillin
C. Azithromycin
D. Amoxicillin–clavulanate (Correct Answer)
E. Clindamycin

Explanation: ***Amoxicillin–clavulanate*** - This patient presents with a **cat or dog bite** wound, manifesting as puncture wounds, erythema, and induration on the finger, indicating a **localized infection**. - **Amoxicillin–clavulanate** is the recommended first-line prophylactic and therapeutic antibiotic for animal bites due to its coverage of common pathogens like *Pasteurella multocida*, *Staphylococcus aureus*, and anaerobes. *Doxycycline* - While doxycycline has broad-spectrum activity, it is typically used as an alternative for animal bites in cases of **penicillin allergy** or for specific infections like **tularemia**. - It does not offer the same comprehensive coverage for typical animal bite pathogens as amoxicillin-clavulanate. *Amoxicillin* - **Amoxicillin alone** lacks coverage against **beta-lactamase producing bacteria**, which are commonly found in animal oral flora and can cause infections in bite wounds. - The addition of clavulanate is crucial to inhibit beta-lactamase and broaden the spectrum of coverage. *Azithromycin* - Azithromycin is a macrolide that is generally **not recommended** as a first-line agent for animal bite infections due to inconsistent coverage against primary bite pathogens. - It might be considered in specific cases of **penicillin allergy** but is less effective than amoxicillin-clavulanate or even doxycycline. *Clindamycin* - Clindamycin offers good coverage against **anaerobes** and some gram-positive bacteria, particularly **Staphylococcus** species. - However, it has **poor gram-negative coverage** and would need to be combined with another agent (e.g., a fluoroquinolone) to provide adequate empirical coverage for animal bite infections.

Question 23: Five days after being admitted to the hospital for an open cholecystectomy, a 56-year-old woman develops difficulty breathing. She also has fevers, chills, and malaise. She has a cough productive of minimal amounts of yellowish-white sputum that started two days prior. She has type 2 diabetes mellitus, hypertension, and a history of gallstones. Her current medications include metformin, lisinopril, and atorvastatin. Her temperature is 39.5°C (103.1°F), pulse is 104/minute, blood pressure is 94/68 mm Hg, and respirations are 30/minute. Pulse oximetry on 2 L of oxygen via nasal cannula shows an oxygen saturation of 92%. Examination reveals decreased breath sounds over the right lung base. Abdominal examination shows a well-healing scar without erythema or discharge in the right upper quadrant. The skin is warm and well-perfused. Her hemoglobin concentration is 10.5 g/dL, leukocyte count is 16,000/mm3, platelet count is 345,000/mm3, and creatinine is 1.5 mg/dL. She is admitted to the ICU and started on IV fluids. Blood and urine for cultures are obtained. X-ray of the chest reveals a right sided pleural effusion. Which of the following is the next best step in management?

A. Intravenous ceftriaxone and azithromycin
B. Intravenous dobutamine
C. CT of the chest with contrast
D. Intravenous vancomycin and cefepime (Correct Answer)
E. External cooling and intravenous acetaminophen

Explanation: ***Intravenous vancomycin and cefepime*** - The patient presents with classic signs of **sepsis** and **septic shock** (fever, tachypnea, tachycardia, hypotension, elevated WBC, acute organ dysfunction with increased creatinine) following surgery, pointing to a **healthcare-associated infection (HCAI)**, likely pneumonia given the respiratory symptoms and CXR. - **Vancomycin** provides coverage against **methicillin-resistant Staphylococcus aureus (MRSA)**, a common pathogen in HCAI, especially in patients with recent hospitalization. **Cefepime** is a broad-spectrum anti-pseudomonal beta-lactam that covers other gram-negative and gram-positive pathogens. *Intravenous ceftriaxone and azithromycin* - This regimen is more appropriate for **community-acquired pneumonia (CAP)**, but not for severe healthcare-associated infections due to insufficient coverage for resistant organisms, such as MRSA and *Pseudomonas*. - The patient's recent hospitalization and surgery increase the risk for **multidrug-resistant (MDR)** organisms, which necessitate broader coverage than ceftriaxone and azithromycin. *Intravenous dobutamine* - **Dobutamine** is an inotropic agent used to improve cardiac contractility in **cardiogenic shock** or when cardiac output is low despite adequate fluid resuscitation. - While the patient is hypotensive, she is in **septic shock**, and the initial management involves fluid resuscitation and broad-spectrum antibiotics, not primarily inotropes. Inotropes might be considered if hypotension persists after fluid resuscitation. *CT of the chest with contrast* - A chest CT may be useful for further characterization of the pleural effusion or to rule out other pathologies like pulmonary embolism if suspicion is high. - However, given the signs of **septic shock**, initiating **empiric broad-spectrum antibiotics** is the most urgent step to stabilize the patient and treat the suspected infection. Diagnostic imaging can be pursued once the patient is stable and initial management is underway. *External cooling and intravenous acetaminophen* - **External cooling** and **acetaminophen** are antipyretic measures to reduce fever, which can improve patient comfort. - While fever control is part of supportive care, it does not address the underlying **septic shock** and **infection**, which are life-threatening and require immediate aggressive antibiotic therapy and fluid resuscitation.

Question 24: A 73-year-old man is brought to the emergency department because of fever, headaches, and confusion for the past 24 hours. Three years ago, he underwent heart transplantation because of congestive heart failure. His temperature is 38.1°C (100.5°F). He is oriented only to person. Physical examination shows nuchal rigidity. A cerebrospinal fluid culture on blood agar grows colonies of a gram-positive bacillus surrounded by a narrow transparent rim. Administration of which of the following antibiotics is most likely to be effective in the treatment of this patient's condition?

A. Ampicillin (Correct Answer)
B. Doxycycline
C. Chloramphenicol
D. Erythromycin
E. Vancomycin

Explanation: ***Ampicillin*** - This patient presents with symptoms of **meningitis** (fever, headache, confusion, nuchal rigidity) and is immunocompromised due to a **heart transplant**. The CSF culture revealing a **gram-positive bacillus** with a narrow transparent rim on blood agar strongly suggests **Listeria monocytogenes**. - **Ampicillin** is the first-line treatment for **Listeria meningitis**, as it is bactericidal and effectively penetrates the central nervous system. *Doxycycline* - Doxycycline is a **tetracycline antibiotic** that is effective against a broad range of bacteria, including some gram-positive organisms, but it is not the drug of choice for **Listeria meningitis**. - It is primarily **bacteriostatic**, and for serious infections like bacterial meningitis, a bactericidal agent is preferred, especially in immunocompromised patients. *Chloramphenicol* - Chloramphenicol is a broad-spectrum antibiotic that can be effective against some gram-positive bacteria, but its use is limited due to significant side effects like **bone marrow suppression** (aplastic anemia). - It is not considered a first-line agent for **Listeria meningitis** due to the availability of safer and equally effective alternatives like ampicillin. *Erythromycin* - Erythromycin is a **macrolide antibiotic** primarily used for respiratory tract infections and certain skin and soft tissue infections. - While it has activity against some gram-positive bacteria, it is generally **not effective against Listeria monocytogenes** and does not adequately penetrate the central nervous system for meningitis treatment. *Vancomycin* - Vancomycin is a glycopeptide antibiotic primarily used for serious infections caused by **methicillin-resistant Staphylococcus aureus (MRSA)** and other resistant gram-positive bacteria. - Although it is effective against many gram-positive organisms, **Listeria monocytogenes is inherently resistant to vancomycin**, making it an ineffective treatment choice for this patient's condition.

Question 25: A 72-year-old man is admitted to the hospital with productive cough and fever. A chest radiograph is obtained and shows lobar consolidation. The patient is diagnosed with pneumonia. He has a history of penicillin allergy. The attending physician orders IV levofloxacin as empiric therapy. On morning rounds the next day, the team discovers that the patient was administered ceftriaxone instead of levofloxacin. The patient has already received a full dose of ceftriaxone and had no signs of allergic reaction, and his pneumonia appears to be improving clinically. What is the most appropriate next step?

A. Administer diphenhydramine as prophylaxis against allergic reaction
B. Continue with ceftriaxone as empiric therapy
C. Switch the patient to oral azithromycin in preparation for discharge and home therapy
D. Switch the patient back to levofloxacin and discuss the error with the patient
E. Continue with ceftriaxone and add azithromycin as inpatient empiric pneumonia therapy (Correct Answer)

Explanation: ***Continue with ceftriaxone and add azithromycin as inpatient empiric pneumonia therapy*** - This is the **guideline-recommended approach** for hospitalized community-acquired pneumonia (CAP) according to ATS/IDSA guidelines. - Ceftriaxone (beta-lactam) plus azithromycin (macrolide) provides **dual coverage** for typical bacteria (Streptococcus pneumoniae) and atypical organisms (Mycoplasma, Chlamydophila, Legionella). - Since the patient has already tolerated ceftriaxone without allergic reaction despite penicillin allergy history, continuing it is safe, and **adding azithromycin completes appropriate empiric therapy** for a 72-year-old hospitalized patient. - The cross-reactivity between penicillins and cephalosporins is low (1-3%), and the patient's tolerance of ceftriaxone confirms safety. *Continue with ceftriaxone as empiric therapy* - While the patient is improving on ceftriaxone and tolerated it without allergic reaction, **monotherapy with a beta-lactam alone is suboptimal** for hospitalized CAP. - Guidelines recommend dual therapy (beta-lactam + macrolide) or fluoroquinolone monotherapy for hospitalized non-ICU patients to ensure adequate atypical coverage. - Continuing ceftriaxone alone misses potential atypical pathogens that may be contributing to the pneumonia. *Switch the patient to oral azithromycin in preparation for discharge and home therapy* - It is **premature to switch to oral therapy** or consider discharge after only one day of treatment for a 72-year-old with pneumonia requiring hospitalization. - The patient should remain on IV therapy until clinically stable (afebrile, hemodynamically stable, improving oxygenation) for an appropriate duration. *Administer diphenhydramine as prophylaxis against allergic reaction* - Since the patient has already tolerated a full dose of ceftriaxone without any allergic reaction, **prophylactic antihistamines are unnecessary**. - The low cross-reactivity between penicillins and third-generation cephalosporins, combined with the successful first dose, indicates minimal risk. *Switch the patient back to levofloxacin and discuss the error with the patient* - Switching back to levofloxacin is **unnecessary and potentially disruptive** given that the patient is clinically improving on ceftriaxone and has demonstrated tolerance to it. - While the original plan was levofloxacin (appropriate fluoroquinolone monotherapy), the inadvertent use of ceftriaxone has proven safe and provides an opportunity to implement the preferred dual-therapy regimen. - While discussing medication errors is important for transparency, the immediate medical priority is optimizing pneumonia treatment.

Question 26: Three days after undergoing outpatient percutaneous coronary intervention with stent placement in the right coronary artery, a 60-year-old woman has left-sided painful facial swelling. The pain is worse while chewing. The patient has hypertension and coronary artery disease. Her current medications include enalapril, metoprolol, aspirin, clopidogrel, simvastatin, and a multivitamin. She does not smoke or drink alcohol. Her temperature is 38.1°C (100.5°F), pulse is 72/min, respirations are 16/min, and blood pressure is 128/86 mm Hg. Examination shows swelling and tenderness of the left parotid gland. Intraoral examination shows erythema with scant purulent drainage. Which of the following is the most appropriate next step in management?

A. Perform salivary duct dilation
B. Obtain a parotid biopsy
C. Parotidectomy
D. Administer clindamycin
E. Administer amoxicillin-clavulanate (Correct Answer)

Explanation: ***Administer amoxicillin-clavulanate*** - The patient's symptoms (painful facial swelling worse with chewing, fever, erythema with purulent drainage from the parotid gland) are classic for **acute bacterial parotitis**. - **Amoxicillin-clavulanate** is the **first-line antibiotic** for acute bacterial parotitis, providing excellent coverage of typical pathogens including *Staphylococcus aureus*, oral anaerobes, and *Streptococcus* species. - **Critical consideration:** This patient is on **dual antiplatelet therapy** (aspirin + clopidogrel) following recent coronary stent placement. Amoxicillin-clavulanate has **no significant drug interactions** with antiplatelet agents, making it the safest choice. - The β-lactamase inhibitor (clavulanate) extends coverage to β-lactamase-producing organisms commonly found in oral flora. *Administer clindamycin* - While clindamycin provides good coverage for gram-positive organisms and anaerobes typical in parotitis, it is **not the best choice in this patient**. - **Clindamycin is a CYP3A4 inhibitor** that can interfere with the activation of clopidogrel (a prodrug requiring CYP metabolism), potentially **reducing its antiplatelet effect** and increasing the risk of stent thrombosis. - Given the patient's recent coronary stent placement, avoiding this drug interaction is crucial. *Perform salivary duct dilation* - Salivary duct dilation is indicated for **sialolithiasis** (salivary stones) or ductal strictures causing obstruction. - While obstruction can predispose to infection, the primary issue here is an **active bacterial infection** requiring antibiotics first. - Dilation is not the initial treatment for acute bacterial parotitis. *Obtain a parotid biopsy* - Parotid biopsy is reserved for suspicion of **neoplasms**, autoimmune conditions (e.g., Sjögren syndrome), or chronic inflammatory processes unresponsive to treatment. - Acute bacterial parotitis is a **clinical diagnosis** based on presentation, and biopsy is not indicated as an initial step. *Parotidectomy* - Parotidectomy (surgical removal of the parotid gland) is reserved for **malignant tumors**, large benign tumors, or refractory chronic infection. - It is overly aggressive and inappropriate for acute bacterial parotitis, which typically responds well to antibiotic therapy.

Question 27: A 9-year-old boy is brought to the pediatrician by his parents with a fever, cough, and cold symptoms that began 7 days ago. He has been complaining of right ear pain for the last 2 days. He is otherwise a completely healthy child with no known medical conditions. On physical examination, the temperature is 39.0°C (102.2°F), the pulse is 114 /min, the blood pressure is 106/74 mm Hg, and the respiratory rate is 26/min. On chest auscultation, rales are heard over the right subscapular region accompanied by bronchial breathing in the same region. Examination of the right external auditory canal reveals an erythematous, bulging tympanic membrane. The results of a complete blood count are as follows: Hemoglobin % 11 g/dL WBC count 12,000/mm3 Neutrophils 88% Lymphocytes 10% Monocytes 2% Platelet count 200,000/mm3 A chest radiograph shows a focal homogenous opacity in the right lung suggestive of consolidation. Bacteriologic cultures of the blood, nasopharynx, and sputum grew Moraxella catarrhalis. Which of the following is the antibiotic of choice?

A. Azithromycin
B. Amoxicillin-clavulanate (Correct Answer)
C. Amoxicillin
D. Cefuroxime
E. Erythromycin

Explanation: ***Correct Option: Amoxicillin-clavulanate*** - The patient has **community-acquired pneumonia** and **acute otitis media** caused by *Moraxella catarrhalis*, confirmed by cultures. - **>90% of *Moraxella catarrhalis* isolates produce beta-lactamase**, making them **resistant to amoxicillin alone**. - **Amoxicillin-clavulanate** is the **first-line treatment** as clavulanate inhibits beta-lactamase, restoring activity against this organism. - This combination provides **appropriate coverage** for both the pneumonia and otitis media in this pediatric patient. *Incorrect Option: Amoxicillin* - While amoxicillin is first-line for many respiratory infections, it is **ineffective against beta-lactamase-producing *M. catarrhalis***. - Using amoxicillin alone would likely result in **treatment failure** given the high prevalence of beta-lactamase production in this organism. - The presence of **documented *M. catarrhalis*** on culture makes beta-lactamase coverage essential. *Incorrect Option: Azithromycin* - This **macrolide antibiotic** is effective against *M. catarrhalis* and could be used as an alternative. - However, it is **not first-line** when *M. catarrhalis* is documented, especially in a patient with concurrent pneumonia and otitis media where broader coverage is preferred. - **Increasing macrolide resistance** in respiratory pathogens makes beta-lactam combinations more reliable for documented bacterial infections. *Incorrect Option: Cefuroxime* - This **second-generation cephalosporin** is **beta-lactamase stable** and effective against *M. catarrhalis*. - While it would be an acceptable alternative, **amoxicillin-clavulanate is preferred** as first-line therapy for community-acquired respiratory infections in children per IDSA guidelines. - Cefuroxime is typically reserved for **penicillin allergy** or **treatment failure** with first-line agents. *Incorrect Option: Erythromycin* - This older **macrolide antibiotic** has activity against *M. catarrhalis* but is **less preferred** than newer macrolides or beta-lactam combinations. - It has **more gastrointestinal side effects** than azithromycin and **increasing resistance** among respiratory pathogens. - Not considered first-line therapy for documented *M. catarrhalis* infections in current practice.

Question 28: A 64-year-old female with type 2 diabetes mellitus comes to the physician because of a 1-week history of painful red swelling on her left thigh. Examination shows a 3- x 4-cm, tender, fluctuant mass. Incision and drainage of the abscess are performed. Culture of the abscess fluid grows gram-positive, coagulase-positive cocci that are resistant to oxacillin. Which of the following best describes the mechanism of resistance of the causal organism to oxacillin?

A. Degradation of the antibiotic
B. Decreased uptake of the antibiotic
C. Decreased activation of the antibiotic
D. Altered target of the antibiotic (Correct Answer)
E. Acetylation of the antibiotic

Explanation: ***Altered target of the antibiotic*** - The organism described (gram-positive, coagulase-positive cocci, oxacillin-resistant) is **methicillin-resistant *Staphylococcus aureus* (MRSA)**. - MRSA achieves oxacillin (and other beta-lactam) resistance by acquiring the ***mecA* gene**, which encodes for a **modified penicillin-binding protein (PBP2a)** with reduced affinity for beta-lactam antibiotics. *Degradation of the antibiotic* - This mechanism, primarily through the production of **beta-lactamase enzymes**, can degrade beta-lactam antibiotics. - While *Staphylococcus aureus* can produce beta-lactamases, oxacillin (a **penicillinase-resistant penicillin**) is specifically engineered to be stable against these enzymes. *Decreased uptake of the antibiotic* - Reduced permeability of the bacterial cell wall can lead to decreased uptake, a mechanism more commonly associated with **gram-negative bacteria** due to their outer membrane. - This is not the primary mechanism of resistance for MRSA to oxacillin. *Decreased activation of the antibiotic* - Some antibiotics are prodrugs that require activation by bacterial enzymes, and resistance can arise from mutations affecting this activation. - Oxacillin is active in its administered form and does not require bacterial activation. *Acetylation of the antibiotic* - **Enzymatic modification**, such as acetylation, adenylylation, or phosphorylation, is a common mechanism of resistance, particularly against **aminoglycoside antibiotics**. - This specific mechanism is not responsible for oxacillin resistance in MRSA.

Question 29: Three days after admission to the hospital following a motor vehicle accident, a 45-year-old woman develops a fever. A central venous catheter was placed on the day of admission for treatment of severe hypotension. Her temperature is 39.2°C (102.5°F). Examination shows erythema surrounding the catheter insertion site at the right internal jugular vein. Blood cultures show gram-positive, catalase-positive cocci that have a high minimum inhibitory concentration when exposed to novobiocin. Which of the following is the most appropriate pharmacotherapy?

A. Clarithromycin
B. Vancomycin (Correct Answer)
C. Metronidazole
D. Penicillin G
E. Polymyxin B

Explanation: ***Vancomycin*** - The description of **gram-positive, catalase-positive cocci** that are **novobiocin-resistant** (high MIC) strongly points to **Staphylococcus epidermidis** or other coagulase-negative staphylococci. *S. epidermidis* is the most common cause of **catheter-related bloodstream infections** and is often **methicillin-resistant**, making **vancomycin** the drug of choice. - The presence of erythema at the catheter site and fever in a patient with a central venous catheter indicates a **central line-associated bloodstream infection (CLABSI)**, for which empiric coverage with vancomycin is standard until sensitivities are known. - The novobiocin resistance test helps differentiate *S. epidermidis* (resistant) from *S. saprophyticus* (sensitive). *Clarithromycin* - **Clarithromycin** is a macrolide antibiotic primarily used for respiratory tract infections and *Mycobacterium avium complex*. - It is **not effective** against methicillin-resistant staphylococci and would not be appropriate for a suspected CLABSI. *Metronidazole* - **Metronidazole** is an antibiotic mainly used for **anaerobic bacterial infections** and certain parasitic infections. - It has **no activity** against gram-positive cocci like staphylococci. *Penicillin G* - **Penicillin G** is a narrow-spectrum penicillin effective against some gram-positive cocci, like **Streptococcus pyogenes**. - However, virtually all staphylococci, especially those causing hospital-acquired infections, are **resistant to penicillin G** due to beta-lactamase (penicillinase) production. *Polymyxin B* - **Polymyxin B** is an antibiotic primarily effective against **gram-negative bacteria**, particularly those with multi-drug resistance such as **Pseudomonas aeruginosa** and **Acinetobacter baumannii**. - It has **no significant activity** against gram-positive cocci like staphylococci.

Question 30: A 77-year-old woman is brought to the emergency department from her nursing home because she was found down overnight. On presentation she was found to be delirious and was unable to answer questions. Chart review shows that she is allergic to cephalosporins. Her temperature is 102.2°F (39°C), blood pressure is 105/52 mmHg, pulse is 94/min, and respirations are 23/min. Physical exam reveals a productive cough. A metabolic panel is obtained with the following results: Serum: Na+: 135 mEq/L Cl-: 95 mEq/L K+: 4 mEq/L HCO3-: 19 mEq/L BUN: 40 mg/dL Creatinine: 2.5 mg/dL Glucose: 150 mg/dL Based on these findings two different drugs are started empirically. Gram stain on a blood sample is performed showing the presence of gram-positive organisms on all samples. One of the drugs is subsequently stopped. The drug that was most likely stopped has which of the following characteristics?

A. Resistance conveyed through acetylation
B. Associated with red man syndrome
C. Single-ringed ß-lactam structure (Correct Answer)
D. Causes discolored teeth in children
E. Accumulates inside bacteria via O2-dependent uptake

Explanation: ***Single-ringed ß-lactam structure*** - The patient presents with **sepsis** due to **pneumonia** likely caused by **gram-positive organisms**. Given a cephalosporin allergy, **aztreonam** (a monobactam) would be an initial empirical antibiotic choice to cover gram-negative bacteria, alongside a drug for gram-positive coverage (like vancomycin). - Since the **blood cultures** confirmed **gram-positive organisms**, the drug covering gram-negative bacteria (aztreonam) would be stopped. Aztreonam is characterized by its **single-ringed β-lactam structure**. *Resistance conveyed through acetylation* - This mechanism of resistance is typical of **aminoglycosides** (e.g., gentamicin) and **chloramphenicol**. - Aminoglycosides were unlikely to be one of the empirically started drugs, as they are often used in combination with β-lactams, and this patient has a cephalosporin allergy. *Associated with red man syndrome* - **Red man syndrome** is a common adverse effect associated with **vancomycin** administration, especially with rapid infusion. - Vancomycin would likely be continued, as it effectively targets gram-positive organisms, including **MRSA**, and is a suitable alternative given the cephalosporin allergy. *Causes discolored teeth in children* - This is a characteristic side effect of **tetracyclines** (e.g., doxycycline), which are contraindicated in young children and pregnant women due to their effects on bone and teeth development. - Tetracyclines are not typically first-line empiric therapy for severe pneumonia or sepsis, especially in an elderly patient. *Accumulates inside bacteria via O2-dependent uptake* - This describes the mechanism of uptake for **aminoglycosides**. Their entry into bacteria is an **energy-dependent process** requiring oxygen. - As mentioned, aminoglycosides are less likely to be the initial drug stopped in this scenario, as they target gram-negative bacteria.

Question 31: A 68-year-old man comes to the physician because of headache, fatigue, and nonproductive cough for 1 week. He appears pale. Pulmonary examination shows no abnormalities. Laboratory studies show a hemoglobin concentration of 9.5 g/dL and an elevated serum lactate dehydrogenase concentration. A peripheral blood smear shows normal red blood cells that are clumped together. Results of cold agglutinin titer testing show a 4-fold elevation above normal. An x-ray of the chest shows diffuse, patchy infiltrates bilaterally. Treatment is begun with an antibiotic that is also used to promote gut motility. Which of the following is the primary mechanism of action of this drug?

A. Inhibition of bacterial RNA polymerase
B. Inhibition of folic acid synthesis
C. Free radical creation within bacterial cells
D. Inhibition of transpeptidase cross-linking at the cell wall
E. Inhibition of peptide translocation at the 50S ribosomal subunit (Correct Answer)

Explanation: ***Inhibition of peptide translocation at the 50S ribosomal subunit*** - This drug described is likely **erythromycin** or another **macrolide antibiotic**, which inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit** and preventing translocation. - Macrolides are used to treat **atypical pneumonia** caused by *Mycoplasma pneumoniae*, which is indicated by the patient's symptoms (headache, fatigue, nonproductive cough, bilateral patchy infiltrates) and **cold agglutinin disease**. *Inhibition of bacterial RNA polymerase* - This is the mechanism of action of **rifampin**, which is primarily used for **tuberculosis** and **meningitis prophylaxis**, not for atypical pneumonia. - Rifampin's side effects and spectrum of activity do not align with the implied clinical scenario, especially the gut motility promotion. *Inhibition of folic acid synthesis* - This is the mechanism for **sulfonamides** and **trimethoprim**, which are bacteriostatic and target different pathogens than those causing cold agglutinin positive pneumonia. - These drugs are not known for promoting gut motility. *Free radical creation within bacterial cells* - This mechanism is characteristic of **metronidazole**, an antibiotic used for anaerobic bacterial and parasitic infections. - Metronidazole does not fit the clinical context of atypical pneumonia with cold agglutinins, nor is it a macrolide that promotes gut motility. *Inhibition of transpeptidase cross-linking at the cell wall* - This describes the mechanism of **beta-lactam antibiotics** (e.g., penicillins, cephalosporins), which are ineffective against **atypical pneumonia** because *Mycoplasma* lacks a cell wall. - Beta-lactams do not typically promote gut motility.

Question 32: A 49-year-old man presents to the clinic for evaluation of puncture wounds on the dorsal aspect of his right second and third metacarpals. He states that he was in a fight 3 nights ago and he struck another individual in the mouth. The patient’s medical history is significant for peripheral vascular disease and hypertension. He takes aspirin, sulfasalazine, and lisinopril. He is allergic to penicillin. He drinks socially on weekends and smokes one and one-half packs of cigarettes daily. Vitals of the patient are as follows: blood pressure is 142/88 mm Hg; heart rate is 88/min; respiratory rate is 14/min; temperature is 38.9°C (102.1°F). On physical examination, the patient appears alert and oriented. His BMI is 33 kg/ m². His eyes are without scleral icterus. His right orbital region reveals ecchymosis along the superior and inferior borders. His heart is regular in rhythm and rate without murmurs. Capillary refill is 4 seconds in fingers and toes. His right dorsal second and third metacarpal region reveals two 3 mm lacerations with edema. Which of the following is the most appropriate management strategy for this patient?

A. Irrigation and debridement
B. Clindamycin plus doxycycline with irrigation and debridement (Correct Answer)
C. Amoxicillin-clavulanate with irrigation and debridement
D. Doxycycline with irrigation and debridement
E. Azithromycin with irrigation and debridement

Explanation: **Clindamycin plus doxycycline with irrigation and debridement** - This patient presents with a **"fight bite"** (puncture wounds from striking someone's mouth), which is a **high-risk injury for infection** due to the polymicrobial oral flora. The presence of **fever (38.9°C)**, **edema**, and increased **capillary refill time (4 seconds)** indicates an active infection. - The recommended empirical antibiotic regimen for fight bites includes coverage for **aerobes** (e.g., *Staphylococcus aureus*, *Streptococcus spp.*, *Eikenella corrodens*) and **anaerobes**. **Clindamycin** provides excellent anaerobic coverage, and **doxycycline** or a fluoroquinolone can cover *Eikenella corrodens* and other aerobes, making this a suitable combination, especially given the patient's penicillin allergy. **Irrigation and debridement** are crucial for removing contaminants and necrotic tissue. *Irrigation and debridement* - While **irrigation and debridement** are essential steps in managing infected wounds, they are insufficient on their own for a high-risk infected "fight bite." - **Antibiotic therapy** is also necessary to treat the infection and prevent its spread, especially given the signs of systemic involvement (fever). *Amoxicillin-clavulanate with irrigation and debridement* - **Amoxicillin-clavulanate** is a commonly recommended first-line antibiotic for fight bites due to its broad spectrum, including coverage of aerobes and anaerobes (including *Eikenella corrodens*). - However, this patient has a **penicillin allergy**, making amoxicillin-clavulanate an inappropriate choice. *Doxycycline with irrigation and debridement* - **Doxycycline** covers *Eikenella corrodens* and some other aerobes, but it provides **insufficient coverage for anaerobes**, which are a significant component of oral flora involved in fight bite infections. - Monotherapy with doxycycline would likely not be effective against the polymicrobial infection present. *Azithromycin with irrigation and debridement* - **Azithromycin** has good activity against some aerobes but provides **poor coverage against anaerobes** and *Eikenella corrodens*, making it an unsuitable empirical choice for a fight bite. - It would not adequately address the polymicrobial nature of the infection.

Question 33: A 29-year-old woman presents to the emergency department with a history of a fever that "won't break." She has taken acetaminophen without relief. Upon obtaining a past medical history you learn that the patient is a prostitute who is homeless with a significant history of intravenous drug use and alcohol abuse. The patient uses barrier protection occasionally when engaging in intercourse. On physical exam you note a murmur heard along the left mid-sternal border. The pulmonary exam reveals minor bibasilar crackles. Examination of the digits is notable for linea melanonychia. The patient's upper limbs demonstrate many bruises and scars in the antecubital fossa. Her temperature is 103.5°F (39.5°C), blood pressure is 100/70 mmHg, pulse is 112/min, respirations are 18/min, and oxygen saturation is 93% on room air. The patient's BMI is 16 kg/m^2. The patient is started on vancomycin and gentamicin and sent for echocardiography. Based on the results of echocardiography the patient is scheduled for surgery the next day. Vegetations are removed from the tricuspid valve during the surgical procedure and vancomycin and gentamicin are continued over the next 5 days. On post-operative day five, the patient presents with bleeding from her gums, oozing from her surgical sites, and recurrent epitaxis. Lab value are obtained as seen below: Serum: Na+: 135 mEq/L Cl-: 90 mEq/L K+: 4.4 mEq/L HCO3-: 23 mEq/L BUN: 20 mg/dL Glucose: 110 mg/dL Creatinine: 1.0 mg/dL Ca2+: 10.1 mg/dL AST: 9 U/L ALT: 9 U/L Leukocyte count and differential: Leukocyte count: 6,000 cells/mm^3 Lymphocytes: 20% Monocytes: 1% Neutrophils: 78% Eosinophils: 1% Basophils: 0% PT: 27 seconds aPTT: 84 seconds D-dimer: < 50 µg/L Hemoglobin: 14 g/dL Hematocrit: 40% Platelet count: 150,000/mm^3 Mean corpuscular volume: 110 fL Mean corpuscular hemoglobin concentration: 34 g/dL RDW: 14% Which of the following is the most likely cause of this patient's current symptoms?

A. Factor VIII deficiency
B. Defect in von Willebrand factor
C. Bacterial infection of the bloodstream
D. Antibiotic therapy (Correct Answer)
E. Coagulation cascade activation

Explanation: ***Correct: Antibiotic therapy*** - The patient developed **antibiotic-associated vitamin K deficiency** after 5 days of broad-spectrum antibiotics (vancomycin and gentamicin) - **Mechanism**: Broad-spectrum antibiotics eliminate gut flora that synthesize **vitamin K**, leading to deficiency of vitamin K-dependent clotting factors (II, VII, IX, X) - **Clinical features support this**: malnourished (BMI 16 kg/m²), alcohol abuse, post-operative NPO status—all risk factors for vitamin K deficiency - **Lab findings**: Prolonged **both PT and aPTT** (vitamin K-dependent factors are in both pathways), normal D-dimer and platelet count (rules out DIC) - **Macrocytosis (MCV 110 fL)** suggests chronic malnutrition and alcohol abuse, predisposing to vitamin deficiencies *Incorrect: Factor VIII deficiency* - Hemophilia A causes isolated **aPTT prolongation** with **normal PT** - This patient has prolonged PT (factor VII is vitamin K-dependent, not affected in hemophilia) - Would present earlier in life, not acutely post-operatively *Incorrect: Defect in von Willebrand factor* - Von Willebrand disease causes **normal PT** and variably prolonged aPTT - Primarily affects **platelet function** and would show prolonged bleeding time - Does not explain the marked PT prolongation seen here *Incorrect: Bacterial infection of the bloodstream* - While the patient had endocarditis, it was surgically treated - Active **sepsis with DIC** would show elevated D-dimer, thrombocytopenia, and consumptive coagulopathy - Normal D-dimer (< 50 µg/L) and adequate platelet count (150,000/mm³) rule out DIC *Incorrect: Coagulation cascade activation* - This refers to **DIC (disseminated intravascular coagulation)** - DIC presents with elevated D-dimer, low platelets, low fibrinogen, and schistocytes - Patient's **normal D-dimer** and normal platelet count exclude DIC as the primary diagnosis

Question 34: An endocervical swab is performed and nucleic acid amplification testing via polymerase chain reaction is conducted. It is positive for Chlamydia trachomatis and negative for Neisseria gonorrhoeae. Which of the following is the most appropriate pharmacotherapy?

A. Oral azithromycin (Correct Answer)
B. Intramuscular ceftriaxone plus oral azithromycin
C. Oral doxycycline
D. Intramuscular ceftriaxone
E. Intravenous cefoxitin plus oral doxycycline

Explanation: ***Oral azithromycin*** - A single 1-gram oral dose of **azithromycin** is a highly effective and convenient first-line treatment for uncomplicated **Chlamydia trachomatis** infections. - Its long half-life allows for once-daily dosing, improving patient adherence. *Intramuscular ceftriaxone plus oral azithromycin* - This combination therapy is primarily used for suspected or confirmed **gonorrhea** and chlamydia coinfection, particularly if N. gonorrhoeae cannot be ruled out. - Since **Neisseria gonorrhoeae** was explicitly negative, the ceftriaxone component is unnecessary. *Oral doxycycline* - **Doxycycline** (100 mg twice daily for 7 days) is an alternative first-line treatment for **Chlamydia trachomatis** infections and is highly effective. - However, azithromycin is often preferred for its single-dose regimen which can improve treatment adherence, especially in asymptomatic patients. *Intramuscular ceftriaxone* - **Ceftriaxone** is the primary treatment for **Neisseria gonorrhoeae** infections. - As the test for **N. gonorrhoeae** was negative, this treatment is not indicated for the current patient's diagnosis. *Intravenous cefoxitin plus oral doxycycline* - This regimen is typically reserved for more severe infections, such as **pelvic inflammatory disease (PID)**, often requiring hospitalization, which is not indicated by the simple positive chlamydia swab. - Administering **IV cefoxitin** is an escalation beyond what is necessary for uncomplicated chlamydial cervicitis.

Question 35: A 22-year-old man presents to clinic with a chief concern about a painless ulcer on his penis that he noticed 4 weeks ago and resolved one week ago. He denies any pain on urination or changes in urinary patterns. He admits to having multiple sexual partners in the past 3 months and inconsistent use of barrier protection. His vitals are within normal limits and his physical exam is unremarkable. He is given the appropriate antibiotic for this condition and sent home. What molecular structure is mimicked by the antibiotic most likely prescribed in this case?

A. D-Ala-D-Ala (Correct Answer)
B. Retinoic acid
C. Uracil
D. Adenine
E. Folate intermediates

Explanation: ***D-Ala-D-Ala*** - The patient's presentation of a **painless penile ulcer** (chancre) that resolves spontaneously, along with high-risk sexual behavior, is highly suggestive of **primary syphilis**. - The standard treatment for primary syphilis is **penicillin G**, a beta-lactam antibiotic that targets bacterial cell wall synthesis by mimicking the **D-Ala-D-Ala** terminus of peptidoglycan precursors. - Penicillin binds to penicillin-binding proteins (transpeptidases) that normally recognize D-Ala-D-Ala, thereby inhibiting cell wall synthesis. *Retinoic acid* - **Retinoic acid** is a derivative of vitamin A involved in cell growth and differentiation. - It is not a molecular structure mimicked by antibiotics used to treat bacterial infections like syphilis. *Uracil* - **Uracil** is a pyrimidine base found in RNA. - While some antibiotics target nucleic acid synthesis, they do not specifically mimic uracil as their mechanism of action. *Adenine* - **Adenine** is a purine base found in both DNA and RNA. - Antibiotics do not mimic adenine to exert their antibacterial effects. *Folate intermediates* - Some antibiotics, such as **sulfonamides**, do structurally mimic **PABA (para-aminobenzoic acid)**, which is a folate pathway intermediate. - However, these antibiotics are not used to treat syphilis, and penicillin (the correct treatment) does not mimic folate intermediates.

Question 36: A 44-year-old woman presents to her primary care physician for worsening dysuria, hematuria, and lower abdominal pain. Her symptoms began approximately 2 days ago and have progressively worsened. She denies headache, nausea, vomiting, or diarrhea. She endorses feeling "feverish" and notes to having foul smelling urine. She has a past medical history of Romano-Ward syndrome and is not on any treatment. She experiences profuse diarrhea and nausea when taking carbapenems and develops a severe rash with cephalosporins. Her temperature is 100.4°F (38C), blood pressure is 138/93 mmHg, pulse is 100/min, and respirations are 18/min. On physical exam, the patient appears uncomfortable and there is tenderness to palpation around the bilateral flanks and costovertebral angle. A urinalysis and urine culture is obtained and appropriate antibiotics are administered. On her next clinical visit urine studies and a basic metabolic panel is obtained, which is shown below: Serum: Na+: 140 mEq/L Cl-: 101 mEq/L K+: 4.2 mEq/L HCO3-: 22 mEq/L BUN: 20 mg/dL Glucose: 94 mg/dL Creatinine: 2.4 mg/dL Urinalysis Color: Yellow Appearance: Clear Blood: Negative pH: 7 (Normal 5-8) Protein: Negative Nitrite: Negative Leukocyte esterase: Negative Cast: Epithelial casts FeNa: 3% Urine culture Preliminary report: 10,000 CFU/mL E. coli Which of the following antibiotics was most likely given to this patient?

A. Aztreonam (Correct Answer)
B. Vancomycin
C. Clindamycin
D. Levofloxacin
E. Tobramycin

Explanation: ***Aztreonam*** - This patient presents with **pyelonephritis** (fever, flank pain, dysuria, hematuria, CVA tenderness) with confirmed *E. coli* urinary tract infection - She has **severe allergies to both carbapenems and cephalosporins**, eliminating most beta-lactam options - **Aztreonam** is a monobactam antibiotic with excellent activity against **gram-negative bacteria** including *E. coli* - Critically, aztreonam **does not cross-react** with other beta-lactams due to its unique monocyclic structure, making it safe in patients with penicillin/cephalosporin allergies - **No QT prolongation** - safe in Romano-Ward syndrome *Vancomycin* - Primarily effective against **gram-positive bacteria** (MRSA, enterococci) - **No activity against gram-negative organisms** like *E. coli* - Would not be appropriate for this urinary tract infection *Clindamycin* - Used primarily for **anaerobic infections** and some gram-positive bacteria - **Limited to no activity against *E. coli*** and other gram-negative organisms - Not an effective choice for gram-negative pyelonephritis *Levofloxacin* - Fluoroquinolone with excellent gram-negative coverage and urinary penetration - Generally a good choice for *E. coli* pyelonephritis - **CONTRAINDICATED in this patient**: Fluoroquinolones cause **QT interval prolongation**, which is dangerous in patients with **Romano-Ward syndrome (congenital long QT syndrome)** - This critical drug-disease interaction eliminates fluoroquinolones as an option *Tobramycin* - Aminoglycoside with good gram-negative coverage including *E. coli* - **Highly nephrotoxic** - contraindicated in this patient with **acute kidney injury** (elevated creatinine 2.4 mg/dL, epithelial casts, FENa 3%) - Risk of worsening renal function and ototoxicity makes it a poor choice

Question 37: A 26-year-old woman comes to the emergency department 30 minutes after she was bitten by her neighbor's cat. She has no history of serious illness and takes no medications. She received all recommended immunizations during childhood but has not received any since then. Vital signs are within normal limits. Physical examination shows four puncture wounds on the thenar eminence of the right hand. There is mild swelling but no erythema. There is normal range of motion of her right thumb and wrist. The wound is cleaned with povidone iodine and irrigated with saline. Which of the following is the most appropriate next step in management?

A. Administer tetanus toxoid and tetanus IV immunoglobulin
B. Close the wound surgically
C. Administer oral amoxicillin-clavulanate (Correct Answer)
D. Close the wound with cyanoacrylate tissue adhesive
E. Obtain a wound culture

Explanation: ***Administer oral amoxicillin-clavulanate*** - **Cat bite wounds**, especially **puncture wounds** on the hands, have a high risk of infection due to the inoculation of oral bacteria (e.g., *Pasteurella multocida*, *Staphylococcus species*) deep into tissues, making **prophylactic antibiotics** crucial. - **Amoxicillin-clavulanate** is the first-line prophylactic antibiotic for cat bites due to its broad spectrum covering common pathogens. *Administer tetanus toxoid and tetanus IV immunoglobulin* - While **tetanus prophylaxis** is important for wounds, the patient has a history of complete childhood immunizations, suggesting she only needs a **tetanus booster** if her last dose was more than five years ago (for dirty wounds) or ten years ago (for clean wounds), which is not specified but more likely the case than needing both toxoid and immunoglobulin. - **Tetanus immunoglobulin (TIG)** is reserved for patients with unknown or incomplete immunization status, or very high-risk wounds, which is not indicated here given her history. *Close the wound surgically* - **Cat bite wounds**, particularly **puncture wounds**, should generally **not be surgically closed** due to the high risk of trapping bacteria and creating an anaerobic environment, thus increasing the risk of infection. - The goal is to allow the wound to drain and heal by **secondary intention**. *Close the wound with cyanoacrylate tissue adhesive* - Similar to surgical closure, using tissue adhesive on a **cat bite puncture wound** is generally contraindicated due to the high risk of infection. - This method would **seal in bacteria**, preventing drainage and promoting bacterial growth. *Obtain a wound culture* - A **wound culture** is typically obtained if there are already signs of established infection (e.g., significant erythema, purulent discharge, fever) or if prophylaxis fails. - At this early stage, with only mild swelling and no overt signs of infection, **empiric prophylactic antibiotics** are more appropriate than waiting for culture results.

Question 38: A 13-year-old male is admitted to the hospital for treatment of acute lymphoblastic leukemia. During his hospital course, he develops a fever of 39.0 degrees Celsius. A CBC demonstrates a leukocyte count of <500 /mm^3. Which of the following is the most appropriate initial management of this patient?

A. Strict quarantine and hand-washing
B. IV ceftazidime (Correct Answer)
C. Oral ciprofloxacin and amoxicillin/clavulanic acid
D. Granulocyte colony-stimulating factor (G-CSF)
E. Oral doxycycline

Explanation: ***IV ceftazidime*** - This patient presents with **febrile neutropenia** (fever with a leukocyte count of <500/mm³), a life-threatening condition in immunocompromised patients. - **Empiric broad-spectrum intravenous antibiotics**, such as ceftazidime, are crucial to cover potential gram-negative and gram-positive bacterial infections, and should be initiated immediately. *Strict quarantine and hand-washing* - While **infection control measures** like hand-washing and isolation are important for preventing infections, they are **not sufficient as initial management** for febrile neutropenia. - Febrile neutropenia requires **prompt empiric antibiotic treatment** to address existing infections, not just prevention. *Oral ciprofloxacin and amoxicillin/clavulanic acid* - **Oral antibiotics are generally insufficient** for initial management of febrile neutropenia, especially in a hospitalized patient with a severe presentation. - Parenteral administration of broad-spectrum antibiotics is initially preferred for better bioavailability and rapid action against potentially life-threatening infections. *Granulocyte colony-stimulating factor (G-CSF)* - **G-CSF can be used to promote granulocyte recovery** in some cases of chemotherapy-induced neutropenia, but it is **not indicated for the initial management of active febrile neutropenia**. - Its role is primarily supportive, to shorten the duration of neutropenia, not to treat presumed bacterial infections. *Oral doxycycline* - **Doxycycline has a limited spectrum** of activity and is not a broad-spectrum antibiotic appropriate for empiric treatment of febrile neutropenia. - It would **not adequately cover common bacterial pathogens** seen in immunocompromised patients.

Question 39: A 22-year-old female with no past medical history presents to her primary care physician with a 3-day history of knee pain. She denies any recent injury or trauma. On physical examination her knee is warm, erythematous, and has diminished range of movement. The patient reports having multiple sexual partners over the last year and does not use protection regularly. Her blood pressure is 124/85 mmHg, heart rate is 76/min, and temperature is 38.3℃ (101.0℉). A joint aspiration is performed and a growth of gram-negative diplococci is noted on bacterial culture. What is the treatment of choice for this patient's condition?

A. Vancomycin monotherapy
B. Fluoroquinolones
C. Nafcillin monotherapy and joint aspiration
D. Oxacillin and ceftriaxone
E. Ceftriaxone monotherapy and joint aspiration (Correct Answer)

Explanation: ***Ceftriaxone monotherapy and joint aspiration*** - The patient's presentation with **acute monoarthritis**, fever, and **gram-negative diplococci** on joint culture is highly suggestive of **gonococcal arthritis**. Intravenous ceftriaxone is the treatment of choice for disseminated gonococcal infection. - While joint aspiration confirms the diagnosis and can relieve pressure, definitive treatment requires systemic antibiotics to clear the infection. *Vancomycin monotherapy* - **Vancomycin** is primarily effective against **gram-positive bacteria**, particularly MRSA, and would not adequately cover the gram-negative diplococci found in this case. - Using vancomycin alone would leave the patient's gonococcal infection untreated, potentially leading to worsening of symptoms or complications. *Fluoroquinolones* - While some fluoroquinolones have activity against *Neisseria gonorrhoeae*, **widespread resistance** to this class of antibiotics has emerged, making them an unreliable choice for empiric or first-line treatment of gonococcal infections. - The CDC no longer recommends fluoroquinolones for gonococcal infections due to high rates of resistance. *Nafcillin monotherapy and joint aspiration* - **Nafcillin** is a narrow-spectrum penicillin effective primarily against **methicillin-sensitive *Staphylococcus aureus*** and other gram-positive organisms. - It would not provide appropriate coverage for the **gram-negative diplococci** identified in this patient's joint fluid. *Oxacillin and ceftriaxone* - While **ceftriaxone** is appropriate, the addition of **oxacillin** (another anti-staphylococcal penicillin) would be unnecessary. - Oxacillin is primarily used for gram-positive infections and would not add benefit against **gonococcal arthritis**, increasing the risk of adverse effects without improving efficacy.

Question 40: A 61-year-old woman is brought to the emergency department because of fever, chills, and flank pain for 8 hours. Her temperature is 39.1°C (102.4°F). Physical examination shows right costovertebral angle tenderness. Urine dipstick is positive for nitrites. Urinalysis shows gram-negative rods. The patient is admitted to the hospital and treatment with a drug that directly inhibits bacterial DNA replication is begun. This drug inhibits a protein that is normally responsible for which of the following steps of DNA replication?

A. Excising RNA fragments in 5' to 3' direction
B. Cleaving DNA to relieve supercoils (Correct Answer)
C. Binding to single-stranded DNA to prevent reannealing
D. Unwinding DNA at replication fork
E. Joining of short DNA fragments

Explanation: ***Cleaving DNA to relieve supercoils*** - The patient's symptoms (fever, chills, flank pain, CVA tenderness, nitrites in urine, gram-negative rods) are consistent with **pyelonephritis**, typically caused by **gram-negative bacteria**. - The drug described is an **antibiotic** that inhibits bacterial **DNA replication**. This mechanism points towards **fluoroquinolones**, which inhibit **DNA gyrase (topoisomerase II)** and **topoisomerase IV**. These enzymes are responsible for **cleaving DNA** to relieve supercoils during replication and transcription. *Excising RNA fragments in 5' to 3' direction* - This function is primarily carried out by **DNA polymerase I** in prokaryotes, which removes **RNA primers** during replication. - While essential for replication, it is not the direct target of antibiotics that inhibit overall bacterial DNA replication in the described scenario. *Binding to single-stranded DNA to prevent reannealing* - This role is performed by **single-stranded binding proteins (SSBs)**, which stabilize the separated DNA strands at the replication fork. - These proteins are not typically targeted by antibiotics that inhibit DNA replication. *Unwinding DNA at replication fork* - The unwinding of DNA at the replication fork is primarily carried out by **DNA helicase**. - While crucial for replication, antibiotics like fluoroquinolones target different enzymes involved in managing DNA topology. *Joining of short DNA fragments* - The joining of Okazaki fragments on the lagging strand is catalyzed by **DNA ligase**. - This enzyme is not the primary target of antibiotics designed to broadly inhibit bacterial DNA replication by interfering with DNA gyrase or topoisomerase IV.

Question 41: A 54-year-old man presents with fever, abdominal pain, nausea, and bloody diarrhea. He says that his symptoms started 36 hours ago and have not improved. Past medical history is significant for a left-leg abscess secondary to an injury he sustained from a fall 4 days ago while walking his dog. He has been taking clindamycin for this infection. In addition, he has long-standing gastroesophageal reflux disease, managed with omeprazole. His vital signs include: temperature 38.5°C (101.3°F), respiratory rate 19/min, heart rate 90/min, and blood pressure 110/70 mm Hg. Which of the following is the best course of treatment for this patient’s most likely diagnosis?

A. Tetracycline
B. Ciprofloxacin
C. Trimethoprim-sulfamethoxazole
D. Erythromycin
E. Vancomycin (Correct Answer)

Explanation: ***Vancomycin*** - The patient's history of recent **clindamycin** use for an abscess, development of **fever, abdominal pain, nausea, and bloody diarrhea**, and use of **omeprazole** (a risk factor), strongly suggests **_Clostridioides difficile_ infection (CDI)**. - **Oral vancomycin** is a first-line treatment for **severe non-fulminant CDI**, which this patient's symptoms (fever, bloody diarrhea) are consistent with. *Tetracycline* - **Tetracycline** is typically used for bacterial infections like **chlamydia, Lyme disease, and rickettsial infections**; it is not effective against _C. difficile_. - It works by **inhibiting bacterial protein synthesis** but does not target the cell wall of _C. difficile_. *Ciprofloxacin* - **Ciprofloxacin**, a fluoroquinolone, is generally **contraindicated in CDI** as it can be a risk factor for developing the infection or exacerbate it due to disruption of gut flora. - While effective against many gram-negative bacteria, it has **no significant activity against _C. difficile_**. *Trimethoprim-sulfamethoxazole* - **Trimethoprim-sulfamethoxazole** is a combination antibiotic used for various bacterial infections, including **UTIs and some respiratory infections**. - It is **not effective against _C. difficile_** and is not recommended for its treatment. *Erythromycin* - **Erythromycin**, a macrolide, is effective against a range of bacterial infections including **atypical pneumonia and skin infections**. - It has **no role in the treatment of _C. difficile_ infection** and its use could potentially further disrupt the gut microbiome.

Question 42: An investigator is studying the chemical structure of antibiotics and its effect on bacterial growth. He has synthesized a simple beta-lactam antibiotic and has added a bulky side chain to the molecule that inhibits the access of bacterial enzymes to the beta-lactam ring. The synthesized drug will most likely be appropriate for the treatment of which of the following conditions?

A. Folliculitis (Correct Answer)
B. Nocardiosis
C. Atypical pneumonia
D. Erythema migrans
E. Otitis media

Explanation: ***Folliculitis*** - The bulky side chain provides **steric hindrance** that prevents **staphylococcal beta-lactamases** from accessing and degrading the **beta-lactam ring**. - This modification creates an **anti-staphylococcal penicillin** (similar to methicillin, nafcillin, or oxacillin), which is effective against **methicillin-sensitive *Staphylococcus aureus* (MSSA)**. - **Folliculitis** is most commonly caused by *S. aureus*, making this modified beta-lactam an appropriate treatment choice for MSSA-related folliculitis. - The bulky side chain specifically protects against the **penicillinase** (beta-lactamase) produced by staphylococci. *Otitis media* - Otitis media is commonly caused by beta-lactamase-producing organisms like *Haemophilus influenzae* and *Moraxella catarrhalis*. - However, the beta-lactamases produced by these gram-negative organisms are **not inhibited by bulky side chains** alone. - Treatment of beta-lactamase-producing *H. influenzae* and *M. catarrhalis* requires **beta-lactamase inhibitors** (such as clavulanic acid combined with amoxicillin), not steric hindrance. - The mechanism of protection differs: beta-lactamase inhibitors **suicide inhibitors** that bind to the enzyme, whereas bulky side chains provide **physical blocking**. *Nocardiosis* - Nocardiosis is caused by *Nocardia* species, which are **aerobic actinomycetes**. - These bacteria are typically treated with **sulfonamides** (trimethoprim-sulfamethoxazole) for prolonged periods. - Beta-lactam antibiotics are generally not first-line treatment, as *Nocardia* species often show intrinsic resistance or require specific antibiotic combinations. *Atypical pneumonia* - Atypical pneumonia is caused by organisms like *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae*, and *Legionella pneumophila*. - These organisms lack a **peptidoglycan cell wall**, which is the target of all **beta-lactam antibiotics**. - Beta-lactams (regardless of modifications) are completely ineffective against atypical pneumonia pathogens. - Treatment requires **macrolides** (azithromycin), **tetracyclines** (doxycycline), or **fluoroquinolones**. *Erythema migrans* - Erythema migrans is the characteristic rash of early **Lyme disease**, caused by *Borrelia burgdorferi*. - While *Borrelia* is sensitive to certain beta-lactam antibiotics (amoxicillin, ceftriaxone), it does **not produce beta-lactamases**. - The bulky side chain modification is unnecessary for treating *Borreria* infections, as there is no beta-lactamase to protect against. - Standard treatment uses doxycycline, amoxicillin, or ceftriaxone—not anti-staphylococcal penicillins.

Question 43: A 49-year-old woman comes to the physician because of a 4-month history of fatigue and recurrent pain in both of her wrists and her fingers. During this time, she has also had stiffness of her joints for about 80 minutes after waking up in the morning. Examination shows swelling and tenderness of the wrists and metacarpophalangeal joints bilaterally. Her serum erythrocyte sedimentation rate is 42 mm/h and rheumatoid factor is positive. Treatment is begun with a drug that results in decreased synthesis of deoxythymidine monophosphate. This mechanism is most similar to the mechanism of action of which of the following drugs?

A. Trimethoprim (Correct Answer)
B. Gentamicin
C. Sulfamethoxazole
D. Doxycycline
E. Azithromycin

Explanation: ***Trimethoprim*** - The patient has **rheumatoid arthritis** being treated with **methotrexate**, which inhibits **dihydrofolate reductase** leading to decreased **deoxythymidine monophosphate (dTMP)** synthesis - **Trimethoprim** also inhibits **dihydrofolate reductase** in bacteria, targeting the same enzyme in the folate metabolism pathway as methotrexate - This makes their mechanisms of action most similar among the options provided *Gentamicin* - Aminoglycoside antibiotic that inhibits bacterial protein synthesis by irreversibly binding to the **30S ribosomal subunit** - Mechanism is entirely different from inhibition of dTMP synthesis *Sulfamethoxazole* - Sulfonamide antibiotic that inhibits bacterial **dihydropteroate synthase** by competing with para-aminobenzoic acid (PABA) - While it targets the folate pathway, it acts **earlier** in the pathway than trimethoprim or methotrexate (before dihydrofolate reductase) *Doxycycline* - Tetracycline antibiotic that inhibits bacterial protein synthesis by reversibly binding to the **30S ribosomal subunit** - Does not involve the folate pathway or dTMP synthesis *Azithromycin* - Macrolide antibiotic that inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit** - Unrelated to dTMP synthesis or folate metabolism

Question 44: A 7-year-old girl is brought by her parents to her pediatrician's office for a persistent cough observed over the past month. She was diagnosed with cystic fibrosis 2 years ago and has been receiving chest physiotherapy regularly and the flu vaccine yearly. Her parents tell the pediatrician that their daughter has been coughing day and night for the past month, and produces thick, purulent, foul-smelling sputum. They are concerned because this is the first time such an episode has occurred. She has not had a fever, chills or any other flu-like symptoms. On examination, her blood pressure is 100/60 mm Hg, the pulse is 82/min, and the respiratory rate is 16/min. Breath sounds are reduced over the lower lung fields along with a presence of expiratory wheezing. Her sputum culture comes back positive for an aerobic, non-lactose fermenting, oxidase-positive, gram-negative bacillus. Which of the following prophylactic regimes should be considered after treating this patient for her current symptoms?

A. Oral trimethoprim-sulfamethoxazole
B. Oral amoxicillin/clavulanic acid
C. Oral ciprofloxacin
D. Inhaled levofloxacin
E. Inhaled tobramycin (Correct Answer)

Explanation: ***Inhaled tobramycin*** - The patient's symptoms (persistent cough, purulent sputum, reduced breath sounds, expiratory wheezing) coupled with a positive culture for an **aerobic, non-lactose fermenting, oxidase-positive, gram-negative bacillus** in a patient with cystic fibrosis (CF) strongly suggest a *Pseudomonas aeruginosa* infection. - **Inhaled tobramycin** is a recommended prophylactic regimen for CF patients with chronic *Pseudomonas aeruginosa* colonization to reduce exacerbations and preserve lung function after initial eradication therapy. *Oral trimethoprim-sulfamethoxazole* - This antibiotic is primarily used for infections caused by *Staphylococcus aureus*, *Haemophilus influenzae*, and *Pneumocystis jirovecii*, but not typically for *Pseudomonas aeruginosa* in CF. - While it has some activity against certain gram-negative bacteria, it is not the preferred prophylactic agent for *Pseudomonas* in CF due to resistance patterns and lack of efficacy compared to antipseudomonal agents. *Oral amoxicillin/clavulanic acid* - This combination antibiotic is effective against a broad spectrum of bacteria, including *Haemophilus influenzae* and *Moraxella catarrhalis*, but it does not have reliable activity against *Pseudomonas aeruginosa*. - It is not indicated for prophylactic use against *Pseudomonas* in CF patients. *Oral ciprofloxacin* - While oral ciprofloxacin is active against *Pseudomonas aeruginosa* and is sometimes used for acute exacerbations, chronic daily oral quinolone use is generally avoided for prophylaxis due to concerns about resistance development and significant side effects. - **Inhaled antibiotics** are preferred for chronic suppression in CF as they deliver high concentrations directly to the lungs, minimizing systemic side effects. *Inhaled levofloxacin* - Similar to other quinolones, inhaled levofloxacin can be used for *Pseudomonas* infections in CF. However, given the options, **inhaled tobramycin** has a more established and broader role as a first-line inhaled prophylactic option for *Pseudomonas* in CF. - Resistance patterns and individual patient response would guide the choice between different inhaled antibiotics, but tobramycin is a classic prophylactic agent in this setting.

Question 45: A 42-year-old man with chronic hepatitis C is admitted to the hospital because of jaundice and abdominal distention. He is diagnosed with decompensated liver cirrhosis, and treatment with diuretics is begun. Two days after admission, he develops abdominal pain and fever. Physical examination shows tense ascites and diffuse abdominal tenderness. Paracentesis yields cloudy fluid with elevated polymorphonuclear (PMN) leukocyte count. A drug with which of the following mechanisms is most appropriate for this patient's condition?

A. Free radical creation within bacterial cell
B. Inhibition of bacterial 50S subunit
C. Inhibition of bacterial RNA polymerase
D. Inhibition of bacterial peptidoglycan crosslinking (Correct Answer)
E. Inhibition of bacterial DNA gyrase

Explanation: ***Inhibition of bacterial peptidoglycan crosslinking*** - The patient's symptoms (fever, abdominal pain, diffuse tenderness, cloudy ascitic fluid with elevated PMN count) are highly suggestive of **spontaneous bacterial peritonitis (SBP)**, a common complication of decompensated cirrhosis. - The most appropriate treatment for SBP is **broad-spectrum antibiotics**, typically a third-generation cephalosporin like **cefotaxime** or **ceftriaxone**, which work by inhibiting bacterial peptidoglycan crosslinking in the cell wall (beta-lactam mechanism). - These agents provide excellent coverage against the common gram-negative enteric pathogens (especially *E. coli*) that cause SBP. *Free radical creation within bacterial cell* - This mechanism is characteristic of **nitroimidazoles** (e.g., metronidazole), which are effective against anaerobic bacteria and certain protozoa. - While anaerobes can occasionally be involved in secondary peritonitis, empiric treatment for SBP typically targets gram-negative enteric bacteria, for which nitroimidazoles are not first-line choices. *Inhibition of bacterial 50S subunit* - This mechanism is common to **macrolides** (e.g., azithromycin) and **lincosamides** (e.g., clindamycin). - These antibiotics are generally not first-line empiric treatment for SBP, which primarily requires coverage of gram-negative aerobes. *Inhibition of bacterial RNA polymerase* - This is the mechanism of action for **rifampin**, which is primarily used for tuberculosis and prophylaxis against certain bacterial meningitis (e.g., *N. meningitidis*). - Rifampin is not suitable as empiric monotherapy for SBP given the typical causative pathogens. *Inhibition of bacterial DNA gyrase* - This is the mechanism of **fluoroquinolones** (e.g., ciprofloxacin, levofloxacin), which inhibit DNA gyrase (topoisomerase II) and topoisomerase IV, preventing bacterial DNA replication. - Fluoroquinolones can be used for SBP treatment and prophylaxis, but third-generation cephalosporins remain the preferred first-line empiric therapy for acute SBP in most clinical guidelines.

Question 46: An 82-year-old man is brought to the emergency department because of severe pain and joint stiffness in his right knee. The pain started 3 days ago and has worsened despite acetaminophen intake. He has benign prostatic hyperplasia and hypertension. One week ago, he had a urinary tract infection and was treated with nitrofurantoin. He does not smoke or drink alcohol. His current medications include enalapril, hydrochlorothiazide, and tamsulosin. He appears to be in severe pain and has trouble moving his right knee. His temperature is 38.7°C (101.5°F), pulse is 92/min, and blood pressure is 135/90 mm Hg. Physical examination shows a swollen, erythematous, warm right knee; range of motion is limited by pain. Synovial fluid aspiration shows a yellow-green turbid fluid. Gram stain of the synovial aspirate shows numerous leukocytes and multiple gram-negative rods. An x-ray of the right knee shows no abnormalities. Which of the following is the most appropriate pharmacotherapy?

A. IV ceftazidime and gentamicin
B. IV cefepime (Correct Answer)
C. IV vancomycin and ceftazidime
D. IV vancomycin
E. IV nafcillin

Explanation: ***IV cefepime*** - This patient presents with **septic arthritis** due to **gram-negative rods**, likely originating from a recent **urinary tract infection** given his history of BPH. **Cefepime** is a **fourth-generation cephalosporin** with broad-spectrum activity against many gram-negative bacteria, including *Pseudomonas aeruginosa*, and provides excellent coverage for this suspected etiology. - The patient's presentation with **fever**, a **hot, swollen, painful joint**, and **turbid synovial fluid** with **numerous leukocytes** and **gram-negative rods** on Gram stain points to severe bacterial infection requiring empiric broad-spectrum intravenous antibiotic coverage targeting gram-negative organisms. *IV ceftazidime and gentamicin* - **Ceftazidime** is a **third-generation cephalosporin** with good activity against gram-negative bacteria, including *Pseudomonas*. However, adding **gentamicin**, an **aminoglycoside**, could increase the risk of **nephrotoxicity** in an elderly patient with potential underlying renal impairment due to hypertension and multiple medications, especially when a single agent like cefepime might suffice initially. - While this combination offers broad gram-negative coverage, **monotherapy with cefepime** is often preferred for empiric treatment of suspected gram-negative sepsis or osteomyelitis to minimize potential adverse effects and simplify treatment, especially in an elderly patient. *IV vancomycin and ceftazidime* - **Vancomycin** is primarily used for **gram-positive organisms**, particularly **MRSA**. While it addresses potential *Staphylococcus* infection if gram stain was equivocal or negative, the presence of **gram-negative rods** makes it less critical as an initial empiric therapy for this specific presentation. - The combination would provide very broad coverage, but the primary pathology involves gram-negative rods, making the inclusion of vancomycin less targeted than alternatives, and risking unnecessary antibiotic exposure while not optimally covering common UTI-related gram-negative pathogens as effectively as cefepime. *IV vancomycin* - **Vancomycin** provides excellent coverage for **methicillin-resistant *Staphylococcus aureus* (MRSA)** and other gram-positive organisms, but it has **no activity against gram-negative rods**. - Since the Gram stain specifically shows **gram-negative rods**, vancomycin monotherapy would be ineffective against the identified pathogen and is therefore an inappropriate choice. *IV nafcillin* - **Nafcillin** is a **penicillinase-resistant penicillin** primarily used for **methicillin-sensitive *Staphylococcus aureus* (MSSA)** and other gram-positive infections. - It has **no significant activity against gram-negative rods**, making it an ineffective treatment option for an infection caused by gram-negative organisms.

Question 47: A 64-year-old woman with a past medical history of poorly managed diabetes presents to the emergency department with nausea and vomiting. Her symptoms started yesterday and have been progressively worsening. She is unable to eat given her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 115/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for left-sided costovertebral angle tenderness, and urinalysis demonstrates bacteriuria and pyuria. The patient is admitted to the hospital and started on IV ceftriaxone. On day 3 of her hospital stay she is afebrile, able to eat and drink, and feels better. Which of the following antibiotic regimens should be started or continued as an outpatient upon discharge?

A. Amoxicillin
B. Nitrofurantoin
C. Ciprofloxacin
D. Ceftriaxone
E. Trimethoprim-sulfamethoxazole (Correct Answer)

Explanation: ***Trimethoprim-sulfamethoxazole*** - This patient presents with **acute pyelonephritis**, indicated by fever, CVA tenderness, bacteriuria, and pyuria, requiring a 7-14 day course of treatment. - After 3 days of IV ceftriaxone with clinical improvement, **step-down to oral therapy** is appropriate. - **Trimethoprim-sulfamethoxazole** is a first-line oral agent for completing treatment of uncomplicated pyelonephritis and is preferred when **local resistance rates are <20%** and no specific resistance data is available. - It achieves adequate concentrations in renal tissue and is cost-effective for outpatient therapy. *Amoxicillin* - **Amoxicillin** is not recommended for pyelonephritis due to **high resistance rates** among common uropathogens like *E. coli* (often >30%). - It does not achieve adequate concentrations in the renal parenchyma to effectively treat **upper urinary tract infections**. *Nitrofurantoin* - **Nitrofurantoin** is concentrated in the bladder and is highly effective for **lower urinary tract infections (cystitis)**. - It is **contraindicated for pyelonephritis** because it does not reach therapeutic levels in the renal parenchyma or bloodstream. - Additionally, it should be avoided in patients with impaired renal function. *Ciprofloxacin* - **Ciprofloxacin** is also a first-line oral agent for pyelonephritis and would be an appropriate choice for step-down therapy. - However, when no culture or susceptibility data is available, **TMP-SMX is generally preferred** as an initial oral choice due to concerns about promoting fluoroquinolone resistance and potential adverse effects (tendonitis, QT prolongation, C. difficile). - Fluoroquinolones are particularly valuable when reserved for cases with known resistance to other agents or specific patient contraindications. *Ceftriaxone* - **Ceftriaxone** is an IV third-generation cephalosporin used for initial empiric treatment of acute pyelonephritis in hospitalized patients. - Once the patient is **clinically stable, afebrile, and tolerating oral intake**, transitioning to oral therapy is standard practice. - Continued IV therapy as an outpatient is unnecessarily invasive and costly when oral options are effective.

Question 48: A 51-year-old man presents to his physician’s office with a persistent fever that started a week ago. He says that his temperature ranges between 37.8–39.1°C (100–102.5°F). He has also had a persistent cough productive of foul-smelling sputum. There is no significant medical history to report, but he does mention that he has been suffering from dental caries for the last month. He has been meaning to see his dentist but has been too busy to do so. His blood pressure is 120/70 mm Hg, the respirations are 18/min, and the temperature is 38.5°C (101.3°F). His oxygen saturation is 90% on room air. On examination, he has decreased breath sounds in his right lung field with the presence of soft inspiratory crackles. He is sent to the laboratory for sputum analysis and chest imaging. Based on his history and physical examination, which of the following would be the next best step in the management of this patient?

A. Bronchoscopy
B. Surgical drainage
C. Hospital admission (Correct Answer)
D. Metronidazole
E. Clindamycin

Explanation: ***Hospital admission*** - This patient presents with signs and symptoms suggestive of **aspiration pneumonia** with possible **lung abscess formation**, indicated by persistent fever, foul-smelling sputum, decreased breath sounds, and a history of dental caries. His **low oxygen saturation (90% on room air)** is a significant finding requiring close monitoring and immediate intervention in an inpatient setting. - Given the severity of his respiratory distress and the potential for rapid deterioration, **hospital admission** is necessary for intravenous antibiotics, respiratory support, and further diagnostic workup, such as a chest CT scan to confirm a lung abscess. *Bronchoscopy* - While bronchoscopy can be used for diagnosis and drainage of a lung abscess, it is typically performed *after* initial stabilization and empiric antibiotic therapy in a hospitalized patient. - It is not the *immediate* next best step given the patient's acute respiratory compromise. *Surgical drainage* - Surgical drainage is a more invasive procedure and is reserved for cases where medical management with antibiotics fails, or when there is a very large or complicated abscess. - It is not the initial treatment strategy for a suspected lung abscess. *Metronidazole* - Metronidazole is an antibiotic that covers anaerobic bacteria, which are commonly implicated in aspiration pneumonia and lung abscesses. - However, it is usually used in combination with other antibiotics (e.g., a beta-lactam) and would be initiated *after* hospital admission and establishment of IV access. *Clindamycin* - Clindamycin is an effective antibiotic against anaerobic bacteria and is a common choice for lung abscesses. - Similar to metronidazole, it would be administered *after* hospital admission as part of the treatment regimen, not as the immediate next step in management.

Question 49: A 37-year-old man with a history of IV drug use presents to the ED with complaints of fevers, chills, and malaise for one week. He admits to recently using IV and intramuscular heroin. Vital signs are as follows: T 40.0 C, HR 120 bpm, BP 110/68 mmHg, RR 14, O2Sat 98%. Examination reveals a new systolic murmur that is loudest at the lower left sternal border. Initial management includes administration of which of the following regimens?

A. IV Vancomycin, IV ceftriaxone, IV fluconazole
B. IV Vancomycin, IV ceftriaxone (Correct Answer)
C. IV Vancomycin, IV levofloxacin
D. IV Vancomycin
E. IV Vancomycin, IV gentamicin, PO rifampin

Explanation: ***IV Vancomycin, IV ceftriaxone*** - The patient's history of **IV drug use**, fevers, chills, new systolic murmur, and likely **tricuspid valve involvement** (murmur loudest at the lower left sternal border) strongly suggest **infective endocarditis**. - The empiric regimen for suspected endocarditis in an IV drug user should cover **methicillin-resistant _Staphylococcus aureus_ (MRSA)** with **vancomycin** and gram-negative organisms with a **third-generation cephalosporin** like **ceftriaxone**. - This combination provides broad coverage for the most common pathogens in native valve endocarditis among IV drug users, including MRSA, streptococci, and many gram-negative organisms. *IV Vancomycin, IV ceftriaxone, IV fluconazole* - While vancomycin and ceftriaxone are appropriate, **fluconazole** is an antifungal and is generally not indicated for empiric treatment of bacterial endocarditis unless there's a strong suspicion of **fungal infection**. - Fungal endocarditis is less common and usually requires prolonged treatment with specific antifungals, often alongside surgical intervention. *IV Vancomycin, IV levofloxacin* - **Levofloxacin** is a fluoroquinolone that covers a broad spectrum of bacteria but is not the preferred empiric agent for gram-negative coverage in suspected endocarditis in IV drug users due to concerns about resistance and lack of superior coverage compared to third-generation cephalosporins. - **Ceftriaxone** provides better coverage for common gram-negative pathogens associated with endocarditis among IV drug users in this context. *IV Vancomycin, IV gentamicin, PO rifampin* - **Gentamicin** is an aminoglycoside that provides effective gram-negative coverage and is often used in combination therapy for endocarditis, but **rifampin** is typically reserved for prosthetic valve endocarditis or refractory cases due to its risk of drug interactions and resistance development. - **Oral rifampin** may not be appropriate for initial aggressive treatment in an acutely ill patient with suspected acute endocarditis, where IV therapy is preferred. *IV Vancomycin* - While **vancomycin** is crucial for covering **MRSA** which is common in IV drug users, it alone does not provide adequate coverage for potential **gram-negative pathogens** that can also cause endocarditis in this population. - **Multidrug empiric therapy** is essential to cover a broad range of likely pathogens causing endocarditis in IV drug users, especially with severe symptoms.

Question 50: A 37-year-old woman with a history of anorectal abscesses complains of pain in the perianal region. Physical examination reveals mild swelling, tenderness, and erythema of the perianal skin. She is prescribed oral ampicillin and asked to return for follow-up. Two days later, the patient presents with a high-grade fever, syncope, and increased swelling. Which of the following would be the most common mechanism of resistance leading to the failure of antibiotic therapy in this patient?

A. Intrinsic absence of a target site for the drug
B. Use of an altered metabolic pathway
C. Production of beta-lactamase enzyme (Correct Answer)
D. Altered structural target for the drug
E. Drug efflux pump

Explanation: ***Production of beta-lactamase enzyme*** - The patient's symptoms of a rapidly worsening infection despite ampicillin treatment suggest the presence of a **beta-lactamase producing organism**. Ampicillin is a **beta-lactam antibiotic** that is inactivated by these enzymes. - Anorectal abscesses and rapidly progressing soft tissue infections are often caused by **polymicrobial flora**, including staphylococci and enterococci, many of which can produce **beta-lactamase**. *Intrinsic absence of a target site for the drug* - While some bacteria inherently lack the target site for certain drugs (e.g., mycoplasma lacking a cell wall, thus being resistant to beta-lactams), this is less likely to be the **most common mechanism of acquired resistance** leading to treatment failure in a typical perianal infection. - The rapid progression and failed initial treatment point towards an **acquired mechanism of resistance** rather than an intrinsic one. *Use of an altered metabolic pathway* - This mechanism, such as altered **folate synthesis pathways** in resistance to trimethoprim-sulfamethoxazole, is less common as the primary mechanism for ampicillin resistance. - Ampicillin's mechanism of action primarily targets the **bacterial cell wall**, not a metabolic pathway in the same way. *Altered structural target for the drug* - This involves modifications to the **penicillin-binding proteins (PBPs)**, which are the targets of beta-lactam antibiotics like ampicillin. While a valid mechanism (e.g., in MRSA), the **production of beta-lactamase** is generally a more widespread and common cause of ampicillin failure, especially in infections involving mixed flora from the perianal region. - Given the abrupt failure of ampicillin, **beta-lactamase inactivation** is a more immediate and common cause than a rapid mutational change in PBPs. *Drug efflux pump* - **Efflux pumps** actively remove antibiotics from the bacterial cell, contributing to resistance against various drug classes. - While efflux pumps can play a role, the dominant mechanism for resistance to **ampicillin** in many common perianal pathogens is the **enzymatic degradation by beta-lactamases**.

Question 51: A 26-year-old immigrant from Mexico presents to your clinic for a physical. He tells you that several weeks ago, he noticed a lesion on his penis which went away after several weeks. It was nontender and did not bother him. He currently does not have any complaints. His temperature is 97.9°F (36.6°C), blood pressure is 139/91 mmHg, pulse is 87/min, respirations are 14/min, and oxygen saturation is 98% on room air. Physical exam is unremarkable and shows no evidence of any rash. A VDRL and FTA-ABS test are both positive. What is the most appropriate management of this patient?

A. Penicillin (Correct Answer)
B. Doxycycline
C. No treatment indicated
D. Acyclovir
E. Azithromycin and ceftriaxone

Explanation: ***Penicillin*** - The patient's history of a **painless genital ulcer** that resolved spontaneously, followed by positive VDRL and FTA-ABS tests, is classic for **syphilis**. Given the VDRL and FTA-ABS are both positive, this indicates a current or treated syphilis infection. - **Penicillin G** is the drug of choice for all stages of syphilis; the specific formulation (e.g., benzathine penicillin G) and duration depend on the stage of infection. *Doxycycline* - **Doxycycline** can be used as an alternative treatment for syphilis in patients with a **penicillin allergy**. - However, it is not the first-line treatment and there is no indication of a penicillin allergy in this patient. *No treatment indicated* - The positive VDRL and FTA-ABS tests definitively confirm an active or recently treated syphilis infection, requiring **treatment**. - Leaving syphilis untreated can lead to severe complications, including **neurosyphilis** and **cardiovascular syphilis**. *Acyclovir* - **Acyclovir** is an antiviral medication used to treat **herpes simplex virus (HSV)** infections, which cause painful genital ulcers, not the painless chancre seen in syphilis. - It has no efficacy against the bacterial pathogen *Treponema pallidum* that causes syphilis. *Azithromycin and ceftriaxone* - The combination of **azithromycin and ceftriaxone** is typically used to treat uncomplicated **gonorrhea** and **chlamydia** simultaneously. - While these are common sexually transmitted infections, they do not cause the painless chancre or result in the serological findings (positive VDRL and FTA-ABS) characteristic of syphilis.

Question 52: A 51-year-old man comes to the physician because of a 1-day history of progressive pain, excessive tearing, and blurry vision of his right eye. He first noticed his symptoms last evening while he was watching a movie at a theater. His left eye is asymptomatic. He wears contact lenses. He has atopic dermatitis treated with topical hydrocortisone. His temperature is 37°C (98.6°F), pulse is 85/min, and blood pressure is 135/75 mm Hg. Examination shows a visual acuity in the left eye of 20/25 and 20/40 in the right eye. The right eye shows conjunctival injection and an edematous cornea with a whitish exudate at the bottom of the anterior chamber. Fluorescein staining shows a round corneal infiltrate. Which of the following is the most appropriate pharmacotherapy?

A. Topical prednisolone
B. Topical ganciclovir
C. Topical ketorolac and artificial tears
D. Topical timolol and pilocarpine
E. Topical ofloxacin (Correct Answer)

Explanation: ***Topical ofloxacin*** - The patient's symptoms (pain, tearing, blurry vision in one eye, conjunctival injection, edematous cornea, whitish exudate in the anterior chamber, and a round corneal infiltrate with fluorescein staining) are highly suggestive of **bacterial keratitis**, likely due to contact lens use. - **Topical fluoroquinolones** like ofloxacin are the first-line treatment for bacterial keratitis due to their broad-spectrum activity and excellent corneal penetration. *Topical prednisolone* - **Corticosteroids** are generally contraindicated in active infectious keratitis, especially bacterial, viral, or fungal infections, as they can worsen the infection and delay healing. - While sometimes used in severe, non-infectious inflammatory conditions, their use here would be inappropriate and potentially harmful. *Topical ganciclovir* - **Ganciclovir** is an antiviral agent used to treat herpes simplex keratitis (HSK) or other viral keratitis. - The clinical presentation with a **round corneal infiltrate** is more typical of bacterial keratitis, whereas HSK often presents with a characteristic **dendritic ulcer** pattern, which is not described. *Topical ketorolac and artificial tears* - **Ketorolac** is a non-steroidal anti-inflammatory drug (NSAID) which can help with pain and inflammation but does not address the underlying bacterial infection. - **Artificial tears** provide symptomatic relief for dry eyes but have no role in treating infectious keratitis and would not resolve the patient's condition. *Topical timolol and pilocarpine* - **Timolol** is a beta-blocker that reduces intraocular pressure, and **pilocarpine** is a miotic agent and also reduces intraocular pressure, used primarily in glaucoma. - These medications are not indicated for the treatment of infectious keratitis and would not address the bacterial cause of the patient's symptoms.

Question 53: A 36-year-old woman comes to the emergency department because of an itchy lesion on her skin. The rash developed shortly after she took an antibiotic for a urinary tract infection. Her temperature is 37.5°C (99.3°F), pulse is 99/min, and blood pressure is 100/66 mm Hg. Physical examination shows swelling of the face and raised, erythematous plaques on her trunk and extremities. Which of the following is the most likely cause of this patient's current condition?

A. Deficiency of C1 inhibitor
B. Secretion of cytokines by T cells
C. Deposition of immune complexes
D. Release of a vasoactive amine (Correct Answer)
E. Activation of complement cascade

Explanation: ***Release of a vasoactive amine*** - The rapid onset of **urticaria (itchy, erythematous plaques)** and **angioedema (facial swelling)** after antibiotic exposure points to a **Type I hypersensitivity (IgE-mediated) reaction**. - This reaction is characterized by the release of **histamine** and other vasoactive amines from mast cells and basophils, leading to capillary dilation, increased vascular permeability, and the observed symptoms. *Deficiency of C1 inhibitor* - A deficiency in **C1 inhibitor** causes **hereditary angioedema**, which typically presents with recurrent episodes of swelling but **without urticaria or itching**, as bradykinin, not histamine, is the primary mediator. - The episodes are often triggered by trauma or stress and are not typically associated with drug-induced allergic reactions in this manner. *Secretion of cytokines by T cells* - Secretion of cytokines by T cells (e.g., in a **Type IV hypersensitivity reaction**) generally causes a **delayed-type hypersensitivity**, manifesting as contact dermatitis or drug rash that appears days after exposure. - This mechanism would not explain the rapid onset of urticaria and angioedema observed just after antibiotic intake. *Deposition of immune complexes* - **Immune complex deposition** (a **Type III hypersensitivity reaction**) can cause conditions like serum sickness or vasculitis, which typically present with fever, arthralgia, and a rash that is often purpuric or palpable, not an itchy, transient urticarial rash. - The onset of symptoms in Type III reactions is usually hours to days after exposure, not immediately post-ingestion. *Activation of complement cascade* - While complement activation can occur in various immune reactions, it is primarily central to **Type II (cytotoxic)** and **Type III (immune complex)** hypersensitivity. - Although it plays a role in enhancing inflammation, it is not the primary mechanism responsible for the immediate release of vasoactive amines in an **IgE-mediated allergic reaction** leading to urticaria and angioedema.

Question 54: Six days after undergoing an elective hip replacement surgery, a 79-year-old man develops dysuria, flank pain, and fever. His temperature is 38.5°C (101.3°F). Examination shows marked tenderness in the right costovertebral area. Treatment with an antibiotic is begun, but his symptoms do not improve. Further evaluation shows that the causal organism produces an enzyme that inactivates the antibiotic via phosphorylation. An agent from which of the following classes of antibiotics was most likely administered?

A. Macrolides
B. Tetracyclines
C. Aminoglycosides (Correct Answer)
D. Glycopeptides
E. Fluoroquinolones

Explanation: ***Aminoglycosides*** - **Aminoglycosides** are commonly inactivated by bacterial enzymes through **phosphorylation**, acetylation, or adenylation, leading to resistance. - The patient's lack of improvement despite antibiotic treatment and the mechanism of inactivation point towards this class of antibiotics. *Macrolides* - **Macrolide resistance** typically involves mechanisms such as modification of the ribosomal binding site (e.g., methylation), drug efflux pumps, or enzymatic inactivation by esterases, not phosphorylation. - While macrolides can treat various infections, their inactivation mechanism is different from what is described. *Tetracyclines* - **Tetracycline resistance** is primarily mediated by bacterial efflux pumps that actively transport the antibiotic out of the cell, or by ribosomal protection proteins that interfere with drug binding. - **Enzymatic inactivation via phosphorylation** is not a characteristic resistance mechanism for tetracyclines. *Glycopeptides* - **Glycopeptide resistance**, particularly to vancomycin, is mainly associated with alterations in the cell wall precursor target (e.g., D-Ala-D-Lac modification), which prevents the antibiotic from binding. - This mechanism is distinct from enzymatic phosphorylation of the antibiotic molecule itself. *Fluoroquinolones* - **Fluoroquinolone resistance** primarily arises from mutations in the genes encoding bacterial DNA gyrase and topoisomerase IV, or via efflux pumps. - There is no significant mechanism of resistance involving direct enzymatic phosphorylation of fluoroquinolone drugs.

Question 55: A 51-year-old man with alcohol use disorder comes to the physician because of a fever and productive cough. An x-ray of the chest shows a right lower lobe consolidation and a diagnosis of aspiration pneumonia is made. The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit. Which of the following drugs was most likely prescribed?

A. Ceftriaxone
B. Doxycycline
C. Metronidazole
D. Clindamycin (Correct Answer)
E. Azithromycin

Explanation: ***Clindamycin*** - **Clindamycin** is a lincosamide antibiotic that **blocks peptide transfer** by binding to the **50S ribosomal subunit**, inhibiting bacterial protein synthesis. - It is a highly effective treatment for **aspiration pneumonia** due to its excellent activity against the **anaerobic bacteria** commonly found in oral flora, which are the primary pathogens in this condition. *Ceftriaxone* - **Ceftriaxone** is a third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to **penicillin-binding proteins**, not the 50S ribosomal subunit. - While it has broad-spectrum activity, it is typically used for community-acquired pneumonia and is less effective against the **anaerobic organisms** predominant in aspiration pneumonia. *Doxycycline* - **Doxycycline** is a tetracycline antibiotic that binds to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. - While effective against some respiratory pathogens, it is not the first-line choice for **aspiration pneumonia** as its anaerobic coverage is insufficient. *Metronidazole* - **Metronidazole** acts by forming **cytotoxic compounds** that damage bacterial DNA after reduction by anaerobic enzymes, rather than binding to ribosomal subunits. - While effective against many **anaerobes**, it is often used in combination with other antibiotics for aspiration pneumonia, and its mechanism of action is distinct from that described. *Azithromycin* - **Azithromycin** is a macrolide antibiotic that also binds to the **50S ribosomal subunit**, but it **inhibits translocation** of the growing peptide chain, not primarily peptide transfer. - While used for community-acquired pneumonia, its coverage for **oropharyngeal anaerobes** can be inconsistent, making clindamycin a more reliable choice for aspiration pneumonia.

Question 56: A 37-year-old man previously treated with monotherapy for latent tuberculosis develops new-onset cough, night sweats and fever. He produces a sputum sample that is positive for acid-fast bacilli. Resistance testing of his isolated bacteria finds a mutation in the DNA-dependent RNA polymerase. To which of the following antibiotics might this patient's infection be resistant?

A. Isoniazid
B. Rifampin (Correct Answer)
C. Pyrazinamide
D. Streptomycin
E. Ethambutol

Explanation: **Rifampin is correct** - A mutation in the **DNA-dependent RNA polymerase** gene (*rpoB*) is the primary mechanism of resistance to **rifampin**. - **Rifampin** specifically targets bacterial **RNA polymerase**, inhibiting RNA synthesis. *Isoniazid is incorrect* - Resistance to **isoniazid** is typically associated with mutations in the **katG** gene (encoding catalase-peroxidase) or the **inhA** gene (involved in mycolic acid synthesis). - It does not directly affect **DNA-dependent RNA polymerase**. *Pyrazinamide is incorrect* - Resistance to **pyrazinamide** is primarily linked to mutations in the **pncA** gene, which encodes pyrazinamidase, an enzyme required to activate pyrazinamide. - This drug's mechanism of action and resistance pathways are unrelated to **RNA polymerase**. *Streptomycin is incorrect* - Resistance to **streptomycin**, an aminoglycoside, primarily involves mutations in the **rrs** gene (16S rRNA) or the **rpsL** gene (ribosomal protein S12). - It works by inhibiting bacterial protein synthesis and is not directly related to **RNA polymerase**. *Ethambutol is incorrect* - Resistance to **ethambutol** is mainly due to mutations in the **embB** gene, which encodes arabinosyl transferases involved in arabinogalactan synthesis in the cell wall. - Its mechanism of action involves inhibiting cell wall synthesis, not **RNA polymerase**.

Question 57: A 42-year-old homeless man presents to the emergency department complaining of pain in his right knee and fever. The patient is having difficulty walking and looks visibly uncomfortable. On examination, he is disheveled but his behavior is not erratic. The patient’s right knee is erythematous, edematous, and warm, with evidence of a 3 cm wound that is weeping purulent fluid. The patient has a decreased range of motion secondary to pain and swelling. The wound is cultured and empiric antibiotic therapy is initiated. Four minutes into the patient’s antibiotic therapy, he develops a red, pruritic rash on his face and neck. What is the most likely antibiotic this patient is being treated with?

A. Gentamicin
B. Linezolid
C. Penicillin G
D. Erythromycin
E. Vancomycin (Correct Answer)

Explanation: ***Vancomycin*** - The rapid development of a **red, pruritic rash** on the face and neck shortly after starting antibiotic therapy for a systemic infection (likely **septic arthritis** given the symptoms) is highly characteristic of **Red Man Syndrome**. - **Red Man Syndrome** is a pseudoallergic reaction caused by rapid infusion of **vancomycin**, leading to **histamine release**. *Gentamicin* - **Gentamicin** is an aminoglycoside antibiotic used for gram-negative infections, but it is not typically associated with a rapid-onset facial rash. - Its primary adverse effects include **ototoxicity** and **nephrotoxicity**, which develop with prolonged use rather than acute infusion. *Linezolid* - **Linezolid** is an oxazolidinone antibiotic primarily used for resistant gram-positive bacteria like MRSA. - While it can cause side effects like **myelosuppression** and **serotonin syndrome** (if co-administered with serotonergic drugs), it does not typically cause a rapid, prominent facial rash. *Penicillin G* - **Penicillin G** is a beta-lactam antibiotic that can cause allergic reactions, but these are typically **IgE-mediated hypersensitivity reactions** (e.g., anaphylaxis, urticaria, angioedema) and less commonly present as a specific "red man" flush. - The rash associated with penicillin allergy is usually a more widespread **maculopapular rash** or urticaria, not localized to the face and neck in this specific fashion minutes after administration. *Erythromycin* - **Erythromycin** is a macrolide antibiotic whose common side effects include **gastrointestinal upset** (e.g., nausea, vomiting, abdominal pain) and QT prolongation. - It is not known to cause a rapid-onset, pruritic facial rash like the one described.

Question 58: A 26-year-old African American woman presents to the clinic with burning upon urination. The patient describes increased frequency, urgency, and a painful sensation at the urethra when urinating for the past 3 days. She also reports increased vaginal discharge and abnormal odor during the same time. The patient denies fever, flank pain, or hematuria (though the patient does report a dark brown color of the urine). Her past medical history is significant for Crohn disease that is controlled with sulfasalazine. Vital signs are within normal limits. What is the definitive treatment of the described condition?

A. Surgery
B. IV ceftriaxone
C. Increase in sulfasalazine dose
D. IM ceftriaxone and oral azithromycin (Correct Answer)
E. Bactrim

Explanation: ***IM ceftriaxone and oral azithromycin*** - This combination is the recommended treatment for **gonorrhea (IM ceftriaxone)** and presumptive or confirmed **chlamydia (oral azithromycin)**, which are common causes of urethritis and cervicitis, fitting the patient's symptoms of dysuria, frequency, urgency, and vaginal discharge. - The patient's symptoms are suggestive of a **sexually transmitted infection (STI)** causing urethritis and cervicitis, rather than a typical uncomplicated urinary tract infection (UTI) due to the presence of vaginal discharge and odor. - The **dark brown urine** is likely due to **sulfasalazine**, which commonly causes orange-brown discoloration of urine and body fluids, not hematuria. *Surgery* - Surgery is typically reserved for **complications** of STIs or UTIs, such as abscesses or structural abnormalities, which are not indicated by the patient's current presentation. - While Crohn disease can sometimes lead to fistulas that might require surgery, the described urinary symptoms and vaginal discharge point more directly to an infection rather than a primary surgical issue. *IV ceftriaxone* - **Intravenous (IV) ceftriaxone** is used in cases of severe or disseminated infections, such as **gonococcal bacteremia** or **meningitis**, or when oral treatment is not feasible. - The patient's current presentation does not suggest a severe or life-threatening infection requiring IV administration; intramuscular (IM) administration is sufficient for uncomplicated urogenital gonorrhea. *Increase in sulfasalazine dose* - **Sulfasalazine** is an anti-inflammatory drug used to manage **Crohn's disease** and will not treat bacterial infections causing urethritis or cervicitis. - Increasing its dose would not address the patient's symptoms of dysuria, frequency, urgency, or vaginal discharge, as these are infectious in nature. *Bactrim* - **Bactrim (trimethoprim-sulfamethoxazole)** is a common antibiotic for **uncomplicated UTIs** caused by bacteria like E. coli. - It is not effective against *Neisseria gonorrhoeae* and is showing increasing resistance against *Chlamydia trachomatis*, making it an inappropriate choice for suspected STIs.

Question 59: A 46-year-old man presents to his primary care provider for an ulcerating skin lesion on his leg for the past week. He says that the week prior he slipped while hiking and scraped his left leg. Over the course of the next week, he noticed redness and swelling of the scraped area and the development of a nodule that eventually ulcerated. On exam, his temperature is 99.5°F (37.5°C), blood pressure is 136/92 mmHg, pulse is 88/min, and respirations are 12/min. Over his left lateral leg is an erythematous patch with a 2-cm nodule with central ulceration. Staining of a sample from the nodule demonstrates gram-positive organisms that are also weakly acid-fast. Morphologically, the organism appears as branching filaments. Which of the following should be used to treat this infection?

A. Streptomycin
B. Clindamycin
C. Doxycycline
D. Penicillin
E. Trimethoprim-sulfamethoxazole (Correct Answer)

Explanation: ***Trimethoprim-sulfamethoxazole*** - The patient's symptoms (nodule on the leg after skin trauma, progressing to ulceration) and the microbiology findings (gram-positive, weakly acid-fast, branching filaments) are highly suggestive of a **Nocardia infection**. - **Trimethoprim-sulfamethoxazole (TMP-SMX)** is the antimicrobial agent of choice for treating Nocardiosis, including both cutaneous and disseminated disease. - Treatment typically requires prolonged therapy (3-12 months depending on severity and immune status). *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily used to treat **tuberculosis** and some other severe bacterial infections. - It is not considered first-line therapy for Nocardia infections. *Clindamycin* - **Clindamycin** is effective against many gram-positive bacteria and anaerobes. - However, it is not the preferred treatment for **Nocardia** infections, which have a distinct susceptibility profile. *Doxycycline* - **Doxycycline** is a broad-spectrum tetracycline antibiotic often used for atypical infections, skin infections, and Lyme disease. - While it may have some activity against Nocardia, it is not the **first-line agent** for severe or localized Nocardiosis. - Alternative agents for TMP-SMX-allergic patients or severe disease include imipenem, amikacin, or linezolid. *Penicillin* - **Penicillin** is effective against a wide range of gram-positive bacteria, but **Nocardia species** are typically resistant to penicillin. - The branching filament morphology characteristic of Nocardia makes penicillin an inappropriate choice.

Question 60: A 67-year-old man presents to the emergency department for altered mental status. The patient is a member of a retirement community and was found to have a depressed mental status when compared to his baseline. The patient has a past medical history of Alzheimer dementia and diabetes mellitus that is currently well-controlled. His temperature is 103°F (39.4°C), blood pressure is 157/108 mmHg, pulse is 110/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for a somnolent elderly man who is non-verbal; however, his baseline status is unknown. Musculoskeletal exam of the patient’s lower extremities causes him to recoil in pain. Head and neck exam reveals a decreased range of motion of the patient's neck. Flexion of the neck causes discomfort in the patient. No lymphadenopathy is detected. Basic labs are ordered and a urine sample is collected. Which of the following is the best next step in management?

A. Ceftriaxone and vancomycin
B. CT scan of the head
C. Ceftriaxone, vancomycin, ampicillin, and steroids (Correct Answer)
D. Ceftriaxone, vancomycin, and ampicillin
E. Trimethoprim-sulfamethoxazole

Explanation: ***Ceftriaxone, vancomycin, ampicillin, and steroids*** - The patient presents with **fever**, **altered mental status**, and **nuchal rigidity**, highly suggestive of **bacterial meningitis**. - Per **IDSA guidelines**, empiric treatment for bacterial meningitis in adults ≥50 years includes: **dexamethasone** (given before or with the first dose of antibiotics) + **ceftriaxone** + **vancomycin** + **ampicillin**. - **Dexamethasone** reduces inflammation, mortality, and neurological complications, especially in pneumococcal meningitis. - This regimen provides broad-spectrum coverage: **_Streptococcus pneumoniae_** (ceftriaxone, vancomycin), **_Neisseria meningitidis_** (ceftriaxone), and **_Listeria monocytogenes_** (ampicillin). *Ceftriaxone, vancomycin, and ampicillin* - While this provides appropriate antibiotic coverage for the likely pathogens in elderly patients with meningitis, it is **incomplete** without steroids. - **Dexamethasone should be administered before or with the first dose of antibiotics**, not delayed or omitted. - Omitting steroids increases the risk of adverse neurological outcomes. *Trimethoprim-sulfamethoxazole* - This antibiotic is primarily used for urinary tract infections, certain skin infections, and **_Pneumocystis jirovecii_ pneumonia**. - It does not provide adequate coverage for the common bacterial causes of meningitis, nor does it achieve sufficient CNS penetration for empiric treatment. *Ceftriaxone and vancomycin* - This combination is appropriate for meningitis in younger adults (< 50 years). - However, in older adults (≥ 50 years), there is an increased risk of **_Listeria monocytogenes_** infection, which this regimen does not cover. - Additionally, steroids are missing from this regimen. *CT scan of the head* - While a CT scan of the head is often performed to rule out **mass effect** or **contraindications to lumbar puncture** (e.g., focal neurological deficits, papilledema), it should **not delay the administration of empiric antibiotics and steroids**. - In suspected bacterial meningitis, treatment should be initiated immediately; imaging can be performed afterward if needed.

Question 61: A 31-year-old female with a bacterial infection is prescribed a drug that binds the dipeptide D-Ala-D-Ala. Which of the following drugs was this patient prescribed?

A. Polymyxin B
B. Nalidixic acid
C. Chloramphenicol
D. Vancomycin (Correct Answer)
E. Penicillin

Explanation: ***Vancomycin*** - **Vancomycin** is a glycopeptide antibiotic that directly binds to the **D-Ala-D-Ala** terminus of peptidoglycan precursors. - This binding prevents the **transpeptidation** and **transglycosylation** steps required for bacterial cell wall synthesis, leading to cell lysis. *Polymyxin B* - **Polymyxins** are **cationic detergents** that disrupt the integrity of the bacterial **outer membrane** in Gram-negative bacteria. - They bind to **lipopolysaccharide (LPS)**, causing increased permeability and leakage of intracellular components, but do not target D-Ala-D-Ala. *Nalidixic acid* - **Nalidixic acid** is a **quinolone antibiotic** that inhibits bacterial **DNA gyrase (topoisomerase II)** and **topoisomerase IV**. - Its mechanism of action involves preventing DNA replication and transcription, not cell wall synthesis or D-Ala-D-Ala binding. *Chloramphenicol* - **Chloramphenicol** is an antibiotic that inhibits bacterial **protein synthesis** by binding to the **50S ribosomal subunit**. - It prevents the formation of **peptide bonds** by inhibiting peptidyl transferase, an entirely different target from D-Ala-D-Ala in the cell wall. *Penicillin* - **Penicillin** is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to and inactivating **penicillin-binding proteins (PBPs)**. - PBPs are **transpeptidases** involved in cross-linking peptidoglycan, but penicillin does not directly bind to the D-Ala-D-Ala substrate itself; instead, it prevents the enzymes from using it.

Question 62: A 42-year-old man with hypertension and type 2 diabetes mellitus is admitted to the hospital because of swelling and redness of the left leg for 3 days. He has chills and malaise. He is treated with intravenous clindamycin for 7 days. On the 8th day at the hospital, he has profuse, foul-smelling, and watery diarrhea. He has nausea and intermittent abdominal cramping. His temperature is 38°C (100.4°F), pulse is 97/min, and blood pressure is 110/78 mm Hg. Bowel sounds are hyperactive. Abdominal examination shows mild tenderness in the left lower quadrant. Rectal examination shows no abnormalities. His hemoglobin concentration is 14.3 g/dL, leukocyte count is 12,300/mm3, and C-reactive protein concentration is 62 mg/L (N=0.08–3.1). After discontinuing clindamycin, which of the following is the most appropriate pharmacotherapy for this patient's condition?

A. Intravenous vancomycin
B. Oral fidaxomicin (Correct Answer)
C. Intravenous metronidazole
D. Oral metronidazole
E. Oral rifaximin

Explanation: ***Oral fidaxomicin*** - The patient's presentation with profuse, foul-smelling, watery diarrhea, abdominal cramping, and fever after prolonged antibiotic use (clindamycin) is highly suggestive of **Clostridioides difficile infection (CDI)**. - **Oral fidaxomicin** is a first-line agent for initial CDI episodes with **superior efficacy** in reducing recurrence rates compared to metronidazole and similar cure rates to oral vancomycin. It is preferred due to its **narrow spectrum**, **bactericidal activity against C. difficile**, and **minimal disruption to normal colonic flora**. - Current IDSA/SHEA guidelines recommend fidaxomicin or oral vancomycin as first-line therapy for initial CDI episodes. *Intravenous vancomycin* - **Intravenous vancomycin** has poor penetration into the GI tract and is therefore **ineffective for C. difficile infection (CDI)**, which is an intraluminal infection. - Oral vancomycin is effective for CDI, but intravenous administration will not treat the infection. *Intravenous metronidazole* - **Intravenous metronidazole** has limited efficacy in treating **Clostridioides difficile infection (CDI)** as first-line therapy. - While it achieves some colonic concentration even when given intravenously, oral agents (fidaxomicin or vancomycin) are preferred for initial episodes. - IV metronidazole may be used as adjunctive therapy in fulminant cases with ileus when oral agents cannot reach the colon. *Oral metronidazole* - **Oral metronidazole** was previously used for non-severe CDI but is **no longer recommended as first-line therapy** per updated IDSA/SHEA guidelines due to inferior cure rates and higher recurrence rates compared to vancomycin and fidaxomicin. - It may be considered only when fidaxomicin and vancomycin are unavailable. *Oral rifaximin* - **Oral rifaximin** is sometimes used as **adjunctive therapy following standard treatment** to prevent recurrent C. difficile infection (CDI). - It is **not recommended as initial monotherapy** for an active CDI episode.

Question 63: A 15-year-old boy presents with his father to the urgent care department with a 5-day history of frequent diarrhea, occasionally mixed with streaks of blood. Stool cultures are pending, but preliminary stool samples demonstrate fecal leukocytes and erythrocytes. The patient's vital signs are within normal limits, and he is started on outpatient therapy for presumed Shigella infection. Which of the following was the young man most likely started on?

A. Oral vancomycin
B. Oral erythromycin
C. Oral metronidazole
D. An oral quinolone
E. Oral trimethoprim-sulfamethoxazole (TMP-SMX) (Correct Answer)

Explanation: **Oral trimethoprim-sulfamethoxazole (TMP-SMX)** - **TMP-SMX** is a traditional first-line treatment for **Shigella infection** in settings where susceptibility is expected or confirmed. - The patient's presentation with **bloody diarrhea**, **fecal leukocytes**, and **erythrocytes** is classic for **Shigella dysentery**. - While **resistance rates vary by region**, TMP-SMX remains an appropriate choice when local susceptibility patterns support its use. - It is cost-effective, well-tolerated, and appropriate for outpatient management of uncomplicated cases. *Oral vancomycin* - Vancomycin is specifically used for **Clostridioides difficile infection** and does not treat Shigella. - It has **poor oral absorption** and no activity against Gram-negative enteric pathogens like Shigella. *Oral erythromycin* - Erythromycin is primarily effective against **Campylobacter jejuni** and respiratory pathogens. - It has **limited activity against Shigella** and resistance rates are high, making it an inappropriate choice. *Oral metronidazole* - Metronidazole treats **anaerobic bacteria** and protozoal infections (*Giardia*, *Entamoeba histolytica*). - It has **no significant activity against Shigella**, a facultative anaerobic Gram-negative bacillus. *An oral quinolone* - **Fluoroquinolones** (e.g., ciprofloxacin) are highly effective against Shigella and often used as first-line therapy, particularly in areas with high TMP-SMX resistance. - They are increasingly preferred in current guidelines due to rising resistance to TMP-SMX. - However, in the context of empiric outpatient treatment where susceptibility is presumed, **TMP-SMX** may still be chosen initially as a narrower-spectrum, cost-effective option, with fluoroquinolones reserved based on culture results or treatment failure.

Question 64: An 89-year-old woman presents to clinic complaining of a cough. She reports that she has never had a cough like this before. She takes a deep breath and then coughs multiple times, sometimes so much that she vomits. When she tries to catch her breath after a coughing spell, she has difficulty. She reports the cough has persisted for 3 weeks and usually comes in fits. Vital signs are stable. Physical examination is benign. You send cultures and a PCR of her secretions, both of which come back positive for the organism you had suspected. You tell her to stay away from her grandchildren because her illness may be fatal in infants. You also start her on medication. The illness affecting this patient would be best treated by a class of antibiotics...

A. that is known to cause nephrotoxicity and ototoxicity
B. that may cause tooth discoloration and inhibit bone growth in children
C. that may prolong the QT interval (Correct Answer)
D. that may cause gray baby syndrome in premature infants
E. that may cause a disulfiram-like reaction when taken with alcohol

Explanation: ***that may prolong the QT interval*** - The patient's symptoms (paroxysms of cough followed by vomiting, difficulty catching breath, persistence for 3 weeks) are classic for **pertussis (whooping cough)**, caused by *Bordetella pertussis*. - Macrolide antibiotics, such as **azithromycin** or **erythromycin**, are the primary treatment for pertussis and are known to prolong the **QT interval**. *that is known to cause nephrotoxicity and ototoxicity* - This adverse effect profile is characteristic of **aminoglycosides** (e.g., gentamicin, tobramycin). - Aminoglycosides are **not the primary treatment** for pertussis. *that may cause tooth discoloration and inhibit bone growth in children* - These side effects are associated with **tetracyclines** (e.g., doxycycline, tetracycline). - Tetracyclines are **not the first-line treatment** for pertussis, especially in the context of preventing transmission to infants. *that may cause gray baby syndrome in premature infants* - **Chloramphenicol** is associated with **gray baby syndrome** due to impaired glucuronidation in neonates. - Chloramphenicol is **not indicated** for the treatment of pertussis. *that may cause a disulfiram-like reaction when taken with alcohol* - This reaction (facial flushing, headache, nausea, vomiting) is typically caused by **metronidazole** or **cephalosporins with a methylthiotetrazole side chain**. - These antibiotics are **not used** for the treatment of pertussis.

Question 65: A 29-year-old woman comes to the physician because of a 4-day history of fever with chills, nausea, myalgias, and malaise. One week ago, she returned from a trip to Rhode Island, where she participated in a month-long program to become an assistant park ranger. Laboratory studies show a leukocyte count of 1,400/mm3. A peripheral blood smear shows dark purple, mulberry-like inclusions inside the granulocytes. A presumptive diagnosis is made and pharmacotherapy is initiated with the drug of choice for this condition. The bacteriostatic effect of this drug is most likely due to inhibition of which of the following processes?

A. Bacterial peptidyl transferase activity at the 50S subunit
B. Bacterial topoisomerase II and topoisomerase IV activity
C. Binding of bacterial tRNA to the acceptor site of ribosomes (Correct Answer)
D. Transcription of bacterial DNA by RNA-polymerase
E. Peptidoglycan crosslinking and bacterial cell wall synthesis

Explanation: ***Binding of bacterial tRNA to the acceptor site of ribosomes*** This clinical presentation, including travel to an **endemic area** (Rhode Island), **fever, chills, myalgias, malaise, leukopenia**, and particularly the presence of **mulberry-like inclusions (morulae) in granulocytes**, is highly suggestive of **Anaplasmosis** caused by *Anaplasma phagocytophilum*. The drug of choice for Anaplasmosis is **doxycycline**, a **tetracycline antibiotic**. Tetracyclines exert their **bacteriostatic effect** by **binding to the 30S ribosomal subunit**, thereby **preventing the attachment of aminoacyl-tRNA to the acceptor (A) site** and inhibiting bacterial protein synthesis. *Bacterial peptidyl transferase activity at the 50S subunit* Inhibition of bacterial **peptidyl transferase activity at the 50S ribosomal subunit** is the mechanism of action for **macrolides** (e.g., azithromycin, erythromycin) and **chloramphenicol**. While these are also bacteriostatic, they are not the first-line treatment for Anaplasmosis, and their ribosomal binding site differs from tetracyclines. *Bacterial topoisomerase II and topoisomerase IV activity* Inhibition of bacterial **topoisomerase II (DNA gyrase)** and **topoisomerase IV** is the mechanism of action for **fluoroquinolone antibiotics** (e.g., ciprofloxacin, levofloxacin). These drugs interfere with DNA replication and repair but are not the primary treatment for Anaplasmosis. *Transcription of bacterial DNA by RNA-polymerase* Inhibition of **bacterial RNA-polymerase** and thus bacterial DNA transcription is the mechanism of action for **rifampin**. Rifampin is primarily used for tuberculosis and some other infections, but not for Anaplasmosis. *Peptidoglycan crosslinking and bacterial cell wall synthesis* Inhibition of **peptidoglycan crosslinking** and bacterial **cell wall synthesis** is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **vancomycin**. These are generally bactericidal, and *Anaplasma* is an intracellular bacterium that lacks a peptidoglycan cell wall, rendering these antibiotics ineffective.

Question 66: A 13-year-old boy is brought to the emergency department because of a 2-day history of fever, headache, and irritability. He shares a room with his 7-year-old brother, who does not have any symptoms. The patient appears weak and lethargic. His temperature is 39.1°C (102.4°F) and blood pressure is 99/60 mm Hg. Physical examination shows several purple spots over the trunk and extremities. A lumbar puncture is performed. Gram stain of the cerebrospinal fluid shows numerous gram-negative diplococci. Administration of which of the following is most likely to prevent infection of the patient's brother at this time?

A. Penicillin G
B. Rifampin (Correct Answer)
C. Conjugated vaccine
D. Doxycycline
E. Cephalexin

Explanation: ***Rifampin*** - The patient has bacterial meningitis due to **Neisseria meningitidis**, identified by the gram-negative diplococci and classic symptoms (fever, headache, irritability, petechiae). - **Rifampin** is commonly used for **chemoprophylaxis** against *N. meningitidis* in close contacts due to its excellent penetration into saliva and nasopharyngeal secretions, effectively eradicating carriage. *Penicillin G* - While **Penicillin G** is an effective treatment for established meningococcal meningitis, it is **not appropriate for prophylaxis** due to its poor penetration into respiratory secretions and its inability to reliably eradicate the nasopharyngeal carriage of *N. meningitidis*. - Its use for prophylaxis would mainly target systemic infection rather than preventing transmission from a carrier state. *Conjugated vaccine* - The **meningococcal conjugated vaccine** provides active immunity against specific serogroups of *N. meningitidis*. - However, it requires time for an immune response to develop and is therefore **not effective for immediate post-exposure prophylaxis** in a household contact. *Doxycycline* - **Doxycycline** is a broad-spectrum antibiotic but is **not the preferred agent for meningococcal prophylaxis**. - Its primary uses include atypical bacterial infections, tick-borne diseases, and some sexually transmitted infections, rather than *N. meningitidis* chemoprophylaxis. *Cephalexin* - **Cephalexin** is a first-generation cephalosporin primarily used for skin and soft tissue infections and some urinary tract infections. - It has **limited activity against *N. meningitidis*** and is not recommended for either treatment or prophylaxis of meningococcal disease.

Question 67: A 63-year-old man with non-Hodgkin lymphoma is brought to the emergency department because of fever and confusion that have progressively worsened over the past 3 days. He also has a 3-day history of loose stools. He returned from France 2 weeks ago where he stayed in the countryside and ate typical French cuisine, including frog, snail, and various homemade cheeses. His last chemotherapy cycle was 3 weeks ago. He is oriented to person but not to place or time. His temperature is 39.5°C (103.1°F), pulse is 110/min, and blood pressure is 100/60 mm Hg. Examination shows cervical and axillary lymphadenopathy. The lungs are clear to auscultation. There is involuntary flexion of the bilateral hips and knees with passive flexion of the neck. Neurologic examination shows no focal findings. Laboratory studies show: Hemoglobin 9.3 g/dL Leukocyte count 3600/mm3 Platelet count 151,000/mm3 Serum Na+ 134 mEq/L Cl- 103 mEq/L K+ 3.7 mEq/L Glucose 102 mg/dL Creatinine 1.3 mg/dL A lumbar puncture is performed. Cerebrospinal fluid analysis shows a leukocyte count of 1200/mm3 (76% segmented neutrophils, 24% lymphocytes), a protein concentration of 113 mg/dL, and a glucose concentration of 21 mg/dL. The results of blood cultures are pending. Which of the following is the most appropriate initial pharmacotherapy?

A. Acyclovir and dexamethasone
B. Vancomycin, ampicillin, and cefepime (Correct Answer)
C. Ampicillin, gentamicin, and dexamethasone
D. Ampicillin and cefotaxime
E. Acyclovir

Explanation: **Vancomycin, ampicillin, and cefepime** - The patient has bacterial meningitis with features suggesting **immunosuppression** (non-Hodgkin lymphoma, recent chemotherapy, leukopenia), placing him at risk for a broad spectrum of pathogens including *Listeria*, gram-negative rods, *S. pneumoniae*, and *N. meningitidis*. - This combination provides broad-spectrum coverage: **vancomycin** for resistant *S. pneumoniae* and methicillin-resistant *Staphylococcus aureus* (MRSA), **ampicillin** for *Listeria monocytogenes*, and **cefepime** for gram-negative bacteria, including those common in immunocompromised hosts. *Acyclovir and dexamethasone* - **Acyclovir** is used for **viral meningitis/encephalitis**, which is less likely given the CSF profile (high neutrophils, low glucose, high protein) strongly indicative of bacterial infection. - **Dexamethasone** may be considered as an adjunct in some cases of bacterial meningitis (e.g., *S. pneumoniae*), but should be given with antibiotics, and its use alone or with acyclovir is inappropriate for suspected bacterial meningitis. *Ampicillin, gentamicin, and dexamethasone* - While **ampicillin** covers *Listeria* and **dexamethasone** can be an adjunct, **gentamicin** is generally not a first-line agent for meningitis due to poor CSF penetration and potential for nephrotoxicity/ototoxicity, and it does not adequately cover *S. pneumoniae* or gram-negative bacilli as well as a third or fourth-generation cephalosporin. - This combination lacks robust coverage against **resistant *S. pneumoniae*** and broad gram-negative bacteria, which are crucial in an immunocompromised patient. *Ampicillin and cefotaxime* - This combination covers common pathogens like *S. pneumoniae*, *N. meningitidis*, and *Listeria*. However, given the patient's **immunosuppression** and risk factors (recent travel, potential foodborne exposure), it might lack sufficient coverage for **resistant *S. pneumoniae*** (addressed by vancomycin) and **extended-spectrum gram-negative rods** (better covered by cefepime). - The patient's risk profile warrants broader initial empiric coverage until sensitivities are known. *Acyclovir* - **Acyclovir** specifically targets **herpes simplex virus (HSV)**, which causes viral encephalitis/meningitis. - The patient's CSF findings (marked pleocytosis with high neutrophils, very low glucose, and high protein) are highly suggestive of **bacterial meningitis**, not viral.

Question 68: A 60-year-old woman presents to the physician with a 2-day history of fever and painful swelling of the left knee. She was diagnosed with rheumatoid arthritis about 15 years ago and has a 7-year history of diabetes mellitus. Over the past year, she has been admitted to the hospital twice for acute, painful swelling of the knees and hands. She is on insulin therapy and takes methotrexate, metformin, aspirin, and prednisolone 5 mg/day. Her temperature is 38.5°C (101.3°F), pulse is 86/min, respirations are 14/min, and blood pressure is 125/70 mm Hg. A finger-stick glucose test shows 230 mg/dL. Her left knee is diffusely swollen, warm, and painful on both active and passive motion. There is evidence of deformity in several small joints of the hands and feet without any acute swelling or pain. Physical examination of the lungs, abdomen, and perineum shows no abnormalities. The synovial fluid analysis shows the following: Color turbid, purulent, gray Viscosity reduced WBC 25,000/µL–250,000/µL Neutrophils > 90% Crystals may be present (presence indicates coexistence, but does not rule out infection) Which of the following is the most appropriate initial pharmacotherapy in this patient?

A. Intra-articular triamcinolone acetonide
B. Intravenous methylprednisolone
C. Intra-articular ceftriaxone
D. Oral ciprofloxacin
E. Intravenous vancomycin (Correct Answer)

Explanation: ***Intravenous vancomycin*** - The patient's presentation with **fever**, a **swollen, warm, and painful knee**, and **turbid, purulent synovial fluid** with a high white blood cell count (25,000–250,000/µL) and >90% neutrophils is highly suggestive of **septic arthritis**. - Given her history of **rheumatoid arthritis** (which can predispose to joint infections) and **diabetes mellitus** (increasing infection risk), empirical intravenous antibiotics covering **gram-positive organisms** like *Staphylococcus aureus* (a common cause of septic arthritis) are crucial. **Vancomycin** is an appropriate choice for initial broad-spectrum coverage, especially if **MRSA** is a concern. *Intra-articular triamcinolone acetonide* - This is an **anti-inflammatory corticosteroid** used to manage chronic joint inflammation in conditions like rheumatoid arthritis or osteoarthritis. - It is **contraindicated** in suspected or confirmed septic arthritis because it can suppress the local immune response and potentially worsen the infection. *Intravenous methylprednisolone* - This is a **systemic corticosteroid** used for acute inflammatory conditions, including flares of rheumatoid arthritis. - While it has anti-inflammatory effects, it does **not treat infection** and can globally **immunosuppress** the patient, making the existing septic arthritis potentially more severe. *Intra-articular ceftriaxone* - **Ceftriaxone is an antibiotic**, but administering it directly into the joint (**intra-articular**) is **not the standard or recommended route** for treating septic arthritis. - Systemic intravenous administration is necessary to achieve adequate antibiotic concentrations throughout the joint and combat potential bacteremia. *Oral ciprofloxacin* - **Ciprofloxacin is an antibiotic**, but **oral administration** may not achieve sufficient drug levels in the joint quickly enough for acute septic arthritis, especially in a patient with a severe presentation. - While it covers some gram-negative organisms, initial empirical therapy for septic arthritis often prioritizes coverage for gram-positive bacteria like *Staphylococcus aureus* before culture results are available.

Question 69: A 28-year-old man presents to the Emergency Department after a window he was installing fell on him. The patient complains of left ocular pain, blurred vision, and obscured lower portion of the left visual field. The patient’s vital signs are as follows: blood pressure 140/80 mm Hg, heart rate 88/min, respiratory rate 14/min, and temperature 36.9℃ (98.4℉). On physical examination, he has multiple superficial lacerations on his face, arms, and legs. Examination of his right eye shows a superficial upper eyelid laceration. Examination of the left eye shows conjunctival hyperemia, peaked pupil, iridial asymmetry, hyphema, and vitreous hemorrhage. The fundus is hard to visualize due to the vitreous hemorrhage. The visual acuity is 20/25 in the right eye and difficult to evaluate in the left. Which of the following is a proper step to undertake in the diagnosis and management of this patient?

A. Examination of the left eye with fluorescein
B. Systemic administration of vancomycin and levofloxacin
C. Examination of the fundus with a tropicamide application
D. Placing an ocular pad onto the affected eye
E. Ultrasound examination of the left eye (Correct Answer)

Explanation: ***Ultrasound examination of the left eye*** - The patient presents with classic signs of an **open globe injury**, including hyphema, peaked pupil, iridial asymmetry, and vitreous hemorrhage, making direct funduscopic examination difficult. - An ultrasound can effectively detect **intraocular foreign bodies**, retinal detachment, or other posterior segment injuries in the setting of opaque media without placing pressure on the globe. *Examination of the left eye with fluorescein* - Fluorescein examination is used to detect **corneal abrasions** or **ulcers** and assess for a Seidel sign, which indicates leakage of aqueous humor from an open globe. - However, applying fluorescein and manipulating an eye with a suspected open globe injury can **increase intraocular pressure** and worsen prolapse of intraocular contents. *Systemic administration of vancomycin and levofloxacin* - While prophylaxis against **endophthalmitis** is crucial in open globe injuries, this patient has not undergone surgical repair yet, and the immediate concern is diagnosis to guide definitive treatment. - The choice of antibiotics and timing is usually after initial assessment and typically includes an **intravenous broad-spectrum antibiotic** to cover common ocular pathogens. *Examination of the fundus with a tropicamide application* - Tropicamide is a **mydriatic agent** used to dilate the pupil for funduscopic examination; however, it can worsen an open globe injury by potentially increasing herniation of intraocular contents through the wound. - Given the severe vitreous hemorrhage and suspicion of an open globe, forcing pupil dilation and direct fundoscopy is inappropriate and **contraindicated**. *Placing an ocular pad onto the affected eye* - An ocular pad might apply pressure to the eye, which is **contraindicated** in a suspected open globe injury, as it can cause extrusion of intraocular contents. - The appropriate management for an open globe injury is to **protect the eye with a rigid shield** (not a pad) and avoid any pressure until surgical repair.

Question 70: An 18-year old college freshman presents to his university clinic because he has not been feeling well for the past two weeks. He has had a persistent headache, occasional cough, and chills without rigors. The patient’s vital signs are normal and physical exam is unremarkable. His radiograph shows patchy interstitial lung infiltrates and he is diagnosed with atypical pneumonia. The patient is prescribed azithromycin and takes his medication as instructed. Despite adherence to his drug regimen, he returns to the clinic one week later because his symptoms have not improved. The organism responsible for this infection is likely resistant to azithromycin through which mechanism?

A. Mutation in topoisomerase II
B. Methylation of ribosomal binding site
C. Presence of a beta-lactamase
D. Decreased binding to RNA polymerase
E. Insertion of drug efflux pumps (Correct Answer)

Explanation: ***Insertion of drug efflux pumps*** - **Azithromycin** is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**. - In **Mycoplasma pneumoniae** (the most common cause of atypical pneumonia in young adults), the **most common** mechanism of macrolide resistance is through **efflux pumps**, particularly the **mef genes**. - These efflux pumps actively transport macrolides out of the bacterial cell, reducing intracellular drug concentration and conferring resistance. - This mechanism is responsible for the majority of macrolide-resistant *M. pneumoniae* isolates worldwide. *Methylation of ribosomal binding site* - **Methylation** of the ribosomal binding site (specifically the **23S rRNA** via erm genes) does prevent azithromycin from binding effectively. - While this is a valid macrolide resistance mechanism seen in organisms like *Streptococcus pneumoniae* and *Streptococcus pyogenes*, it is **less common** in *Mycoplasma pneumoniae*. - Efflux pumps (mef) are the predominant mechanism in *M. pneumoniae* resistant strains. *Mutation in topoisomerase II* - **Topoisomerase II** (DNA gyrase) is the target of **fluoroquinolone antibiotics**, not macrolides. - Mutations in this enzyme lead to resistance against fluoroquinolones, such as **ciprofloxacin**. *Presence of a beta-lactamase* - **Beta-lactamase enzymes** inactivate **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) by hydrolyzing their beta-lactam ring. - Additionally, *Mycoplasma pneumoniae* **lacks a cell wall**, making it inherently resistant to all beta-lactam antibiotics regardless of beta-lactamase production. *Decreased binding to RNA polymerase* - **RNA polymerase** is the target for antibiotics like **rifampin**, which inhibits bacterial transcription. - Decreased binding to RNA polymerase would lead to rifampin resistance, not azithromycin resistance.

Question 71: A 17-year-old girl comes to the physician because of a 2-day history of pain in her right knee. Last week she had right wrist pain. She has no history of recent trauma. She returned from summer camp in Connecticut 2 weeks ago. She is sexually active with one male partner and uses an oral contraceptive. Her temperature is 38°C (100.4°F). Examination shows several painless vesiculopustular lesions on the back and one lesion on the right sole of the foot. There is swelling of the right knee with tenderness to palpation. Passive extension of the right wrist and fingers elicits pain. Which of the following is the most likely diagnosis?

A. Acute rheumatic fever
B. Staphylococcus aureus arthritis
C. Reactive arthritis
D. Systemic lupus erythematosus
E. Disseminated gonococcal infection (Correct Answer)

Explanation: ***Disseminated gonococcal infection*** - The presentation of **migratory polyarthralgia** (wrist and knee pain), **tenosynovitis** (pain with passive finger extension), **fever**, and characteristic **vesiculopustular skin lesions** in a sexually active young woman strongly suggests disseminated gonococcal infection (DGI). - **Sexually active history** and the specific skin lesions (few, scattered on trunk/extremities, often painless) are key features that differentiate DGI from other arthritic conditions. *Acute rheumatic fever* - Typically presents with **migratory polyarthritis** following a **Streptococcus pyogenes** infection, often pharyngitis. - It lacks the characteristic **vesiculopustular skin lesions** and tenosynovitis seen in this case. *Staphylococcus aureus arthritis* - Usually presents as **monoarticular septic arthritis** with severe pain, swelling, and fever, often without migratory polyarthralgia or the specific skin lesions. - **Tenosynovitis** and **painless vesiculopustular lesions** are not typical features. *Reactive arthritis* - Characterized by a triad of **arthritis**, **urethritis/cervicitis**, and **conjunctivitis** (can't see, can't pee, can't climb a tree) following a genitourinary or gastrointestinal infection. - While it can cause polyarthritis, it does not typically present with the specific **vesiculopustular skin lesions** or tenosynovitis seen here. *Systemic lupus erythematosus* - Can cause **arthralgia** or **arthritis**, but usually presents with a broader range of systemic symptoms like **malar rash, photosensitivity, serositis, renal involvement**, and does not typically involve vesiculopustular skin lesions or acute tenosynovitis as a primary presentation. - The **acute onset** with specific skin and joint findings is less suggestive of SLE.

Question 72: A 22-year-old female is brought to the emergency department by her roommate with a one day history of fever and malaise. She did not feel well after class the previous night and has been in her room since then. She has not been eating or drinking due to severe nausea. Her roommate checked on her one hour ago and was alarmed to find a fever of 102°F (38.9°C). On physical exam temperature is 103°F (40°C), blood pressure is 110/66 mmHg, pulse is 110/min, respirations are 23/min, and pulse oximetry is 98% on room air. She refuses to move her neck and has a rash on her trunk. You perform a lumbar puncture and the CSF analysis is shown below. Appearance: Cloudy Opening pressure: 180 mm H2O WBC count: 150 cells/µL (93% PMN) Glucose level: < 40 mg/dL Protein level: 50 mg/dL Gram stain: gram-negative diplococci Based on this patient's clinical presentation, which of the following should most likely be administered?

A. Ceftriaxone (Correct Answer)
B. Dexamethasone
C. Rifampin
D. Acyclovir
E. Erythromycin

Explanation: ***Ceftriaxone*** - The patient presents with classic signs of **bacterial meningitis** (fever, neck stiffness, rash, altered mental status) and CSF analysis confirms, showing **cloudy appearance**, **elevated opening pressure**, **high WBC count with PMN predominance**, **low glucose**, and **gram-negative diplococci** on Gram stain, typical for *Neisseria meningitidis*. - **Ceftriaxone** is a third-generation cephalosporin, a first-line antibiotic for treating bacterial meningitis, particularly effective against *Neisseria meningitidis*. *Dexamethasone* - While **dexamethasone** can be used as an adjunct in bacterial meningitis, particularly when caused by *Streptococcus pneumoniae*, it's administered *before or with* the first dose of antibiotics to mitigate inflammation. - It is not the primary treatment to *eradicate* the infection and is less critical than immediate antibiotic therapy. *Rifampin* - **Rifampin** is primarily used for chemoprophylaxis in close contacts of individuals with meningococcal meningitis, or as part of a multi-drug regimen for tuberculosis. - It is not the recommended first-line monotherapy for acute bacterial meningitis. *Acyclovir* - **Acyclovir** is an antiviral medication used to treat herpes simplex virus (HSV) meningitis or encephalitis. - The CSF analysis showing **gram-negative diplococci** clearly indicates a bacterial etiology, not viral, making acyclovir inappropriate. *Erythromycin* - **Erythromycin** is a macrolide antibiotic with a narrower spectrum of activity and is not typically used as first-line treatment for bacterial meningitis, especially not for *Neisseria meningitidis*. - Its use is often limited by resistance and side effects compared to third-generation cephalosporins.

Question 73: A 12-year-old girl is brought to the physician by her mother because of high fever and left ankle and knee joint swelling. She had a sore throat 3 weeks ago. There is no family history of serious illness. Her immunizations are up-to-date. She had an episode of breathlessness and generalized rash when she received dicloxacillin for a skin infection 2 years ago. She appears ill. Her temperature is 38.8°C (102.3°F), pulse is 87/min, and blood pressure is 98/62 mm Hg. Examination shows left ankle and knee joint swelling and tenderness; range of motion is limited. Breath sounds over both lungs are normal. A grade 3/6 holosytolic murmur is heard best at the apex. Abdominal examination is normal. Which of the following is the most appropriate pharmacotherapy?

A. Amoxicillin
B. Ciprofloxacin
C. Clarithromycin (Correct Answer)
D. Methotrexate
E. High-dose glucocorticoids

Explanation: ***Clarithromycin*** - This patient presents with **acute rheumatic fever (ARF)** following pharyngitis, evidenced by polyarthritis (ankle and knee swelling) and carditis (holosystolic murmur at the apex indicating mitral regurgitation). - The cornerstone of ARF treatment is **eradication of Streptococcus pyogenes** to prevent ongoing immune response and recurrent episodes. - This patient has a **documented penicillin allergy** (previous reaction to dicloxacillin with breathlessness and rash), making penicillin-based antibiotics contraindicated. - **Macrolides** (clarithromycin, azithromycin, erythromycin) are the **first-line alternative** for streptococcal eradication in penicillin-allergic patients. - Anti-inflammatory therapy (aspirin for arthritis/mild carditis, or corticosteroids for severe carditis with heart failure) would also be initiated, but antibiotic therapy is the essential pharmacotherapy. *Amoxicillin* - Amoxicillin is a **beta-lactam antibiotic** and would typically be first-line for streptococcal eradication in ARF. - However, this patient has a **documented penicillin allergy** (reaction to dicloxacillin), making amoxicillin **contraindicated** due to high cross-reactivity between penicillin derivatives. - Using amoxicillin could precipitate anaphylaxis or severe allergic reaction. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone antibiotic** with poor activity against **Streptococcus pyogenes**, the causative organism of ARF. - Fluoroquinolones are not indicated for streptococcal pharyngitis or ARF treatment. - Use in children should be avoided when effective alternatives exist due to potential musculoskeletal side effects. *Methotrexate* - Methotrexate is a **disease-modifying antirheumatic drug (DMARD)** used for chronic inflammatory conditions like rheumatoid arthritis. - It has **no role in acute rheumatic fever** management. - Its slow onset of action and mechanism make it completely inappropriate for ARF. *High-dose glucocorticoids* - Glucocorticoids are reserved for **severe carditis with congestive heart failure** in ARF. - This patient has carditis (murmur) but shows **no signs of heart failure** (normal breath sounds, no respiratory distress, stable vital signs). - For arthritis and mild-moderate carditis, **aspirin or other NSAIDs** are preferred anti-inflammatory agents. - Corticosteroids do NOT replace antibiotic therapy, which is the primary treatment to eradicate the streptococcal infection.

Question 74: A 60-year-old diabetic male presents to your clinic for right ear pain. The patient reports noting worsening right ear pain for three weeks, purulent otorrhea initially which has resolved, and facial asymmetry for the past several days. He reports being poorly compliant with his diabetes medication regimen. His temperature is 100.4 deg F (38 deg C), blood pressure is 140/90 mmHg, pulse is 90/min, and respirations are 18/min. On physical exam, the patient’s right external auditory canal is noted to have granulation tissue at the bony cartilaginous junction. He is also noted to have right facial droop. Which of the following is the best next step in treatment?

A. Topical polymyxin and neosporin for 14 days
B. Surgical intervention
C. Hyperbaric oxygen treatment for 4 weeks
D. Intravenous ciprofloxacin for 6 weeks (Correct Answer)
E. Oral amoxicillin-clavulanic acid for 10 days

Explanation: ***Intravenous ciprofloxacin for 6 weeks*** - This patient presents with symptoms highly suggestive of **malignant otitis externa (MOE)**: diabetic, ear pain, granulation tissue in the external auditory canal, and facial nerve palsy. - **Ciprofloxacin** is a first-line treatment for MOE, targeting **Pseudomonas aeruginosa**, the most common causative organism, and typically requires prolonged intravenous therapy. *Topical polymyxin and neosporin for 14 days* - Topical antibiotics alone are insufficient for treating MOE, which is an invasive infection extending beyond the external auditory canal. - These agents do not penetrate deep tissues and will not address the underlying osteomyelitis or cranial nerve involvement. *Surgical intervention* - Surgical debridement is generally reserved for cases of **extensive necrosis** or **failure of aggressive medical therapy** in MOE. - Initial management always involves medical therapy with appropriate antibiotics. *Hyperbaric oxygen treatment for 4 weeks* - **Hyperbaric oxygen therapy** is considered an **adjunctive treatment** in refractory cases of MOE, not a first-line therapy. - It enhances tissue oxygenation, which can improve antibiotic effectiveness and wound healing, but it does not replace antibiotic therapy. *Oral amoxicillin-clavulanic acid for 10 days* - **Amoxicillin-clavulanic acid** does not provide adequate coverage against **Pseudomonas aeruginosa**, the predominant pathogen in MOE. - Oral antibiotics for only 10 days are insufficient for deep-seated infections like MOE, which requires prolonged, often intravenous, treatment.

Question 75: Ten days after being discharged from the hospital, a 42-year-old man comes to the emergency department because of reduced urine output for 3 days. Physical examination is normal. Serum creatinine concentration is 2.9 mg/dL. Urinalysis shows brownish granular casts and 2+ proteinuria. Renal biopsy shows patchy necrosis of the proximal convoluted tubule with sloughing of tubular cells into the lumen and preservation of tubular basement membranes. Administration of which of the following drugs during this patient's hospitalization is most likely the cause of the observed decrease in renal function?

A. Aspirin
B. Acyclovir
C. Omeprazole
D. Captopril
E. Gentamicin (Correct Answer)

Explanation: ***Gentamicin*** - The patient's presentation with **acute kidney injury** (reduced urine output, elevated creatinine) and characteristic urinalysis findings (**brownish granular casts**, proteinuria) points to **acute tubular necrosis (ATN)**. - **Gentamicin** is an **aminoglycoside antibiotic** well-known for causing ATN, particularly with prolonged use or in susceptible patients. The biopsy findings of **patchy necrosis of the proximal convoluted tubule** and **sloughing of tubular cells** with preserved basement membranes are classic for ATN. *Aspirin* - **Aspirin**, especially at high doses or in sensitive individuals, can cause **analgesic nephropathy** (chronic interstitial nephritis) or, less commonly, acute interstitial nephritis. - It does not typically cause ATN with the specific biopsy findings described, and its primary renal toxicity is often related to **prostaglandin inhibition**. *Acyclovir* - **Acyclovir** can cause acute kidney injury, but it primarily does so through **crystalluria** and **tubular obstruction**, leading to acute interstitial nephritis or acute kidney injury due to crystal deposition. - The biopsy findings described (patchy tubular necrosis, sloughing cells) are not typical for acyclovir-induced nephrotoxicity. *Omeprazole* - **Omeprazole**, a proton pump inhibitor, is most commonly associated with **acute interstitial nephritis (AIN)**, an allergic reaction affecting the renal interstitium. - AIN would typically present with eosinophiluria, white blood cell casts, and interstitial inflammation on biopsy, rather than primary tubular necrosis. *Captopril* - **Captopril**, an ACE inhibitor, can cause acute kidney injury, particularly in patients with **renal artery stenosis** or volume depletion, by altering glomerular hemodynamics. - It typically does not cause direct tubular necrosis or the specific histological changes seen in ATN; rather, it primarily reduces **glomerular filtration pressure**.

Question 76: A 57-year-old woman is brought to the emergency department because of crampy abdominal pain and foul-smelling, watery diarrhea. One week ago, she underwent treatment of cellulitis with clindamycin. She has developed shortness of breath and urticaria after treatment with vancomycin in the past. Her temperature is 38.4°C (101.1°F). Abdominal examination shows mild tenderness in the left lower quadrant. Her leukocyte count is 12,800/mm3. An enzyme immunoassay is positive for glutamate dehydrogenase antigen and toxins A and B. Which of the following is the mechanism of action of the most appropriate pharmacotherapy for this patient's condition?

A. Blocking of protein synthesis at 50S ribosomal subunit
B. Inhibition of cell wall peptidoglycan formation (Correct Answer)
C. Inhibition of RNA polymerase sigma subunit
D. Inhibition of bacterial topoisomerases II and IV
E. Generation of toxic free radical metabolites

Explanation: ***Inhibition of cell wall peptidoglycan formation*** - The patient presents with **foul-smelling, watery diarrhea**, recent **clindamycin use**, fever, **leukocytosis**, and positive **_C. difficile_ toxins A and B**, indicating **_C. difficile_ infection (CDI)**. - According to **current IDSA/SHEA guidelines (2021)**, **oral vancomycin** is the **first-line therapy** for CDI, regardless of severity. - While the patient has a history of adverse reactions to vancomycin in the past, this was likely with **IV vancomycin**. **Oral vancomycin** has **negligible systemic absorption** (<1%) and rarely causes systemic allergic reactions, making it safe to use even in patients with IV vancomycin allergy. - **Vancomycin** acts by **inhibiting cell wall peptidoglycan formation**, binding to the D-Ala-D-Ala terminus of peptidoglycan precursors and preventing cross-linking. *Generation of toxic free radical metabolites* - This describes the mechanism of action of **metronidazole**, which was historically used as first-line therapy for mild-to-moderate CDI. - However, **metronidazole is no longer recommended as first-line therapy** due to lower cure rates and higher recurrence rates compared to vancomycin. - Metronidazole is now reserved for situations where vancomycin and fidaxomicin are unavailable. *Blocking of protein synthesis at 50S ribosomal subunit* - This mechanism describes drugs like **clindamycin**, **macrolides**, and **linezolid**. - **Clindamycin** was the precipitating factor for this patient's CDI and should not be used for treatment. *Inhibition of RNA polymerase sigma subunit* - This describes the mechanism of action of **fidaxomicin**, which is also a first-line option for CDI with potentially lower recurrence rates than vancomycin. - **Rifaximin** also inhibits bacterial RNA polymerase but is not typically used for initial CDI treatment. - Fidaxomicin could be considered if oral vancomycin were truly contraindicated, but given the minimal systemic absorption of oral vancomycin, this is unlikely to be necessary. *Inhibition of bacterial topoisomerases II and IV* - This is the mechanism of action of **fluoroquinolones** (e.g., ciprofloxacin, levofloxacin). - Fluoroquinolones are associated with an **increased risk of _C. difficile_ infection** and are contraindicated in its treatment.

Question 77: A 15-year-old boy presents with his father to the urgent care with 5 days of frequent diarrhea, occasionally with streaks of blood mixed in. Stool cultures are pending, but preliminary stool samples demonstrate fecal leukocytes and erythrocytes. His vital signs are as follows: blood pressure is 126/83 mm Hg, heart rate is 97/min, and respiratory rate is 15/min. He is started on outpatient therapy for presumed Shigella infection. Which of the following is the most appropriate therapy?

A. Oral doxycycline
B. Oral vancomycin
C. Oral TMP-SMX
D. Oral azithromycin (Correct Answer)
E. Oral ciprofloxacin

Explanation: ***Oral azithromycin*** - **Azithromycin** is the **first-line empiric treatment** for suspected **Shigella infection** based on current CDC and WHO guidelines, particularly in pediatric and adolescent patients. - The presence of **fecal leukocytes and erythrocytes** indicates an invasive bacterial infection, which warrants antibiotic therapy to shorten the course of illness and reduce transmission risks. - Azithromycin has excellent efficacy against Shigella with relatively low resistance rates compared to older agents, and it is well-tolerated in adolescents. *Oral TMP-SMX* - **TMP-SMX (trimethoprim-sulfamethoxazole)** was historically first-line for Shigella, but **widespread resistance** (often >50% globally) has made it no longer recommended for empiric therapy. - It may still be used if culture and susceptibility testing confirm sensitivity, but should not be chosen empirically. *Oral ciprofloxacin* - **Ciprofloxacin**, a fluoroquinolone, is highly effective against **Shigella** and is first-line in adults. - However, its use in **pediatric patients under 18 years** is generally limited due to potential adverse effects on **cartilage development** and risk of tendinopathy. - In a 15-year-old, while approaching adult age, azithromycin remains preferred unless there are specific contraindications. *Oral doxycycline* - **Doxycycline** has limited activity against **Shigella** and is not considered appropriate empiric therapy for this infection. - It is more commonly used for atypical pathogens, certain sexually transmitted infections, or specific tick-borne diseases. *Oral vancomycin* - **Oral vancomycin** is primarily used to treat **Clostridioides difficile infection** (CDI) and is completely ineffective against **Shigella**. - Vancomycin acts only on gram-positive bacteria and does not penetrate the systemic circulation when given orally, making it unsuitable for gram-negative enteric infections.

Question 78: A 22-year-old man presents to a physician with a single painless ulcer on his glans penis that he first noticed 2 weeks ago. He mentions that he is sexually active with multiple partners. There is no history of fevers. Initially, he thought that the ulcer would go away on its own, but decided to come to the clinic because the ulcer persisted. On palpation of the ulcer, the edge and base are indurated. There is no purulence. Multiple painless, firm, and non-fixed lymph nodes are present in the inguinal regions bilaterally. The physician orders a Venereal Disease Research Laboratory (VDRL) test, which is positive. The Treponema pallidum particle agglutination assay is also positive. Upon discussing the diagnosis, the patient informs the physician that he has a severe allergy to penicillin and he declines treatment with an injectable medicine. Which of the following drugs is most appropriate for this patient?

A. Metronidazole
B. Azithromycin (Correct Answer)
C. Trimethoprim-sulfamethoxazole
D. Chloramphenicol
E. Ciprofloxacin

Explanation: ***Azithromycin*** - This patient presents with **primary syphilis**, characterized by a **painless chancre** with indurated borders, bilateral painless inguinal lymphadenopathy, and positive VDRL and T. pallidum particle agglutination assay. - First-line treatment is **benzathine penicillin G** (intramuscular), but this patient has a severe penicillin allergy and refuses injectable treatment. - **Doxycycline 100 mg PO twice daily for 14 days** is the **CDC-recommended alternative** for penicillin-allergic patients with primary syphilis. - **Azithromycin** (2 g single dose) was historically used as an alternative but is **no longer recommended by the CDC** due to widespread macrolide resistance in *Treponema pallidum*. - However, among the options listed, azithromycin has some historical efficacy against *T. pallidum*, making it the only potentially active agent presented, though suboptimal. *Metronidazole* - Used primarily for **anaerobic bacterial** and **protozoal infections** (*Trichomonas vaginalis*, *Giardia*, *Bacteroides*). - Has **no activity** against *Treponema pallidum*. *Trimethoprim-sulfamethoxazole* - Broad-spectrum antibiotic effective for **urinary tract infections**, **Pneumocystis jirovecii** pneumonia, and some respiratory infections. - **Not effective** against *Treponema pallidum* and not used for syphilis treatment. *Chloramphenicol* - Reserved for serious infections (typhoid fever, certain bacterial meningitis) due to risk of **aplastic anemia** and **bone marrow suppression**. - **Not a standard treatment** for syphilis and carries significant toxicity risks. *Ciprofloxacin* - **Fluoroquinolone** antibiotic effective against many gram-negative bacteria and used for urinary tract and respiratory infections. - **No significant activity** against *Treponema pallidum* and not used for syphilis treatment.

Question 79: A 61-year-old woman who recently emigrated from India comes to the physician because of a 2-month history of fever, fatigue, night sweats, and a productive cough. She has had a 5-kg (11-lb) weight loss during this period. She has a history of type 2 diabetes mellitus and poorly controlled asthma. She has had multiple asthma exacerbations in the past year that were treated with glucocorticoids. An x-ray of the chest shows a cavitary lesion of the posterior apical segment of the left upper lobe with consolidation of the surrounding parenchyma. The pathogen identified on sputum culture is found to be resistant to multiple drugs, including streptomycin. Which of the following mechanisms is most likely involved in bacterial resistance to this drug?

A. Alteration in the sequence of gyrA genes
B. Upregulation of arabinosyl transferase production
C. Upregulation of mycolic acid synthesis
D. Alteration in 30S ribosomal subunit (Correct Answer)
E. Inhibition of bacterial synthesis of RNA

Explanation: ***Alteration in 30S ribosomal subunit*** - Streptomycin is an **aminoglycoside antibiotic** that acts by binding to the **16S rRNA of the 30S ribosomal subunit**, which interferes with bacterial protein synthesis. - **Resistance to streptomycin** most commonly arises from mutations in the genes encoding ribosomal proteins (e.g., *rpsL*) or the 16S rRNA that alter the drug's binding site on the 30S ribosomal subunit, preventing its inhibitory effect. *Alteration in the sequence of gyrA genes* - Mutations in the *gyrA* gene typically confer resistance to **fluoroquinolone antibiotics**, such as ciprofloxacin and levofloxacin. - Fluoroquinolones target **DNA gyrase (topoisomerase II)**, which is encoded by *gyrA*, not the ribosomes. *Upregulation of arabinosyl transferase production* - **Arabinogalactan**, a major component of the mycobacterial cell wall, is synthesized by **arabinosyl transferases** (e.g., EmbB). - Resistance to **ethambutol** is often associated with mutations or upregulation of these enzymes, leading to increased synthesis of the arabinogalactan layer. *Upregulation of mycolic acid synthesis* - **Mycolic acid** is a crucial component of the mycobacterial cell wall, and its synthesis is inhibited by drugs like **isoniazid**. - Upregulation of mycolic acid synthesis or mutations in genes related to its production (e.g., *kasA*) can lead to **isoniazid resistance**, but not directly to streptomycin resistance. *Inhibition of bacterial synthesis of RNA* - **Rifampin** is an antibiotic that inhibits bacterial RNA synthesis by binding to the **DNA-dependent RNA polymerase**. - While resistance to rifampin often involves mutations in the *rpoB* gene, this mechanism is specific to rifampin and not streptomycin.

Question 80: A 35-year-old woman visits the office with complaints of yellowish vaginal discharge and increased urinary frequency for a week. She also complains of pain during urination. Past medical history is irrelevant. She admits to having multiple sexual partners in the past few months. Physical examination is within normal limits except for lower abdominal tenderness. Urine culture yields Chlamydia trachomatis. What is the most appropriate next step in the management of this patient?

A. Acyclovir
B. Doxycycline (Correct Answer)
C. Metronidazole
D. Clindamycin
E. Boric acid

Explanation: ***Doxycycline*** - **Doxycycline** is a recommended first-line treatment for **Chlamydia trachomatis** infections (along with azithromycin). - A 7-day course of **doxycycline 100 mg orally twice daily** is highly effective in eradicating the infection. - **Alternative:** Azithromycin 1 g PO single dose is also first-line and may be preferred for compliance. *Acyclovir* - **Acyclovir** is an antiviral medication used to treat **herpes simplex virus (HSV)** infections. - It is ineffective against **bacterial infections** like Chlamydia. *Metronidazole* - **Metronidazole** is an antibiotic primarily used for **anaerobic bacterial** and **parasitic infections** (e.g., bacterial vaginosis, trichomoniasis). - It is not effective against **Chlamydia trachomatis**. *Clindamycin* - **Clindamycin** is an antibiotic effective against a range of **bacterial infections**, including some anaerobic bacteria. - However, it is not a recommended treatment for **Chlamydia trachomatis** infections. *Boric acid* - **Boric acid** is an antifungal agent primarily used for treating **recurrent vulvovaginal candidiasis** (yeast infections). - It has no role in treating **bacterial infections** like Chlamydia.

Question 81: A 30-year-old woman with HIV comes to the emergency department because of fever and multiple skin lesions for 1 week. She also has nausea, anorexia, and abdominal pain. The skin lesions are non-pruritic and painless. She has smoked one pack of cigarettes daily for 15 years and drinks 2 beers daily. She has been using intravenous crack cocaine for 6 years. She appears ill. Her temperature is 38°C (100.4°F), pulse is 105/min, blood pressure is 110/75 mm Hg. Her BMI is 19 kg/m2. Examination shows track marks on both cubital fossae. There are white patches on her palate that can be scraped off. There are several red papules measuring 1 to 2 cm on her face and trunk. Her CD4+T-lymphocyte count is 98/mm3 (N ≥ 500). Biopsy of a skin lesion shows vascular proliferation and small black bacteria on Warthin-Starry stain. Which of the following is the most appropriate pharmacotherapy?

A. Erythromycin (Correct Answer)
B. Vinblastine
C. Pyrimethamine and sulfadiazine
D. Nitazoxanide
E. Azithromycin and ethambutol

Explanation: ***Erythromycin*** - This patient presents with **bacillary angiomatosis**, characterized by distinctive **red papules** on the skin, systemic symptoms, history of HIV with a **low CD4+ count**, and **intravenous drug use**. The diagnosis is confirmed by skin biopsy showing **vascular proliferation** and **small black bacteria on Warthin-Starry stain**, indicative of **Bartonella infection**. - **Erythromycin** is the first-line and highly effective antibiotic for treating **bacillary angiomatosis**, targeting the Bartonella bacteria responsible for the infection. *Vinblastine* - **Vinblastine** is a **chemotherapeutic agent** used in certain cancers, especially Kaposi sarcoma, which also presents with skin lesions in HIV patients. - However, the biopsy findings of **Bartonella infection** and vascular proliferation rule out Kaposi sarcoma, as Kaposi sarcoma is caused by **human herpesvirus 8 (HHV-8)** and has different histological features. *Pyrimethamine and sulfadiazine* - This combination is the standard treatment for **toxoplasmosis**, a common opportunistic infection in HIV patients with low CD4+ counts. - **Toxoplasmosis** primarily affects the **central nervous system**, causing focal neurological deficits, and does not typically present with the type of skin lesions and specific histopathology seen in this case. *Nitazoxanide* - **Nitazoxanide** is an **antiparasitic agent** used to treat infections like **cryptosporidiosis** and **giardiasis**, which cause gastrointestinal symptoms, particularly diarrhea. - While this patient has abdominal pain, nausea, and anorexia the skin lesions and specific biopsy findings are not consistent with parasitic infections typically treated by nitazoxanide. *Azithromycin and ethambutol* - This combination is part of the treatment regimen for **Mycobacterium avium complex (MAC) infection**, which is an opportunistic infection in HIV patients with very low CD4+ counts (<50 cells/mm3). - MAC infection can cause disseminated disease affecting multiple organs, but its skin manifestations are different, and the biopsy findings of **small black bacteria on Warthin-Starry stain** are characteristic of **Bartonella**, not mycobacteria.

Question 82: You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?

A. It binds the 50S ribosomal subunit and inhibits formation of the initiation complex
B. It binds the 30S ribosomal subunit and inhibits formation of the initiation complex (Correct Answer)
C. It binds the 30S ribosomal subunit and reversibly inhibits translocation
D. It binds the 50S ribosomal subunit and inhibits peptidyltransferase
E. It binds the 50S ribosomal subunit and reversibly inhibits translocation

Explanation: ***It binds the 30s ribosomal subunit and inhibits formation of the initiation complex*** - The second antibiotic, X, is likely an **aminoglycoside**, such as **gentamicin** or **amikacin**, which are commonly used in combination with ampicillin for neonatal meningitis and are known to cause ototoxicity. - Aminoglycosides exert their bactericidal effect by **irreversibly binding to the 30S ribosomal subunit**, thereby **inhibiting the formation of the initiation complex** and leading to misreading of mRNA. *It binds the 50S ribosomal subunit and inhibits formation of the initiation complex* - This mechanism is characteristic of **linezolid**, which targets the 50S ribosomal subunit to prevent the formation of the initiation complex. - While linezolid can cause side effects, **ototoxicity** is less commonly associated with it compared to aminoglycosides, and it is not a primary drug for neonatal meningitis alongside ampicillin. *It binds the 50S ribosomal subunit and inhibits peptidyltransferase* - This is the mechanism of action for **chloramphenicol**, which inhibits **peptidyltransferase** activity on the 50S ribosomal subunit, preventing peptide bond formation. - Although chloramphenicol can cause **ototoxicity** and **aplastic anemia**, its use in neonates is limited due to the risk of **Gray Baby Syndrome**. *It binds the 30s ribosomal subunit and reversibly inhibits translocation* - This describes the mechanism of action of **tetracyclines**, which reversibly bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA, thereby inhibiting protein synthesis. - Tetracyclines are **contraindicated in neonates** due to their potential to cause **tooth discoloration** and **bone growth inhibition**, and ototoxicity is not their primary adverse effect. *It binds the 50s ribosomal subunit and reversibly inhibits translocation* - This mechanism of reversibly inhibiting translocation by binding to the 50S ribosomal subunit is characteristic of **macrolides** (e.g., erythromycin, azithromycin) and **clindamycin**. - While some macrolides can cause **transient ototoxicity**, they are not typically the second antibiotic of choice for neonatal meningitis in combination with ampicillin, and clindamycin's side effect profile is different.

Question 83: A 22-year-old female presents to an urgent care clinic for evaluation of a loose bowel movement that she developed after returning from her honeymoon in Mexico last week. She states that she has been having watery stools for the past 3 days at least 3 times per day. She now has abdominal cramps as well. She has no significant past medical history, and the only medication she takes is depot-medroxyprogesterone acetate. Her blood pressure is 104/72 mm Hg; heart rate is 104/min; respiration rate is 14/min, and temperature is 39.4°C (103.0°F). Her physical examination is normal aside from mild diffuse abdominal tenderness and dry mucous membranes. Stool examination reveals no ova. Fecal leukocytes are not present. A stool culture is pending. In addition to oral rehydration, which of the following is the best treatment option for this patient?

A. Trimethoprim-sulfamethoxazole
B. Ciprofloxacin (Correct Answer)
C. Metronidazole
D. Albendazole
E. Doxycycline

Explanation: ***Ciprofloxacin*** - This patient presents with **traveler's diarrhea** characterized by watery stools, abdominal cramps, and fever after returning from Mexico. **Ciprofloxacin** is a fluoroquinolone antibiotic that is highly effective against common bacterial causes of traveler's diarrhea, such as **enterotoxigenic E. coli (ETEC)** and **Campylobacter**. - Given her symptoms (fever, systemic symptoms, moderate-to-severe diarrhea), empirical antibiotic treatment is indicated in addition to oral rehydration, and ciprofloxacin is a preferred first-line agent. *Trimethoprim-sulfamethoxazole* - While **trimethoprim-sulfamethoxazole (TMP-SMX)** can be used for some enteric infections, resistance to this antibiotic among common pathogens causing traveler's diarrhea, particularly in regions like Mexico, is high. - Due to increasing resistance, it is generally not recommended as a first-line empirical treatment for traveler's diarrhea, especially when fever is present. *Metronidazole* - **Metronidazole** is primarily effective against **anaerobic bacteria** and **parasites** like *Giardia* and *Entamoeba histolytica*. - It is not the drug of choice for acute bacterial traveler's diarrhea, as the most common causes are aerobic gram-negative bacteria. *Albendazole* - **Albendazole** is an **antihelminthic** medication used to treat various parasitic worm infections. - It is not indicated for acute bacterial causes of traveler's diarrhea, which is the most likely etiology given the rapid onset and systemic symptoms. *Doxycycline* - **Doxycycline** can be used as prophylaxis or treatment for certain bacterial infections, including some diarrheal diseases. - However, for acute traveler's diarrhea with fever, **ciprofloxacin** offers broader and more reliable coverage against the common bacterial pathogens.

Question 84: A 22-year-old woman presents to the doctor's office seeking evaluation for her recurrent urinary tract infections. She admits to urinary frequency and a burning sensation when urinating. This is her 3rd UTI in the past year. She has a history of generalized anxiety disorder for which she takes paroxetine. She is sexually active and has had multiple partners during the past year. The patient’s blood pressure is 116/72 mm Hg, the heart rate is 76/min, the respiratory rate is 12/min and the temperature is 36.8°C (98.2°F). On physical examination, she is alert and oriented to time, place, and person. There is no murmur. Her lungs are clear to auscultation bilaterally. Her abdomen is soft and non-tender to palpation. The distance from the urethra to anus is shorter than the average female her age. Urinalysis and urine culture results are provided: Urine culture results 200 CFUs of Escherichia coli (normal < 100 if symptomatic) Leukocyte esterase positive WBC 50-100 cells/hpf Nitrite positive RBC 3 cells/hpf Epithelial cells 2 cells/hpf pH 5.2 (normal 4.5–8) Which of the following recommendations would be most appropriate for this patient?

A. Cranberry juice
B. Trimethoprim-sulfamethoxazole
C. Trimethoprim-sulfamethoxazole, and urinating before and after intercourse (Correct Answer)
D. Urinating before and after intercourse
E. Cephalexin

Explanation: **Trimethoprim-sulfamethoxazole, and urinating before and after intercourse** - The patient has recurrent UTIs with symptomatic bacteriuria, indicating a need for **prophylactic antibiotics** and **behavioral modifications**. Trimethoprim-sulfamethoxazole is a common and effective antibiotic for UTI. - Urinating before and after intercourse helps to flush out bacteria introduced into the urethra, reducing the risk of ascending infection, which is crucial given her sexually active status and recurrent infections. *Cranberry juice* - While sometimes suggested for UTI prevention, the evidence supporting the efficacy of cranberry products in preventing recurrent UTIs is **limited and inconsistent**. - It is not considered a primary recommendation for patients with recurrent, symptomatic infections requiring medical intervention. *Trimethoprim-sulfamethoxazole* - This option correctly identifies the need for antibiotic treatment and prevention based on the urinalysis and culture results, but it **omits important behavioral modifications**. - Without addressing risk factors like sexual activity, the likelihood of recurrence remains high, making the treatment less comprehensive. *Urinating before and after intercourse* - This is an important **behavioral modification** that can help reduce UTI risk, especially in sexually active women. - However, for a patient with established recurrent UTIs and current infection, it is **insufficient as a sole intervention** and does not address the need for antibiotic therapy or prophylaxis. *Cephalexin* - Cephalexin is an antibiotic that can be used to treat UTIs, but **trimethoprim-sulfamethoxazole is often preferred** as a first-line agent given its efficacy against E. coli and its use in prophylactic regimens. - Furthermore, like the trimethoprim-sulfamethoxazole-only option, it **does not include crucial behavioral recommendations** for preventing recurrence.

Question 85: A 41-year-old homeless man is brought to the emergency department complaining of severe fever, dizziness, and a persistent cough. The patient has a history of long-standing alcohol abuse and has frequently presented to the emergency department with acute alcohol intoxication. The patient states that his cough produces ‘dark brown stuff’ and he provided a sample for evaluation upon request. The patient denies having any other underlying medical conditions and states that he has no other symptoms. He denies taking any medications, although he states that he knows he has a sulfa allergy. On observation, the patient looks frail and severely fatigued. The vital signs include: blood pressure 102/72 mm Hg, pulse 98/min, respiratory rate 15/min, and temperature 37.1°C (98.8°F). Auscultation reveals crackles in the left upper lobe and chest X-ray reveals an infiltrate in the same area. Which of the following is the most appropriate treatment for this patient?

A. Trimethoprim-sulfamethoxazole
B. Vancomycin
C. Clindamycin (Correct Answer)
D. Piperacillin-tazobactam
E. Ciprofloxacin

Explanation: ***Clindamycin*** - The patient, a severely fatigued, homeless man with a history of alcohol abuse, presents with **fever, dizziness, cough producing 'dark brown stuff'**, and crackles/infiltrate in the left upper lobe. This clinical picture is highly suggestive of aspiration pneumonia and/or lung abscess, often caused by **anaerobic bacteria** found in the oral flora. - **Clindamycin** is the **first-line treatment** for aspiration pneumonia in stable patients, with excellent activity against oral anaerobes, good lung tissue penetration, and proven efficacy in outpatient management. *Trimethoprim-sulfamethoxazole* - This antibiotic is **contraindicated** due to the patient's stated **sulfa allergy**. - While effective against some respiratory pathogens, it does not provide adequate coverage for the likely anaerobic organisms involved in aspiration pneumonia. *Vancomycin* - Vancomycin is primarily used for serious **Gram-positive infections**, particularly **MRSA**, and does not provide adequate coverage for **anaerobic bacteria** typically involved in aspiration pneumonia. - There is no clinical indication for MRSA coverage in this patient's presentation. *Piperacillin-tazobactam* - While piperacillin-tazobactam has excellent broad-spectrum activity, including against anaerobes, and would be effective for aspiration pneumonia, it is typically reserved for **hospitalized patients with severe pneumonia** or healthcare-associated infections. - For a **stable outpatient** with aspiration pneumonia, clindamycin is preferred as it is more targeted, cost-effective, and the standard first-line therapy. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone** with good activity against many **Gram-negative bacteria** and some atypical respiratory pathogens. - However, it has **poor activity against anaerobic bacteria**, which are the primary concern in aspiration pneumonia.

Question 86: A 51-year-old man is admitted to the hospital because of a 2-day history of fever, nausea, and abdominal pain. His temperature is 39.4°C (102.9°F) and pulse is 106/min. Physical examination shows tenderness in the right upper quadrant. Blood cultures grow nonhemolytic, gram-positive cocci that grow in hypertonic saline. Antibiotic sensitivity testing of the isolated organism shows that gentamicin has a minimum inhibitory concentration (MIC) of 16 μg/mL. The addition of ampicillin, which has an MIC of 2 μg/mL alone, decreases the MIC of gentamicin to 0.85 μg/mL. The decrease in the MIC of gentamicin with the addition of ampicillin is most likely due to which of the following mechanisms?

A. Increase in the intracellular uptake of gentamicin (Correct Answer)
B. Sequential block of essential micronutrient synthesis
C. Inhibition of the acetylation of gentamicin
D. Additive bacteriostatic effect of ampicillin
E. Stabilization of gentamicin binding at the target site

Explanation: ***Increase in the intracellular uptake of gentamicin*** - This scenario describes **synergism**, where ampicillin (a cell wall synthesis inhibitor) damages the bacterial cell wall, allowing better penetration of gentamicin (an aminoglycoside) into the cell. Aminoglycosides require **active transport** across the bacterial cell membrane, which is enhanced by cell wall disruption. - The significant reduction in gentamicin's MIC when combined with ampicillin demonstrates that ampicillin facilitates gentamicin's access to its **ribosomal target**, leading to a more potent bactericidal effect. *Sequential block of essential micronutrient synthesis* - **Sequential block** typically refers to the synergistic action of drugs like trimethoprim and sulfamethoxazole, which inhibit different steps in the **folic acid synthesis pathway**. - This mechanism is not directly applicable to the combination of a cell wall inhibitor and an aminoglycoside, which target different cellular processes. *Inhibition of the acetylation of gentamicin* - **Acetylation** is a common mechanism of aminoglycoside inactivation by bacterial enzymes (aminoglycoside-modifying enzymes). - Ampicillin does not primarily work by inhibiting these enzymes; its main action is on **peptidoglycan synthesis** in the bacterial cell wall. *Additive bacteriostatic effect of ampicillin* - Ampicillin is a **bactericidal antibiotic** that works by inhibiting cell wall synthesis, not typically bacteriostatic in its primary action, especially against susceptible organisms. - The dramatic drop in gentamicin's MIC suggests more than just an additive bacteriostatic effect; it indicates a **synergistic interaction** leading to enhanced bactericidal activity. *Stabilization of gentamicin binding at the target site* - Gentamicin binds to the bacterial **30S ribosomal subunit**, inhibiting protein synthesis. - Ampicillin's mechanism of action is on the **bacterial cell wall**, and it does not directly stabilize the binding of gentamicin to the ribosome. Its role is to facilitate gentamicin's entry into the cell.

Question 87: A 42-year-old woman with a history of multiple sclerosis and recurrent urinary tract infections comes to the emergency department because of flank pain and fever. Her temperature is 38.8°C (101.8°F). Examination shows left-sided costovertebral angle tenderness. She is admitted to the hospital and started on intravenous vancomycin. Three days later, her symptoms have not improved. Urine culture shows growth of Enterococcus faecalis. Which of the following best describes the most likely mechanism of antibiotic resistance in this patient?

A. Increased efflux across bacterial cell membranes
B. Production of beta-lactamase
C. Alteration of penicillin-binding proteins
D. Alteration of peptidoglycan synthesis (Correct Answer)
E. Alteration of ribosomal targets

Explanation: ***Alteration of peptidoglycan synthesis*** - **Vancomycin** targets the **D-Ala-D-Ala terminus** on the peptidoglycan precursor, preventing cross-linking during bacterial cell wall synthesis. - **Vancomycin resistance in Enterococcus faecalis** occurs through acquisition of resistance genes (vanA, vanB) that encode enzymes modifying the peptidoglycan precursor from **D-Ala-D-Ala to D-Ala-D-Lac**. - This structural change reduces vancomycin's binding affinity by approximately 1000-fold, rendering the antibiotic ineffective. - The mechanism directly involves **alteration of the peptidoglycan synthesis pathway**, specifically the terminal amino acid residues of the pentapeptide precursor. *Increased efflux across bacterial cell membranes* - This mechanism involves **efflux pumps that actively transport antibiotics out of the bacterial cell**, reducing intracellular concentration. - While efflux pumps contribute to resistance for antibiotics like **tetracyclines, fluoroquinolones, and macrolides**, this is not the primary mechanism of vancomycin resistance in Enterococcus. *Production of beta-lactamase* - **Beta-lactamase enzymes** hydrolyze the **beta-lactam ring** of antibiotics like **penicillins and cephalosporins**, rendering them inactive. - **Vancomycin is a glycopeptide antibiotic, not a beta-lactam**, so its efficacy is not affected by beta-lactamase production. *Alteration of ribosomal targets* - This mechanism confers resistance to antibiotics that target **bacterial ribosomes** to inhibit protein synthesis, such as **macrolides, aminoglycosides, and tetracyclines**. - **Vancomycin acts on cell wall synthesis**, not protein synthesis, so alteration of ribosomal targets is not relevant to vancomycin resistance. *Alteration of penicillin-binding proteins* - **Penicillin-binding proteins (PBPs)** are the targets of **beta-lactam antibiotics** (penicillins, cephalosporins, carbapenems). - Alterations in PBPs cause resistance to beta-lactams, not to vancomycin. - **Vancomycin does not interact with PBPs**; it binds directly to the D-Ala-D-Ala terminus of peptidoglycan precursors in the cell wall.

Question 88: A 56-year-old man presents with breathlessness and altered mental status. The patient’s daughter says that he has been having high fever and cough for the last 3 days. Past medical history is significant for a recent hospitalization 5 days ago, following a successful coronary artery bypass grafting (CABG). In the post-operative period, he was in an intensive care unit (ICU) for 6 days, including 12 hours on mechanical ventilation. Current medications are aspirin and rosuvastatin. The patient’s daughter mentions that he has had anaphylactic reactions to penicillin in the past. His temperature is 39.4°C (103°F), pulse rate is 110/min, blood pressure is 104/78 mm Hg, and respiratory rate is 30/min. On physical examination, the patient is confused and disoriented and shows signs of respiratory distress and cyanosis. On chest auscultation, there is crepitus in the right lung. The patient is immediately started on oxygen therapy, intravenous fluids, and supportive care. After the collection of appropriate samples for bacteriological culture, treatment with empirical intravenous antibiotics are started. After 24 hours of treatment, the microbiology results indicate Pseudomonas aeruginosa infection. Antibiotic therapy is changed to a combination of aztreonam and tobramycin. Which of the following best describes the rationale for choosing this antibiotic combination?

A. Broad-spectrum coverage against anaerobes by adding tobramycin to aztreonam
B. Synergism of aztreonam with tobramycin (Correct Answer)
C. Reduction of the side-effects of both aztreonam and tobramycin
D. Broad-spectrum coverage against gram-positive cocci by adding tobramycin to aztreonam
E. Effective combination of a bactericidal and a bacteriostatic antimicrobial against Pseudomonas aeruginosa

Explanation: ***Synergism of aztreonam with tobramycin*** - This combination provides a **synergistic effect** against *Pseudomonas aeruginosa*, meaning their combined action is greater than the sum of their individual effects. - Aztreonam is a **monobactam** that targets gram-negative bacteria, and tobramycin is an **aminoglycoside**; their co-administration often enhances bactericidal activity and helps overcome resistance. *Broad-spectrum coverage against anaerobes by adding tobramycin to aztreonam* - Tobramycin is an **aminoglycoside** primarily effective against aerobic gram-negative bacteria and has **no significant activity against anaerobes**. - Aztreonam also **lacks activity against anaerobic bacteria**, making this option incorrect. *Reduction of the side-effects of both aztreanam and tobramycin* - Both aztreonam and tobramycin have distinct side effects, including **nephrotoxicity and ototoxicity** for tobramycin. - Combining them, especially tobramycin, generally **increases the risk of side effects** rather than reducing them, necessitating careful monitoring. *Broad-spectrum coverage against gram-positive cocci by adding tobramycin to aztreonam* - Aztreonam has a **narrow spectrum** focusing on gram-negative bacteria, and **lacks activity against gram-positive cocci**. - Tobramycin (an aminoglycoside) also has **limited activity against gram-positive cocci** when used alone, and adding it to aztreonam does not significantly broaden coverage in this regard. *Effective combination of a bactericidal and a bacteriostatic antimicrobial against Pseudomonas aeruginosa* - Both aztreonam (a beta-lactam) and tobramycin (an aminoglycoside) are **bactericidal antibiotics**, meaning they kill bacteria. - This option is incorrect because it inaccurately categorizes one of the drugs as bacteriostatic; the combination consists of two bactericidal agents.

Question 89: A 49-year-old man presents to the emergency department with acute onset of pain and redness of the skin of his lower leg for the past 3 days. He has had type 2 diabetes mellitus for the past 12 years, but he is not compliant with his medications. He has smoked 10–15 cigarettes per day for the past 20 years. His temperature is 38°C (100.4°F), pulse is 95/min, and blood pressure is 110/70 mm Hg. On physical examination, the pretibial area is erythematous, edematous, and tender. He is diagnosed with acute cellulitis, and intravenous ceftazidime sodium is started. On the 5th day of antibiotic therapy, the patient complains of severe watery diarrhea, fever, and abdominal tenderness without rigidity. Complete blood count is ordered for the patient and shows 14,000 white blood cells/mm3. Which of the following is the best initial therapy for this patient?

A. Intravenous vancomycin
B. Oral ciprofloxacin
C. Fecal microbiota transplantation
D. Oral vancomycin (Correct Answer)
E. Oral metronidazole

Explanation: ***Oral vancomycin*** - The patient exhibits classic symptoms of **Clostridioides difficile infection (CDI)**: watery diarrhea, fever, abdominal tenderness, and leukocytosis following antibiotic use (ceftazidime). Oral vancomycin is the **first-line therapy** for severe CDI. - Oral vancomycin achieves high intraluminal concentrations, effectively targeting C. difficile in the colon with minimal systemic absorption. *Intravenous vancomycin* - Intravenous vancomycin has **poor penetration** into the gastrointestinal tract and is therefore ineffective for treating C. difficile infection. - It is primarily used for systemic infections caused by **methicillin-resistant Staphylococcus aureus (MRSA)**. *Oral ciprofloxacin* - **Fluoroquinolones** like ciprofloxacin are associated with an increased risk of developing C. difficile infection due to their broad-spectrum activity. - They are not effective treatments for C. difficile and can potentially worsen the condition or select for resistant strains. *Fecal microbiota transplantation* - **Fecal microbiota transplantation (FMT)** is a highly effective treatment for recurrent C. difficile infection, but it is typically reserved for patients who have failed multiple courses of standard antibiotic therapy. - It is not considered the initial therapy for acute, uncomplicated C. difficile infection. *Oral metronidazole* - **Oral metronidazole** was historically used for C. difficile infection but is **no longer recommended** as first-line therapy per current **2021 IDSA/SHEA guidelines** due to inferior clinical outcomes compared to vancomycin or fidaxomicin. - Given the patient's fever and leukocytosis indicating severe infection, vancomycin is the preferred initial treatment.

Question 90: A 28-year-old gravida 2 para 1 is receiving care from her obstetrician at 28 weeks. She states that she has been having suprapubic pain and urinary frequency for the past week. Her past medical history is significant for dermatomyositis for which she takes prednisone every day. She does not smoke cigarettes or drinks alcohol. Her vital signs are within normal limits. Physical examination of the patient is within normal limits. A urine sample from the patient shows > 100,000 CFU of Escherichia coli. Urinalysis results are provided as follows: Leukocyte esterase positive WBC 50-100 cells/HPF Nitrite positive RBC 2 cells/HPF Epithelial cells 2 cells/HPF Urine pH 5.2 Which of the following is the best pharmacotherapy for this patient’s condition?

A. Tetracycline
B. Nitrofurantoin
C. Amoxicillin
D. Cephalexin (Correct Answer)
E. Trimethoprim-sulfamethoxazole

Explanation: ***Cephalexin*** - **Cephalexin** is the **first-line antibiotic** for uncomplicated UTI in pregnancy according to ACOG guidelines and is safe throughout all trimesters. - It provides **excellent coverage for E. coli**, good tissue penetration, and is particularly appropriate for this patient who is **immunosuppressed** (taking prednisone for dermatomyositis). - Unlike nitrofurantoin, cephalexin achieves therapeutic concentrations in both urine and tissue, reducing the risk of progression to pyelonephritis in immunocompromised patients. - The patient's clinical presentation with **suprapubic pain**, **urinary frequency**, **>100,000 CFU E. coli**, **positive leukocyte esterase**, **positive nitrites**, and **elevated WBCs** confirms acute cystitis requiring treatment. *Nitrofurantoin* - While nitrofurantoin can be used for uncomplicated UTI in pregnancy, it is **less ideal** in this case for several reasons. - It achieves **poor tissue penetration** and only therapeutic levels in urine, making it suboptimal for immunosuppressed patients at higher risk for ascending infection. - At **28 weeks gestation** (approaching third trimester), there is increasing caution about its use, and it is **contraindicated after 38 weeks** due to risk of neonatal hemolytic anemia. - Beta-lactam antibiotics like cephalexin are preferred as first-line agents per current guidelines. *Amoxicillin* - **Amoxicillin** is safe in pregnancy and provides good coverage, but increasing **community resistance rates** among E. coli strains (often 20-30%) make it less reliable as empiric therapy. - While it could be considered if susceptibility is confirmed, cephalexin has better empiric coverage and lower resistance rates. *Tetracycline* - **Tetracyclines** are **absolutely contraindicated** in pregnancy due to risks of **fetal tooth discoloration**, **enamel hypoplasia**, and **inhibition of bone growth**. - This medication can cause permanent damage to fetal development and should never be used in pregnant women. *Trimethoprim-sulfamethoxazole* - **TMP-SMX** is **contraindicated in the third trimester** due to risk of **neonatal hyperbilirubinemia** and **kernicterus**. - While it can theoretically be used in the second trimester, at **28 weeks** the patient is approaching the third trimester, and safer alternatives (beta-lactams) are available. - Additionally, TMP-SMX should be avoided in the **first trimester** due to risk of neural tube defects (folate antagonism).

Question 91: A 26-year-old woman presents to her primary care physician because she has been experiencing occasional fevers and chills for the last 3 weeks. She says that the fevers have been accompanied by abdominal pain and increased vaginal discharge. On presentation her temperature is 101.0°F (38.3°C), blood pressure is 113/75 mmHg, pulse is 105/min, and respirations are 12/min. On physical exam she is found to have tenderness over the lower abdominal quadrants, and speculum exam shows uterine inflammation as well as a retained intrauterine device. The most likely cause of this patient's symptoms should be treated with an antibiotic with which mechanism of action?

A. Folic acid synthesis inhibitor
B. Protein synthesis inhibitor (Correct Answer)
C. RNA synthesis inhibitor
D. Cell wall synthesis inhibitor
E. DNA synthesis inhibitor

Explanation: ***Protein synthesis inhibitor*** - This patient's presentation (fever, chills, abdominal pain, increased vaginal discharge, uterine inflammation, and retained IUD) is highly suggestive of **Pelvic Inflammatory Disease (PID)**. - The question specifically asks about treating **"the most likely cause"** of PID, which is ***Chlamydia trachomatis*** - the most common causative organism, particularly in young women with IUDs. - **Doxycycline**, a **protein synthesis inhibitor** (tetracycline class - binds 30S ribosomal subunit), is the antibiotic of choice for *Chlamydia trachomatis* and is a **mandatory component** of all CDC-recommended PID treatment regimens. - Standard outpatient PID treatment includes ceftriaxone (for gonorrhea) **plus** doxycycline (for chlamydia), with optional metronidazole for anaerobic coverage. *Folic acid synthesis inhibitor* - This class includes **sulfonamides** and **trimethoprim**, which inhibit bacterial folate synthesis. - These agents are primarily used for urinary tract infections, *Pneumocystis jirovecii* pneumonia, and toxoplasmosis. - They are **not first-line agents** for PID and do not adequately cover *Chlamydia trachomatis*, the most common cause. *RNA synthesis inhibitor* - **Rifamycins** (such as rifampin and rifabutin) inhibit bacterial DNA-dependent RNA polymerase. - These antibiotics are primarily used for **tuberculosis**, atypical mycobacterial infections, and prophylaxis for meningococcal or *H. influenzae* exposure. - They have **no role** in the treatment of PID or chlamydial infections. *Cell wall synthesis inhibitor* - **Ceftriaxone**, a third-generation cephalosporin and beta-lactam antibiotic, is indeed a key component of PID treatment regimens. - However, ceftriaxone primarily targets ***Neisseria gonorrhoeae***, not *Chlamydia trachomatis* (the most common cause). - *Chlamydia* is an **intracellular organism without peptidoglycan** in its cell wall, making beta-lactams ineffective against it. - While ceftriaxone is used in PID treatment, it does **not treat the most likely causative organism** specified in the question. *DNA synthesis inhibitor* - **Metronidazole** and **quinolones** are DNA synthesis inhibitors that disrupt bacterial DNA replication. - Metronidazole is often added to PID regimens to provide **anaerobic coverage**, particularly for *Bacteroides* species and other anaerobes associated with bacterial vaginosis. - However, metronidazole has **no activity against *Chlamydia trachomatis***, the most common cause of PID. - Quinolones are no longer recommended for PID due to increasing resistance in *N. gonorrhoeae*.

Question 92: A 24-year-old woman comes to the physician because of a 3-day history of lower abdominal pain and dysuria. She has a history of recurring urinary tract infections that have resolved with antibiotic treatment. She is sexually active with one male partner and they do not use condoms. She had mild pain during her last sexual intercourse one week ago. Her temperature is 38.2°C (100.8°F), pulse is 86/min, and blood pressure is 110/70 mm Hg. Physical examination shows lower abdominal tenderness and bilateral inguinal lymphadenopathy. There is a small amount of purulent vaginal discharge. Bimanual examination shows uterine and cervical motion tenderness. Laboratory studies show: Hemoglobin 12 g/dL Leukocyte count 13,500/mm3 Segmented neutrophils 75% Eosinophils 1% Lymphocytes 22% Monocytes 2% Platelet count 328,000/mm3 Erythrocyte sedimentation rate 82 mm/h Urine RBC 1–2/hpf WBC 0–1/hpf Nitrite negative Bacteria occasional Urine pregnancy test negative Which of the following is the most appropriate pharmacotherapy?

A. Oral levofloxacin and azithromycin
B. Oral metronidazole
C. Oral trimethoprim-sulfamethoxazole
D. Intramuscular ceftriaxone and oral doxycycline (Correct Answer)
E. Intramuscular leuprolide

Explanation: ***Intramuscular ceftriaxone and oral doxycycline*** - This combination provides broad-spectrum coverage for **Neisseria gonorrhoeae** (with ceftriaxone) and **Chlamydia trachomatis** (with doxycycline), the two most common causes of **pelvic inflammatory disease (PID)**, which is strongly suggested by the patient's symptoms (lower abdominal pain, cervical motion tenderness, purulent discharge, fever, and elevated ESR). - The patient's history of unprotected sex, dysuria, and a negative urine analysis for typical UTI pathogens further support a **sexually transmitted infection (STI)** leading to PID. *Oral levofloxacin and azithromycin* - While azithromycin is effective against **Chlamydia trachomatis**, levofloxacin has shown increasing resistance in **Neisseria gonorrhoeae** and is not the preferred first-line treatment for suspected gonococcal infection. - This regimen is less optimal initially for broad empiric coverage of both common PID pathogens compared to ceftriaxone and doxycycline. *Oral metronidazole* - Metronidazole is effective against **anaerobic bacteria** and **Trichomonas vaginalis** but does not cover **Neisseria gonorrhoeae** or **Chlamydia trachomatis**, the primary pathogens causing PID in this clinical context. - It would be used as an adjunct, often with other antibiotics, if anaerobic superinfection is suspected, but it's not sufficient as monotherapy for PID. *Oral trimethoprim-sulfamethoxazole* - This antibiotic is primarily used for uncomplicated **urinary tract infections (UTIs)** and certain bacterial infections, but it does not provide adequate coverage for **Neisseria gonorrhoeae** or **Chlamydia trachomatis**. - The patient's urine analysis showing negative nitrites and few WBCs suggests the abdominal pain and dysuria are not due to a typical UTI. *Intramuscular leuprolide* - Leuprolide is a **GnRH agonist** used to treat conditions like **endometriosis** or **uterine fibroids** by inducing a hypoestrogenic state. - It has no role in treating acute infections such as **pelvic inflammatory disease (PID)**.

Question 93: Blood cultures are sent to the laboratory. Antibiotic treatment is started. Blood cultures confirm an infection with methicillin-susceptible Staphylococcus epidermidis in a patient with a prosthetic heart valve. Which of the following is the most appropriate next step in management?

A. Intravenous ampicillin + rifampin + ceftriaxone for 2 weeks
B. Oral gentamicin + ceftriaxone for 4 weeks
C. Intravenous nafcillin + rifampin for 6 weeks + gentamicin for 2 weeks (Correct Answer)
D. Oral penicillin V + gentamicin for 4 weeks
E. Oral amoxicillin for 6 weeks

Explanation: ***Intravenous nafcillin + rifampin for 6 weeks + gentamicin for 2 weeks*** - For **methicillin-susceptible Staphylococcus epidermidis** prosthetic valve endocarditis, the recommended treatment combines an anti-staphylococcal penicillin (like **nafcillin**), an agent active against biofilms (**rifampin**), and an aminoglycoside for synergy (**gentamicin**). - The duration of **6 weeks** for nafcillin and rifampin, with **gentamicin for 2 weeks**, is crucial due to the difficulty of eradicating infection on prosthetic material. *Intravenous ampicillin + rifampin + ceftriaxone for 2 weeks* - **Ampicillin** is not the preferred anti-staphylococcal agent for MSSA or MSSE, and **ceftriaxone** is not typically used in this specific *Staphylococcus epidermidis* regimen. - A **2-week duration** is too short for prosthetic valve endocarditis, which requires prolonged treatment due to biofilm formation. *Oral gentamicin + ceftriaxone for 4 weeks* - **Gentamicin** has poor oral bioavailability and is typically given intravenously for serious infections like endocarditis; oral administration would be ineffective. - While ceftriaxone is sometimes used for endocarditis, it is not the primary choice for *Staphylococcus epidermidis*, and a **4-week duration** is still insufficient for prosthetic valve infection. *Oral penicillin V + gentamicin for 4 weeks* - **Penicillin V** is an oral penicillin, not suitable for serious intravenous infections like prosthetic valve endocarditis, and its spectrum does not specifically target *Staphylococcus epidermidis* effectively as a first-line agent. - **Oral gentamicin** is inappropriate, and the **4-week duration** is too short for a prosthetic valve infection. *Oral amoxicillin for 6 weeks* - **Amoxicillin** is an extended-spectrum penicillin but is not the first-line intravenous agent for *Staphylococcus epidermidis* prosthetic valve endocarditis. - **Oral administration** is inadequate for severe infections like endocarditis, which demands intravenous therapy, and a single agent is generally insufficient.

Question 94: A 45-year-old man presents to his primary care physician for lower extremity pain and unsteadiness. He describes the pain as severe and stabbing and affecting his lower extremities. These episodes of pain last for minutes at a time. He also reports knocking into furniture regularly. Medical history is significant for streptococcal pharyngitis, where he had a severe allergic reaction to appropriate treatment. He is currently sexually active with men and does not use condoms. On physical exam, his pupils are miotic in normal and low light. The pupils do not constrict further when exposed to the penlight and there is no direct or consensual pupillary dilation when the penlight is removed. The pupils constrict further when exposed to a near object. He has decreased vibration and proprioception sense in his lower extremities, absent lower extremity deep tendon reflexes, and a positive Romberg test. Which of the following is the best next step in management?

A. Intravenous penicillin
B. Intramuscular penicillin
C. Oral doxycycline
D. Intravenous doxycycline
E. Intramuscular ceftriaxone (Correct Answer)

Explanation: ***Intramuscular ceftriaxone*** - The patient's presentation with **tabes dorsalis** (stabbing pains, ataxia, absent deep tendon reflexes, loss of proprioception/vibration) and **Argyll Robertson pupils** is highly suggestive of **neurosyphilis**. - While **IV penicillin G** is the first-line treatment for neurosyphilis, the patient has a history of **severe penicillin allergy**, making penicillin use dangerous without desensitization. - **Ceftriaxone 2g IM or IV daily for 10-14 days** is an accepted alternative for neurosyphilis in penicillin-allergic patients, with adequate **CSF penetration** to treat CNS infection. - Although there is a small risk of **cross-reactivity** between cephalosporins and penicillin (approximately 1-2% for Type 1 hypersensitivity), this risk is acceptable given the need to treat active neurosyphilis and the lack of other proven effective alternatives. *Intravenous penicillin* - **Aqueous crystalline penicillin G IV** (18-24 million units/day) is the **gold standard** treatment for neurosyphilis. - However, the patient's history of a **severe allergic reaction to penicillin** contraindicates its use without prior **desensitization**. - While desensitization is recommended for neurosyphilis patients with penicillin allergy, among the options listed, ceftriaxone is the safer immediate alternative. *Intramuscular penicillin* - **Intramuscular benzathine penicillin** is used for primary, secondary, or early latent syphilis, but **does NOT achieve adequate CSF concentrations** for neurosyphilis treatment. - The patient's **severe penicillin allergy** also contraindicates its use without desensitization. *Oral doxycycline* - **Oral doxycycline** (100 mg PO BID x 28 days) can be used for primary, secondary, or latent syphilis in penicillin-allergic patients. - However, oral doxycycline **does NOT achieve adequate CSF concentrations** to effectively treat neurosyphilis and is not recommended for this indication. *Intravenous doxycycline* - **IV doxycycline does NOT achieve therapeutic concentrations in the CSF** adequate to treat neurosyphilis effectively. - There is **no established regimen or evidence** supporting IV doxycycline for neurosyphilis treatment. - For penicillin-allergic patients with neurosyphilis, **desensitization followed by IV penicillin** or **ceftriaxone** are the recommended approaches, not IV doxycycline.

Question 95: A 13-year-old girl presents with a right infected ingrown toenail. On examination, the skin on the lateral side of the toe is red, warm, swollen, and severely tender to touch. When gentle pressure is applied, pus oozes out. Culture and sensitivity analysis of the pus shows methicillin-resistant Staphylococcus aureus (MRSA). Which of the following antibiotics is most effective against this organism?

A. Clindamycin (Correct Answer)
B. Oral vancomycin
C. Aztreonam
D. Cefuroxime
E. Cefotetan

Explanation: ***Clindamycin*** - **Clindamycin** is an effective oral antibiotic for **community-acquired MRSA (CA-MRSA)** skin and soft tissue infections, especially when the organism is susceptible. - It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit and is a common first-line choice for superficial MRSA infections that do not require hospitalization or intravenous therapy. - Other oral options for CA-MRSA include **trimethoprim-sulfamethoxazole (TMP-SMX)** and **doxycycline**, but among the options listed, clindamycin is the only effective choice. *Oral vancomycin* - **Vancomycin** is an effective antibiotic for MRSA infections, but its oral form is primarily used for **Clostridioides difficile infection (CDI)** within the gastrointestinal tract. - **Oral vancomycin** is poorly absorbed systemically and therefore not effective for systemic infections or infections outside the GI tract, such as an infected ingrown toenail. *Aztreonam* - **Aztreonam** is a **monobactam antibiotic** that has activity against **Gram-negative bacteria**, including *Pseudomonas aeruginosa*. - It has no significant activity against **Gram-positive bacteria** like *Staphylococcus aureus* (MRSA). *Cefuroxime* - **Cefuroxime** is a **second-generation cephalosporin** that has good activity against sensitive *Staphylococcus aureus* and common Gram-negative organisms. - However, it, like most other cephalosporins, is **not effective against MRSA** due to the altered **penicillin-binding proteins (PBPs)** in MRSA. *Cefotetan* - **Cefotetan** is another **second-generation cephalosporin** with activity against some Gram-negative and anaerobic bacteria. - Similar to cefuroxime, it is generally **not effective against MRSA**, which expresses altered PBPs that confer resistance to beta-lactam antibiotics.

Question 96: An 18-year-old man seeks an evaluation from a physician for painful right axillary swelling since 2 days ago. He has malaise. He has no history of serious illnesses and takes no medications. He has a pet kitten which was recently treated for fleas. The temperature is 38.5℃ (101.3℉), the pulse is 88/min, the respiration rate is 14/min, and the blood pressure is 120/80 mm Hg. There are 2 painless papules on the patient’s right forearm that appeared on the healing scratch marks left by his pet kitten a few days ago. Several lymph nodes in the right axilla are enlarged and tender. The overlying skin is erythematous. No other lymphadenopathy is detected in other areas. The rest of the examination shows no abnormalities. Which of the following is the most appropriate pharmacotherapy at this time?

A. Streptomycin
B. Pyrimethamine
C. Azithromycin (Correct Answer)
D. No pharmacotherapy
E. Doxycycline

Explanation: ***Azithromycin*** - This patient's presentation with **painful axillary swelling**, **fever**, and **papules on a healing cat scratch** is highly characteristic of **cat scratch disease (CSD)**, caused by *Bartonella henselae*. - **Azithromycin** is the preferred first-line antibiotic for CSD, especially in the setting of significant lymphadenopathy, as it can reduce lymph node volume and the duration of symptoms. *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily used for severe infections like tuberculosis or tularemia, and it is **not a first-line treatment for CSD**. - Its use is associated with significant side effects including **ototoxicity** and **nephrotoxicity**. *Pyrimethamine* - **Pyrimethamine** is an antiparasitic drug used mainly for **toxoplasmosis** and some forms of malaria. - It has **no activity against *Bartonella henselae*** and would not be effective in treating CSD. *No pharmacotherapy* - While many cases of CSD may resolve spontaneously, this patient has **significant and painful regional lymphadenopathy** and systemic symptoms (fever, malaise). - **Antibiotic treatment**, particularly with azithromycin, is recommended to alleviate symptoms, reduce lymph node size, and prevent complications in such cases. *Doxycycline* - **Doxycycline** is an alternative antibiotic that can be used for CSD, particularly in older patients or those with disseminated disease, but it is **not generally preferred over azithromycin in children or adolescents** due to concerns about tooth discoloration. - It is also less effective than azithromycin for isolated lymphadenopathy.

Question 97: A 30-year-old man is diagnosed with multi-drug resistant tuberculosis after a recent trip to Eastern Europe. After drug susceptibility testing is completed, he is given a regimen of antibiotics as treatment. He returns two weeks later complaining of decreased visual acuity and color-blindness. What is the mechanism of action of the drug that is most likely to cause this side effect?

A. Inhibition of RNA translation
B. Inhibition of RNA synthesis
C. Binding to ergosterol and formation of a transmembrane channel
D. Inhibition of mycolic acid synthesis
E. Inhibition of arabinogalactan synthesis (Correct Answer)

Explanation: ***Inhibition of arabinogalactan synthesis*** - This mechanism of action describes **ethambutol**, a drug commonly used in **MDR-TB regimens**. - **Optic neuritis**, manifesting as decreased visual acuity and red-green color-blindness, is a classic and dose-dependent side effect of **ethambutol**. *Inhibition of RNA translation* - This mechanism is characteristic of **aminoglycosides** (e.g., streptomycin, amikacin) and **tetracyclines**, which are sometimes used in MDR-TB, but they mainly cause **ototoxicity** and **nephrotoxicity**, not ocular side effects. - While some aminoglycosides are active against mycobacteria, they are not primarily associated with the specific visual disturbances described. *Inhibition of RNA synthesis* - This is the mechanism of action for **rifampin**, a first-line TB drug, and **rifabutin/rifapentine**. - Rifampin's main side effects include **hepatotoxicity** and **red-orange discoloration** of bodily fluids, not visual impairment or color blindness. *Binding to ergosterol and formation of a transmembrane channel* - This is the mechanism of action for **amphotericin B**, an antifungal drug. - Amphotericin B is not used for tuberculosis treatment; its side effects include **nephrotoxicity** and **infusion-related reactions**. *Inhibition of mycolic acid synthesis* - This mechanism describes **isoniazid (INH)**, a cornerstone of TB treatment. - While isoniazid can cause **peripheral neuropathy** (prevented with pyridoxine) and **hepatotoxicity**, it does not typically cause optic neuritis with color blindness.

Question 98: A 67-year-old African American male presents to the emergency room complaining of nausea and right flank pain. He reports that these symptoms have worsened over the past two days. His past medical history is notable for congestive heart failure, hypertension, hyperlipidemia, and diabetes mellitus. He currently takes aspirin, losartan, metoprolol, atorvastatin, hydrochlorothiazide, furosemide, and metformin. He is allergic to fluoroquinolones. His temperature is 102.9°F (39.4°C), blood pressure is 100/50 mmHg, pulse is 120/min, and respirations are 28/min. On exam, he demonstrates right costovertebral angle tenderness. Urinalysis reveals 30 WBCs/hpf and positive leukocyte esterase. He is admitted and started on a broad-spectrum combination intravenous antibiotic. He recovers well and is discharged with plans to follow up in 2 weeks. At his follow-up, he reports that he has developed transient visual blurring whenever he turns his head to the right or left. He also reports that he has fallen at home multiple times. What is the mechanism of action of the drug that is most likely responsible for this patient’s current symptoms?

A. Inhibition of transpeptidase
B. Inhibition of ribosomal 30S subunit (Correct Answer)
C. Inhibition of dihydropteroate synthase
D. Inhibition of ribosomal 50S subunit
E. Inhibition of DNA gyrase

Explanation: ***Inhibition of ribosomal 30S subunit*** - The patient developed **transient visual blurring with head movement** and **falls** after treatment for a severe infection, which is pathognomonic for **aminoglycoside ototoxicity**. The transient visual blurring with head movement is characteristic of **vestibular dysfunction** affecting the **vestibulo-ocular reflex**, which normally stabilizes vision during head movements. - Given the patient's severe **pyelonephritis** requiring broad-spectrum IV antibiotics and his **fluoroquinolone allergy**, an **aminoglycoside** (gentamicin, tobramycin, or amikacin) was likely used as part of the treatment regimen. The combination of balance problems and head-movement-related visual disturbances is pathognomonic for vestibular toxicity from aminoglycosides. *Inhibition of transpeptidase* - This is the mechanism of action for **beta-lactam antibiotics** (penicillins, cephalosporins) which disrupt bacterial **cell wall synthesis** by inhibiting transpeptidases. - While beta-lactams are commonly used broad-spectrum antibiotics, their primary side effects include **hypersensitivity reactions** and gastrointestinal upset, not the **vestibular toxicity** described. *Inhibition of dihydropteroate synthase* - This is the mechanism of action for **sulfonamides** (sulfamethoxazole), which interfere with bacterial **folate synthesis**. - Side effects include **hypersensitivity reactions**, bone marrow suppression, and nephrotoxicity, but not the specific **ototoxicity** causing balance and visual symptoms. *Inhibition of ribosomal 50S subunit* - This mechanism applies to **macrolides** (azithromycin, erythromycin) and **chloramphenicol**, which inhibit bacterial protein synthesis at the 50S ribosomal subunit. - Macrolides typically cause **QT prolongation** and GI effects, while chloramphenicol causes **aplastic anemia**, but neither causes the **vestibular dysfunction** seen in this patient. *Inhibition of DNA gyrase* - This is the mechanism of action for **fluoroquinolones** (ciprofloxacin, levofloxacin), which prevent bacterial DNA replication. - The patient has a documented **fluoroquinolone allergy**, making their use unlikely. Even if used, fluoroquinolones cause **tendon rupture** and peripheral neuropathy, not the specific vestibulo-ocular symptoms described.

Question 99: A 62-year-old man presents with epigastric pain over the last 6 months. He says the pain gets worse with food, especially coffee. He also complains of excessive belching. He says he has tried omeprazole recently, but it has not helped. No significant past medical history or current medications. On physical examination, there is epigastric tenderness present on deep palpation. An upper endoscopy is performed which reveals gastric mucosa with signs of mild inflammation and a small hemorrhagic ulcer in the antrum. A gastric biopsy shows active inflammation, and the specimen stains positive with Warthin–Starry stain, revealing Helicobacter pylori. Which of the following is the next, best step in the management of this patient’s condition?

A. Perform colonoscopy
B. Start famotidine and erythromycin
C. Give amoxicillin, clarithromycin, and omeprazole (Correct Answer)
D. Give amoxicillin, erythromycin and omeprazole
E. Observation

Explanation: ***Give amoxicillin, clarithromycin, and omeprazole*** - The biopsy results confirm **Helicobacter pylori** infection, which is the primary cause of his symptoms and the gastric ulcer. - The standard first-line treatment for H. pylori eradication is **triple therapy**, consisting of a proton pump inhibitor (PPI) like **omeprazole**, and two antibiotics, typically **amoxicillin** and **clarithromycin**. *Perform colonoscopy* - A **colonoscopy** is used to examine the large intestine and is not indicated for **epigastric pain** and a confirmed **gastric ulcer** caused by H. pylori. - There are no symptoms or findings suggestive of **colonic pathology**. *Start famotidine and erythromycin* - **Famotidine** is an H2 receptor blocker, which might help with acid reduction but is insufficient alone to eradicate **H. pylori**. - **Erythromycin** is not a standard antibiotic for H. pylori eradication and is not typically used in this context. *Give amoxicillin, erythromycin and omeprazole* - While **amoxicillin** and **omeprazole** are part of the standard triple therapy, **erythromycin** is not an appropriate antibiotic for H. pylori eradication. - The typical second antibiotic in triple therapy is **clarithromycin** or metronidazole, not erythromycin. *Observation* - **Observation** is not appropriate given the confirmed **H. pylori infection** and gastric ulcer. - Untreated H. pylori can lead to complications such as **peptic ulcer disease**, **gastric adenocarcinoma**, or **MALT lymphoma**.

Question 100: A 34-year-old man comes to the physician for a 1-week history of fever and generalized fatigue. Yesterday, he developed a rash all over his body. Two months ago, he had a painless lesion on his penis that resolved a few weeks later without treatment. He has asthma. Current medications include an albuterol inhaler. He is currently sexually active with 3 different partners. He uses condoms inconsistently. Vital signs are within normal limits. He has a diffuse maculopapular rash involving the trunk, extremities, palms, and soles. An HIV test is negative. Rapid plasma reagin (RPR) and fluorescent treponemal antibody absorption test (FTA-ABS) are positive. The patient receives a dose of intramuscular benzathine penicillin G. Two hours later, he complains of headache, myalgias, and chills. His temperature is 38.8°C (101.8°F) , pulse is 105/min, respirations are 24/min, and blood pressure is 98/67 mm Hg. Which of the following is the most appropriate pharmacotherapy?

A. Epinephrine
B. Methylprednisolone
C. Ceftriaxone
D. Phenylephrine
E. Ibuprofen (Correct Answer)

Explanation: ***Ibuprofen*** - This patient is experiencing a **Jarisch-Herxheimer reaction**, which is an immune-mediated response to endotoxins released by dying spirochetes after initiation of syphilis treatment. - Management involves supportive care with antipyretics and anti-inflammatory agents like ibuprofen, as the reaction is typically self-limiting. *Epinephrine* - **Epinephrine** is used to treat **anaphylaxis**, a severe allergic reaction characterized by widespread systemic symptoms such as bronchospasm, angioedema, and circulatory collapse. - The patient's symptoms are consistent with a Jarisch-Herxheimer reaction, not anaphylaxis, and his blood pressure is not severely low enough to warrant epinephrine. *Methylprednisolone* - **Corticosteroids** like methylprednisolone are used for severe inflammatory conditions or allergic reactions; however, they are generally not needed for the self-limiting Jarisch-Herxheimer reaction. - While steroids can theoretically reduce the inflammatory response, they are not the first-line treatment for an uncomplicated Jarisch-Herxheimer reaction. *Ceftriaxone* - **Ceftriaxone** is an antibiotic used to treat various bacterial infections, including gonorrhea and some forms of syphilis in penicillin-allergic patients. - The patient has already received appropriate penicillin treatment for syphilis, and additional antibiotics are not indicated for the Jarisch-Herxheimer reaction. *Phenylephrine* - **Phenylephrine** is a vasopressor used to treat hypotension by increasing vascular tone. - Although the patient's blood pressure is slightly low, it is not critically low, and the primary issue is the inflammatory response of the Jarisch-Herxheimer reaction, which does not typically require vasopressor support.

Question 101: A patient weighing 70 kg (154 lb) requires intravenous antibiotics for a calcified abscess. The desired target plasma concentration of the antibiotic is 4.5 mg/L. The patient is estimated to have a volume of distribution of 30 L and a clearance rate of 60 mL/min. How many milligrams of the drug should be administered for the initial dose to reach the desired target plasma concentration?

A. 70 mg
B. 35 mg
C. 200 mg
D. 270 mg
E. 135 mg (Correct Answer)

Explanation: ***135 mg*** - The **loading dose (LD)** is calculated using the formula: LD = Vd × Css, where Vd is the **volume of distribution** and Css is the **desired steady-state plasma concentration**. - Given Vd = **30 L** and Css = **4.5 mg/L**, the loading dose is 30 L × 4.5 mg/L = **135 mg**. *70 mg* - This value is significantly lower than the calculated loading dose and would result in an **insufficient initial plasma concentration** to achieve the desired therapeutic effect. - It does not account for the specified **volume of distribution** or the target concentration. *35 mg* - This amount is substantially less than the required loading dose and would be **ineffective** in achieving the target plasma concentration of 4.5 mg/L. - This calculation might arise from incorrect substitution or misunderstanding of the drug dosage formula. *200 mg* - This dose is higher than necessary to achieve the target plasma concentration, potentially increasing the risk of **toxicity** without added therapeutic benefit. - An overdose could lead to **adverse drug reactions** due to exceeding the therapeutic window. *270 mg* - This dose is double the correct loading dose, which would lead to an **excessively high initial plasma concentration**. - Such an overdose could result in **significant side effects** or toxicity, especially with drugs having a narrow therapeutic index.

Question 102: An 8-year-old girl is brought to the emergency room for a 6-hour history of fever, sore throat, and difficulty swallowing. Physical examination shows pooling of oral secretions and inspiratory stridor. Lateral x-ray of the neck shows thickening of the epiglottis and aryepiglottic folds. Throat culture with chocolate agar shows small, gram-negative coccobacilli. The patient's brother is started on the recommended antibiotic for chemoprophylaxis. Which of the following is the primary mechanism of action of this drug?

A. Inhibition of the 50S ribosomal subunit
B. Inhibition of prokaryotic topoisomerase II
C. Inhibition of DNA-dependent RNA-polymerase (Correct Answer)
D. Inhibition of the 30S ribosomal subunit
E. Inhibition of peptidoglycan crosslinking

Explanation: ***Inhibition of DNA-dependent RNA-polymerase*** - The clinical picture strongly suggests **epiglottitis** caused by *Haemophilus influenzae type b* (Hib), characterized by **fever, sore throat, difficulty swallowing, pooling of oral secretions, inspiratory stridor**, and **epiglottic thickening** on X-ray. - **Rifampin** is the recommended antibiotic for chemoprophylaxis in close contacts of Hib patients; its primary mechanism of action is to inhibit bacterial **DNA-dependent RNA polymerase**, thereby preventing **mRNA synthesis**. *Inhibition of the 50S ribosomal subunit* - This mechanism is characteristic of **macrolides** (e.g., azithromycin, erythromycin) and **clindamycin**, which are not the primary choice for Hib chemoprophylaxis. - These drugs prevent **protein synthesis** by interfering with translocation or peptide bond formation on the larger ribosomal subunit. *Inhibition of prokaryotic topoisomerase II* - This is the mechanism of action for **fluoroquinolones** (e.g., ciprofloxacin), which are typically reserved for specific infections due to potential side effects in children. - Fluoroquinolones interfere with **DNA replication** and **transcription** by preventing DNA unwinding and supercoiling. *Inhibition of the 30S ribosomal subunit* - This mechanism is associated with **tetracyclines** and **aminoglycosides** (e.g., doxycycline, gentamicin). - These antibiotics block **protein synthesis** by preventing tRNA attachment or causing misreading of mRNA. *Inhibition of peptidoglycan crosslinking* - This describes the mechanism of **beta-lactam antibiotics** (e.g., penicillin, amoxicillin, cephalosporins), which inhibit bacterial **cell wall synthesis**. - While some beta-lactams are used to treat Hib infections, they are not the primary drug for **chemoprophylaxis**.

Question 103: A 13-year-old boy re-presents to his pediatrician with a new onset rash that began a few days after his initial visit. He initially presented with complaints of sore throat but was found to have a negative strep test. His mother demanded that he be placed on antibiotics, but this was refused by his pediatrician. The boy's father, a neurologist, therefore, started him on penicillin. Shortly after starting the drug, the boy developed a fever and a rash. The patient is admitted and his symptoms worsen. His skin begins to slough off, and the rash covers over 30% of his body. His oropharynx and corneal membranes are also affected. You examine him at the bedside and note a positive Nikolsky's sign. What is the most likely diagnosis?

A. Erythema Multiforme
B. Pemphigus Vulgaris
C. Toxic Epidermal Necrolysis (Correct Answer)
D. Rocky Mountain Spotted Fever
E. Stevens-Johnson Syndrome

Explanation: **Toxic Epidermal Necrolysis** - The rapid onset of a widespread, **sloughing rash** covering **over 30%** of the body surface area, involvement of **mucous membranes** (oropharynx, corneal), **fever**, and a **positive Nikolsky's sign** strongly indicate **Toxic Epidermal Necrolysis (TEN)**. - TEN is most commonly triggered by **drugs**, and the boy's recent initiation of **penicillin** (an antibiotic) aligns with this etiology. *Erythema Multiforme* - Characterized by **target lesions** on the skin, often precipitated by infections (like herpes simplex virus) or drugs. - While it can involve mucous membranes, it typically does not present with diffuse **epidermal sloughing** covering >30% of the body surface. *Pemphigus Vulgaris* - This is a chronic **autoimmune bullous disease** causing intraepidermal blistering, and a positive Nikolsky's sign is characteristic. - However, it typically presents with more protracted disease course and is not usually triggered acutely by a drug in this manner; also, the widespread, rapid sloughing seen here is more characteristic of TEN. *Rocky Mountain Spotted Fever* - Presents with a **maculopapular rash** that typically starts on the extremities and spreads centrally, often involving palms and soles, following a tick bite. - It does not cause widespread **epidermal necrosis** or a positive Nikolsky's sign. *Stevens-Johnson Syndrome* - SJS is indeed a severe mucocutaneous reaction, similar to TEN, often drug-induced, and involves mucous membranes and skin blistering with a positive Nikolsky's sign. - The critical differentiating factor is the body surface area involvement: SJS affects **less than 10%** of the body surface, whereas TEN involves **over 30%**, as described in the patient.

Question 104: A 45-year-old man presents to the physician with complaints of fever with rigors, headache, malaise, muscle pains, nausea, vomiting, and decreased appetite for the past 3 days. He informs the physician that he had been backpacking on the Appalachian Trail in the woods of Georgia in the month of June, 2 weeks ago, and had been bitten by a tick there. His temperature is 39.0°C (102.3°F), pulse is 94/min, respirations are 18/min, and blood pressure is 126/82 mm Hg. His physical exam does not reveal any significant abnormality except for mild splenomegaly. Laboratory studies show: Total white blood cell count 3,700/mm3 (3.7 x 109/L) Differential count Neutrophils 85% Lymphocytes 12% Monocytes 2% Eosinophils 1% Basophils 0% Platelet count 88,000/mm3 (95 x 109/L) Serum alanine aminotransferase 140 IU/L Serum aspartate aminotransferase 80 IU/L Microscopic examination of a peripheral blood smear stained with Wright-Giemsa stain shows the presence of morulae in the cytoplasm of leukocytes. In addition to drugs for symptomatic relief, what is the most appropriate initial step in the treatment of this patient?

A. Doxycycline (Correct Answer)
B. Ceftriaxone
C. Rifampin
D. Ciprofloxacin
E. Daptomycin

Explanation: ***Doxycycline*** - The patient's presentation with **fever, myalgia, headache, thrombocytopenia, leukopenia, elevated liver enzymes**, a history of **tick bite** in an endemic area (Appalachian Trail, Georgia), and the presence of **morulae in leukocytes** strongly indicates **ehrlichiosis** or **anaplasmosis**. - **Doxycycline** is the **first-line treatment** for all rickettsial diseases, including ehrlichiosis and anaplasmosis, regardless of age or pregnancy status, due to its effectiveness in preventing severe complications. *Ceftriaxone* - While effective against many bacterial infections, **ceftriaxone** is **not effective** against intracellular bacteria like *Ehrlichia* or *Anaplasma*. - It is typically used for conditions like Lyme disease (later stages), meningitis, or community-acquired pneumonia, which do not match the complete clinical picture here. *Rifampin* - **Rifampin** is sometimes used for treatment of ehrlichiosis in patients who **cannot tolerate doxycycline**, but it is **not the first-line agent**. - Its primary uses are for tuberculosis and prophylaxis of meningococcal disease, making it an inappropriate initial choice given the classic presentation. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone antibiotic primarily used for urinary tract infections, respiratory infections, and some gastrointestinal infections. - It has **no significant activity** against species of *Ehrlichia* or *Anaplasma* and is therefore not indicated for this condition. *Daptomycin* - **Daptomycin** is a lipopeptide antibiotic used for treating **Gram-positive bacterial infections**, especially those resistant to other antibiotics (e.g., MRSA). - It is **ineffective** against the intracellular Gram-negative bacteria causing ehrlichiosis or anaplasmosis.

Question 105: A 22-year-old male presents to the physician with a 9-year history of recurring acne on his face. He has tried a number of over-the-counter face wash, gels, and supplements over the past few years with temporary relief but no significant lasting effects. The acne has gotten worse over time and now he is especially concerned about his appearance. A physical examination reveals numerous nodulocystic lesions over the face and neck. Scarring is present interspersed between the pustules. There are some lesions on the shoulders and upper back as well. Which of the following is the most appropriate treatment option for this patient at this time?

A. Oral isotretinoin (Correct Answer)
B. Topical isotretinoin
C. Oral erythromycin
D. Oral doxycycline
E. Topical salicylic acid

Explanation: **Oral isotretinoin** - This patient presents with severe **nodulocystic acne** and significant scarring, which has been refractory to topical and over-the-counter treatments for 9 years. **Oral isotretinoin** is the most effective treatment for severe, recalcitrant nodulocystic acne, often leading to long-term remission. - Its mechanism involves reducing **sebaceous gland size and activity**, inhibiting keratinization, and exerting anti-inflammatory effects. *Topical isotretinoin* - **Topical isotretinoin** is effective for mild to moderate inflammatory and comedonal acne, but it is insufficient for severe nodulocystic acne with widespread scarring. - The systemic effects required to address the severity of this patient's condition cannot be achieved with topical application. *Oral erythromycin* - **Oral erythromycin** is an antibiotic that can be used for moderate inflammatory acne, but it is generally less effective than tetracyclines and has a higher risk of bacterial resistance. - For severe nodulocystic acne, particularly when long-standing and scarring, it is not considered a first-line or highly effective treatment option. *Oral doxycycline* - **Oral doxycycline**, a tetracycline antibiotic, is used for moderate to severe inflammatory acne and acts as both an antibacterial and an anti-inflammatory agent. - While effective for some cases, it is typically not sufficient for the most severe forms of **nodulocystic acne associated with significant scarring and long-term recurrence**, where isotretinoin is superior. *Topical salicylic acid* - **Topical salicylic acid** is a comedolytic agent used for mild acne with predominantly blackheads and whiteheads. - It is ineffective for severe, **inflammatory nodulocystic lesions** and does not address the underlying pathology of recalcitrant acne that has already led to scarring.

Question 106: A 26-year-old woman comes to the emergency department with fever, abdominal pain, and nausea for the past 7 hours. The pain started in the right lower abdomen but has now progressed to diffuse abdominal pain. Her temperature is 39.5°C (103.1°F). Physical examination shows generalized abdominal tenderness with rebound, guarding, and decreased bowel sounds. She is taken for an emergency exploratory laparoscopy, which shows a perforated appendix with an adjacent abscess and peritoneal inflammation. Cultures from the abscess fluid grow catalase-producing, anaerobic, gram-negative rods that have the ability to grow in bile. Which of the following is the most appropriate pharmacotherapy for this patient?

A. Cefazolin and doxycycline
B. Aztreonam
C. Piperacillin
D. Vancomycin and azithromycin
E. Ampicillin and sulbactam (Correct Answer)

Explanation: ***Ampicillin and sulbactam*** - This combination is effective against **anaerobic gram-negative rods** (like *Bacteroides fragilis* often found in abdominal abscesses) and covers many **enteric gram-negative aerobes** and **gram-positive organisms** that commonly cause intra-abdominal infections. - The organism description (catalase-producing, anaerobic, gram-negative rod, grows in bile) strongly points to a *Bacteroides* species, for which **beta-lactam/beta-lactamase inhibitors** like ampicillin/sulbactam are a primary treatment. *Cefazolin and doxycycline* - **Cefazolin** is a first-generation cephalosporin primarily active against gram-positive cocci and some gram-negative rods but has **poor anaerobic coverage**. - **Doxycycline** has some activity against atypical organisms and some gram-positives but is not a primary choice for severe intra-abdominal infections with anaerobic components. *Aztreonam* - **Aztreonam** is a monobactam antibiotic with excellent activity against **gram-negative aerobic rods**, but it has **no activity against gram-positive bacteria or anaerobes**. - This makes it an inappropriate single agent for a polymicrobial infection involving anaerobes, as seen in a perforated appendix. *Piperacillin* - While **piperacillin** alone has some activity against gram-negative aerobes, it is a **penicillinase-sensitive penicillin** and lacks sufficient activity against **beta-lactamase-producing anaerobes** like *Bacteroides fragilis* without a beta-lactamase inhibitor. - Therefore, it would not adequately cover the described organism. *Vancomycin and azithromycin* - **Vancomycin** is primarily active against **gram-positive bacteria**, especially MRSA, and has no activity against gram-negative or anaerobic organisms. - **Azithromycin** is a macrolide primarily used for respiratory tract infections and atypical bacteria, with **very limited activity against enteric gram-negative rods and anaerobes**.

Question 107: An 8-year-old girl is brought to the emergency department because of a 2-day history of low-grade fever, itchy rash, and generalized joint pain. The rash initially started in the antecubital and popliteal fossae and then spread to her trunk and distal extremities. One week ago, she was diagnosed with acute sinusitis and was started on amoxicillin. She has no history of adverse drug reactions and immunizations are up-to-date. Her temperature is 37.5°C (99.5°F), pulse is 90/min, and blood pressure is 110/70 mm Hg. Physical examination shows periorbital edema and multiple erythematous, annular plaques of variable sizes over her entire body. One of the lesions in the right popliteal fossa has an area of central clearing and the patient's mother reports that it has been present for over 24 hours. Urinalysis is normal. Which of the following is the most likely diagnosis?

A. Stevens-Johnson syndrome
B. Pemphigus vulgaris
C. Drug reaction with eosinophilia and systemic symptoms
D. Serum sickness-like reaction (Correct Answer)
E. IgA vasculitis

Explanation: ***Serum sickness-like reaction*** - The patient's symptoms, including **low-grade fever, itchy rash (urticarial or morbilliform), generalized joint pain (arthralgia)**, and **periorbital edema**, developing about a week after starting **amoxicillin**, are classic for a serum sickness-like reaction. This reaction is often triggered by **beta-lactam antibiotics** in children. - The presence of **annular plaques with central clearing** (targetoid lesions) and the 24-hour duration of lesions further supports this diagnosis, as these are common cutaneous manifestations. *Stevens-Johnson syndrome* - SJS is characterized by **extensive epidermal necrosis and detachment**, often involving **mucous membranes (oral, ocular, genital)**, which are not described in this patient. - The rash in SJS typically consists of irregular, dusky red or purple macules and plaques with blistering, evolving into significant skin sloughing, unlike the described annular, itchy plaques. *Pemphigus vulgaris* - Pemphigus vulgaris is an **autoimmune blistering disease** causing flaccid bullae and erosions on the skin and mucous membranes. It is not associated with acute drug exposure. - The patient's rash is described as itchy, erythematous, annular plaques, without mention of flaccid blisters or extensive erosions typical of pemphigus vulgaris. *Drug reaction with eosinophilia and systemic symptoms* - **DRESS syndrome** typically presents with a more severe and widespread morbilliform rash, often with **facial edema**, along with systemic symptoms such as **lymphadenopathy, hepatitis, nephritis, and eosinophilia**, which are not indicated in this case (normal urinalysis). - The onset of DRESS syndrome is usually **2-6 weeks** after drug exposure, which is longer than the 1-week interval presented here. *IgA vasculitis* - **IgA vasculitis (Henoch-Schönlein purpura)** characteristically presents with **palpable purpura**, particularly on the lower extremities and buttocks, often accompanied by **arthralgia, abdominal pain, and renal involvement (hematuria/proteinuria)**. - While arthritis and rash are present, the rash is described as erythematous, annular, and itchy, rather than the non-blanching palpable purpura typical of IgA vasculitis, and urinalysis is normal, ruling out renal involvement.

Question 108: A 57-year-old HIV-positive male with a history of intravenous drug abuse presents to the emergency room complaining of arm swelling. He reports that he developed progressively worsening swelling and tenderness over the right antecubital fossa three days prior. He recently returned from a trip to Nicaragua. His past medical history is notable for an anaphylactoid reaction to vancomycin. His temperature is 101.4°F (38.6°C), blood pressure is 140/70 mmHg, pulse is 110/min, and respirations are 20/min. Physical examination reveals an erythematous, fluctuant, and tender mass overlying the right antecubital fossa. Multiple injection marks are noted across both upper extremities. He undergoes incision and drainage and is started on an antibiotic that targets the 50S ribosome. He is discharged with plans to follow up in one week. However, five days later he presents to the same emergency room complaining of abdominal cramps and watery diarrhea. Which of the following classes of pathogens is most likely responsible for this patient’s current symptoms?

A. Gram-negative curved bacillus
B. Gram-negative bacillus
C. Anaerobic flagellated protozoan
D. Gram-positive bacillus (Correct Answer)
E. Gram-positive coccus

Explanation: ***Gram-positive bacillus*** - The patient was administered an antibiotic targeting the **50S ribosomal subunit** following incision and drainage for a suspected skin infection (likely **MRSA** given IV drug abuse). This strongly suggests **clindamycin** was used. - **Clindamycin** is a known risk factor for developing **Clostridioides (formerly Clostridium) difficile infection (CDI)**, which is caused by a **Gram-positive, spore-forming bacillus** and manifests with **abdominal cramps and watery diarrhea**. *Gram-negative curved bacillus* - This class of pathogens includes organisms like **Vibrio cholerae** or **Campylobacter jejuni**, which can cause diarrhea. - However, the patient's presentation with **colitis** after antibiotic use is more consistent with **Clostridioides difficile**, not typically a curved Gram-negative bacillus. *Gram-negative bacillus* - While some Gram-negative bacilli (e.g., E. coli, Salmonella) can cause diarrhea, their association with **antibiotic-induced colitis** following treatment for a skin abscess is less direct than that of *Clostridioides difficile*. - The initial skin infection in IV drug users is most commonly staphylococcal (Gram-positive coccus), for which a 50S targeting antibiotic would be prescribed. *Anaerobic flagellated protozoan* - This description often refers to pathogens like **Giardia lamblia** or **Trichomonas vaginalis**, which are not bacteria. - While *Giardia* can cause diarrhea, it typically causes **malabsorption** and **greasy stools**, and wouldn't be triggered by recent antibiotic use for a skin infection. *Gram-positive coccus* - **Gram-positive cocci** (e.g., Staphylococcus aureus) are the likely cause of the initial skin infection/abscess. - However, they do not typically cause **antibiotic-associated colitis** with watery diarrhea; rather, the *antibiotic treatment itself* for these organisms can predispose to *Clostridioides difficile*.

Question 109: A 70-year-old man presents to his primary care physician for ear pain. The patient states he has had ear pain for the past several days that seems to be worsening. The patient lives in a retirement home and previously worked as a banker. The patient currently is active, swims every day, and drinks 3 to 4 glasses of whiskey at night. There have been multiple cases of the common cold at his retirement community. The patient has a past medical history of myocardial infarction, Alzheimer dementia, diabetes, hypertension, vascular claudication, and anxiety. His current medications include insulin, metformin, aspirin, metoprolol, lisinopril, and buspirone. His temperature is 99.5°F (37.5°C), blood pressure is 167/108 mmHg, pulse is 102/min, respirations are 17/min, and oxygen saturation is 98% on room air. Cardiopulmonary exam is within normal limits. HEENT exam is notable for tenderness over the left mastoid process. Abdominal and musculoskeletal exam are within normal limits. Which of the following is the best management for this patient's condition?

A. Acetic acid drops
B. Amoxicillin
C. Observation
D. Ciprofloxacin (Correct Answer)
E. Amoxicillin/clavulanic acid

Explanation: ***Ciprofloxacin*** - The patient's presentation with worsening ear pain, **daily swimming**, **mastoid tenderness**, diabetes, and age strongly suggests **otitis externa** with concern for **malignant (necrotizing) otitis externa**. - **Otitis externa** is common in swimmers due to water exposure that macerates the ear canal and allows bacterial invasion, primarily by **Pseudomonas aeruginosa**. - **Malignant otitis externa** is a severe, invasive infection that extends beyond the ear canal to adjacent structures (including the mastoid), occurring predominantly in elderly patients with **diabetes** or immunocompromised states. - **Ciprofloxacin** (oral or otic, depending on severity) provides excellent coverage against **Pseudomonas aeruginosa** and is the first-line treatment for severe otitis externa or when malignant otitis externa is suspected. In severe cases, IV antipseudomonal antibiotics may be needed. *Acetic acid drops* - **Acetic acid drops** are appropriate for **mild, uncomplicated otitis externa**, creating an acidic environment that inhibits bacterial growth. - However, given this patient's **diabetes**, **worsening symptoms**, **mastoid tenderness**, and risk for malignant otitis externa, topical acetic acid alone is insufficient. - This patient requires systemic antibiotic therapy with antipseudomonal coverage. *Amoxicillin* - **Amoxicillin** does not provide adequate coverage for **Pseudomonas aeruginosa**, the primary pathogen in otitis externa. - It would be appropriate for **acute otitis media** (middle ear infection), but this patient's presentation with swimming history and external/mastoid findings suggests otitis externa, not AOM. - There is no mention of middle ear findings, tympanic membrane abnormalities, or URI symptoms that would suggest AOM. *Observation* - **Observation** is not appropriate for this elderly diabetic patient with worsening symptoms and mastoid tenderness suggestive of progressive or complicated infection. - Delaying treatment risks progression to **malignant otitis externa**, which can lead to serious complications including **osteomyelitis of the skull base**, **cranial nerve palsies**, **meningitis**, or **death**. - Immediate antibiotic therapy is essential in high-risk patients. *Amoxicillin/clavulanic acid* - **Amoxicillin/clavulanic acid** provides coverage against common respiratory pathogens like **Streptococcus pneumoniae**, **Haemophilus influenzae**, and **Moraxella catarrhalis**, making it appropriate for **acute otitis media**. - However, it does not adequately cover **Pseudomonas aeruginosa**, the predominant pathogen in otitis externa, especially in swimmers. - This patient's clinical presentation (swimmer, external ear/mastoid findings, diabetes) indicates otitis externa, not AOM, making amoxicillin/clavulanic acid an inappropriate choice.

Question 110: A 27-year-old woman comes to the physician because of a 2-day history of severe burning pain with urination, and urinary frequency. She has no history of serious illness. The patient and her husband are currently trying to conceive a child. Her only medication is a prenatal multivitamin. Her temperature is 36.5°C (97.7°F), pulse is 75/min, and blood pressure is 125/78 mm Hg. Examination shows mild tenderness to palpation over the suprapubic region. There is no costovertebral angle tenderness. The remainder of the examination shows no abnormalities. Laboratory studies show: Hemoglobin 14.8 g/dL Leukocyte count 8,200/mm3 Platelet count 230,000/mm3 Urine pH 7 WBC 52/hpf RBC 17/hpf Protein negative Nitrites positive Leukocyte esterase positive A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?

A. Urinary catheterization
B. Urine culture
C. Reassurance and follow-up in 2 weeks
D. Oral fosfomycin (Correct Answer)
E. Oral ciprofloxacin

Explanation: ***Oral fosfomycin*** - This patient presents with symptoms of **uncomplicated cystitis** (dysuria, urinary frequency, suprapubic tenderness) and **positive urinalysis findings** (WBCs, RBCs, nitrites, leukocyte esterase). - Her lack of fever, flank pain, or CVA tenderness, plus the negative pregnancy test, makes her a candidate for **first-line empiric antibiotic treatment**, and fosfomycin is a good choice for *uncomplicated cystitis* due to its single-dose regimen and broad-spectrum activity against common uropathogens. *Urinary catheterization* - **Catheterization** is typically reserved for patients who cannot void, have neurogenic bladder dysfunction, or require sterile urine collection when a clean catch is impossible. - This patient can urinate and has no contraindications to a clean-catch sample, making catheterization an **invasive and unnecessary procedure** at this point. *Urine culture* - While a **urine culture** is often performed, in *uncomplicated cystitis* in healthy, non-pregnant women, **empiric treatment** is usually initiated without waiting for culture results. - Culture results are more critical in cases of *complicated UTIs*, recurrent UTIs, treatment failure, or if pyelonephritis is suspected. *Reassurance and follow-up in 2 weeks* - This patient has classic symptoms and objective evidence of a **urinary tract infection (UTI)**, which requires antibiotic treatment. - Failing to treat a UTI can lead to worsening symptoms, potential **pyelonephritis**, and discomfort, making reassurance an **inappropriate and unsafe** management strategy. *Oral ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone that, while effective against UTIs, is typically **not recommended as a first-line agent for uncomplicated cystitis** due to concerns about increasing antibiotic resistance. - Guidelines recommend reserving fluoroquinolones for more complicated UTIs or when first-line agents are contraindicated or failed.

Question 111: A 25-year-old G1P0 woman at 33 weeks gestation presents to the obstetrician for an episode of postcoital spotting. The patient’s pregnancy is complicated by diet-controlled gestational diabetes. She has no other medical conditions. She takes prenatal vitamins. She denies tobacco, alcohol, or recreational drug use. She is currently sexually active with her boyfriend of 1 year, but prior to her current relationship, she states she had multiple male partners. On physical examination, no vaginal bleeding is appreciated. The cervix is closed, and there is no leakage of fluid or contractions. Fetal movement is normal. Fundal height is 33 cm. Fetal pulse is 138/min. The patient’s temperature is 37.0 °C (98.6°F), blood pressure is 112/75 mm Hg, and pulse is 76/min. A urine dipstick is negative for glucose and protein. Chlamydia trachomatis nucleic acid amplification testing is positive. Which of the following is the mechanism behind the first-line treatment for this patient’s condition?

A. Inhibits transpeptidase and cell wall synthesis
B. Inhibits the 30S ribosome subunit
C. Inhibits the 50S ribosome subunit (Correct Answer)
D. Inhibits DNA gyrase
E. Disrupts peptidoglycan cross-linking

Explanation: ***Inhibits the 50S ribosome subunit*** - The patient has **Chlamydia trachomatis**, which is typically treated using **azithromycin** in pregnant patients; azithromycin is a macrolide antibiotic. - **Macrolide antibiotics** like azithromycin inhibit bacterial protein synthesis by reversibly binding to the **50S ribosomal subunit**, thereby blocking peptide chain elongation. *Inhibits transpeptidase and cell wall synthesis* - This mechanism describes **beta-lactam antibiotics** such as penicillins and cephalosporins. - While some beta-lactams are safe in pregnancy, they are not the first-line treatment for **Chlamydia trachomatis infection**. *Inhibits the 30S ribosome subunit* - This is the mechanism of action for **tetracyclines** (e.g., doxycycline) and **aminoglycosides** (e.g., gentamicin). - **Tetracyclines are contraindicated in pregnancy** due to adverse effects on fetal bone and tooth development. Aminoglycosides are not first-line for Chlamydia. *Inhibits DNA gyrase* - This mechanism is characteristic of **fluoroquinolone antibiotics** (e.g., ciprofloxacin, levofloxacin). - **Fluoroquinolones are generally avoided in pregnancy** due to potential adverse effects on fetal cartilage development. *Disrupts peptidoglycan cross-linking* - This is another way to describe the mechanism of **beta-lactam antibiotics** and other cell wall synthesis inhibitors. - This is not the primary mechanism of action for the first-line treatment of **Chlamydia trachomatis** in pregnant patients.

Question 112: A 27-year-old man presents to the emergency department with loss of consciousness. The patient was brought in 20 minutes ago by the supervisor at a homeless shelter who found him passed out next to a bottle of acetaminophen. The patient has a past medical history of HIV, hepatitis C, IV drug abuse, alcohol abuse, suicide attempt, and constipation. He takes methadone daily but is notably non-compliant with his anti-retroviral therapy. His temperature is 104°F (40°C), blood pressure is 85/40 mmHg, pulse is 180/min, respirations are 18/min, and oxygen saturation is 90% on room air. The patient is started on IV fluids, N-acetylcysteine, and 100% oxygen. Blood cultures are obtained, and lab work is sent off. The patient is then started on broad spectrum antibiotics and given norepinephrine. Repeat vitals demonstrate hypotension and tachycardia. Serum toxicology returns and is positive for alcohol. The patient is transferred to the medicine floor and managed further. Two days later, the patient's vitals have improved. Repeat lab values are ordered and return as follows: Hemoglobin: 11 g/dL Hematocrit: 30% Leukocyte count: 6,500 cells/mm^3 with normal differential Platelet count: 245,000/mm^3 Serum: Na+: 138 mEq/L Cl-: 100 mEq/L K+: 4.1 mEq/L HCO3-: 22 mEq/L BUN: 30 mg/dL Glucose: 145 mg/dL Creatinine: 1.4 mg/dL Ca2+: 9.6 mg/dL AST: 1,440 U/L ALT: 1,350 U/L Which of the following is the best explanation for this patient’s laboratory abnormalities?

A. Antibiotic use
B. Chronic viral infection
C. Alcohol abuse
D. Previous hypotension
E. Toxic liver metabolite (Correct Answer)

Explanation: ***Toxic liver metabolite*** - The patient experienced an **acetaminophen overdose**, which leads to the production of **NAPQI**, a toxic metabolite. This causes significant **hepatocellular injury**, reflected by the extremely elevated AST and ALT levels. - The elevated AST and ALT indicate severe **acute liver damage**, which is characteristic of acetaminophen toxicity. The initial presentation with **loss of consciousness**, subsequent **hypotension**, and a history of **suicide attempt** (with a bottle of acetaminophen found nearby) strongly support this etiology. *Antibiotic use* - While some antibiotics can cause **drug-induced liver injury**, the exceptionally high AST and ALT levels (over 1000 U/L) are more indicative of a **massive hepatocellular insult** like acetaminophen toxicity, rather than a typical antibiotic reaction. - Antibiotic-induced liver damage is usually less severe and often presents with a more **cholestatic pattern** or a different enzyme elevation profile. *Chronic viral infection* - The patient has a history of **hepatitis C** and **HIV**, which can cause chronic liver inflammation and elevated transaminases. However, these conditions typically result in **persistently elevated but less dramatically high** AST and ALT levels. - The acute presentation with **loss of consciousness** and the finding of an acetaminophen bottle point to an acute event rather than a chronic viral exacerbation. *Alcohol abuse* - Chronic alcohol abuse can cause **alcoholic hepatitis** and elevated liver enzymes. However, alcoholic hepatitis typically results in an **AST:ALT ratio of 2:1 or greater**, and the values are usually in the hundreds, not in the thousands as seen here. - While serum toxicology was positive for alcohol, the **extreme transaminase elevation** is more consistent with a acute toxic injury, such as acetaminophen overdose, rather than acute on chronic alcoholic liver disease. *Previous hypotension* - **Ischemic hepatitis**, or "shock liver," can occur due to severe hypotension, leading to a rise in transaminases. However, the AST and ALT levels in ischemic hepatitis often **peak within 24-48 hours** and then fall rapidly. - While the patient was hypotensive, the context of the acetaminophen overdose provides a more specific and potent cause for the observed **massive and sustained liver enzyme elevation**.

Question 113: A 60-year-old man with a history of coronary artery disease and hyperlipidemia presents to his internist for a follow-up visit 3 weeks after visiting an urgent care center for symptoms of cough, fever, and difficulty breathing. He had been prescribed erythromycin in addition to his usual regimen of rosuvastatin and aspirin. With which potential side effect or interaction should the internist be most concerned?

A. Myalgia due to decreased rosuvastatin metabolism in the presence of erythromycin (Correct Answer)
B. Gastric bleeding due to decreased aspirin metabolism in the presence of erythromycin
C. Unstable angina due to decreased rosuvastatin metabolism in the presence of erythromycin
D. Tinnitus due to decreased aspirin metabolism in the presence of erythromycin
E. Metabolic acidosis due to decreased aspirin metabolism in the presence of erythromycin

Explanation: ***Myalgia due to decreased rosuvastatin metabolism in the presence of erythromycin*** - **Rosuvastatin** is metabolized by **CYP3A4** to a lesser extent, but it's also a substrate for **organic anion transporting polypeptide (OATP) 1B1**. **Erythromycin** is a potent **CYP3A4 inhibitor** and can also inhibit **OATP1B1**. - Inhibition of rosuvastatin metabolism/transport by erythromycin can lead to increased serum concentrations of rosuvastatin, increasing the risk of **statin-induced myopathy** and **rhabdomyolysis**, a severe adverse effect characterized by **myalgia**. *Gastric bleeding due to decreased aspirin metabolism in the presence of erythromycin* - **Aspirin's metabolism** is primarily through hydrolysis to salicylic acid; erythromycin does not significantly affect this pathway. - Gastric bleeding with aspirin is related to its **antiplatelet effects** and direct gastrointestinal irritation, not typically altered metabolism by erythromycin. *Unstable angina due to decreased rosuvastatin metabolism in the presence of erythromycin* - While **rosuvastatin levels** might increase, leading to myalgia, this interaction does not directly cause **unstable angina**. - Unstable angina is a cardiac event related to **coronary artery disease progression** or plaque rupture, not typically a direct drug-drug interaction with erythromycin and rosuvastatin. *Tinnitus due to decreased aspirin metabolism in the presence of erythromycin* - **Tinnitus** is a known side effect of **aspirin toxicity**, particularly at high doses (salicylism). - Erythromycin does not significantly alter aspirin metabolism in a way that would lead to increased aspirin levels and associated tinnitus. *Metabolic acidosis due to decreased aspirin metabolism in the presence of erythromycin* - **Metabolic acidosis** can occur with **high-dose aspirin poisoning** (salicylate poisoning). - There is no known direct interaction between erythromycin and aspirin metabolism that would lead to clinically significant changes in aspirin levels sufficient to cause metabolic acidosis.

Question 114: An investigator is studying a strain of bacteria that retains a blue color after crystal violet dye and acetone are applied. The bacteria are inoculated in a petri dish containing hypotonic saline. After the addition of an antibiotic, the bacteria swell and rupture. This antibiotic most likely belongs to which of the following classes?

A. Macrolide
B. Cephalosporin (Correct Answer)
C. Sulfonamide
D. Fluoroquinolone
E. Tetracycline

Explanation: ***Cephalosporin*** - This scenario describes a **Gram-positive bacterium** (retains blue color) which, after antibiotic treatment, swells and lyses in a hypotonic solution. This indicates a defect in the **peptidoglycan cell wall**. - **Cephalosporins** are **β-lactam antibiotics** that inhibit bacterial cell wall synthesis by interfering with **peptidoglycan cross-linking**, leading to osmotic lysis in hypotonic environments. *Macrolide* - Macrolides like **azithromycin** and **erythromycin** inhibit bacterial **protein synthesis** by binding to the 50S ribosomal subunit. - They do not directly target the cell wall, so they would not cause immediate osmotic lysis in this manner. *Sulfonamide* - Sulfonamides inhibit bacterial **folic acid synthesis** by acting as a competitive inhibitor of dihydropteroate synthase, disrupting DNA and RNA production. - Their mechanism of action does not involve direct cell wall disruption or osmotic lysis. *Fluoroquinolone* - Fluoroquinolones interfere with bacterial **DNA replication and transcription** by inhibiting **DNA gyrase** and **topoisomerase IV**. - This class of antibiotics does not primarily target the cell wall, and therefore would not lead to prompt osmotic swelling and rupture. *Tetracycline* - Tetracyclines inhibit bacterial **protein synthesis** by binding to the 30S ribosomal subunit, preventing the attachment of aminoacyl-tRNA. - They do not affect the cell wall, so they would not cause the observed osmotic lysis.

Question 115: A 61-year-old woman comes to the physician because of a 6-day history of cough, shortness of breath, and fever. She also reports that she has had 4 episodes of watery diarrhea per day for the last 3 days. She has chronic bronchitis. She has smoked one pack of cigarettes daily for the past 30 years. Her temperature is 39°C (102.2°F) and pulse is 65/min. Examination shows diffuse crackles over the left lower lung field. Laboratory studies show: Hemoglobin 13.8 g/dL Leukocyte count 16,000/mm3 Platelet count 150,000/mm3 Serum Na+ 131 mEq/L Cl- 102 mEq/L K+ 4.7 mEq/L An x-ray of the chest shows consolidation of the left lower lobe. A Gram stain of induced sputum shows numerous neutrophils but no organisms. Which of the following is the most appropriate pharmacotherapy?

A. Amoxicillin
B. Vancomycin
C. Levofloxacin (Correct Answer)
D. Rifampin
E. Cotrimoxazole

Explanation: ***Levofloxacin*** - The patient presents with **pneumonia** symptoms (cough, shortness of breath, fever, lung crackles, left lower lobe consolidation), **hyponatremia**, and **diarrhea**. This constellation of symptoms, especially in an older patient with chronic bronchitis and smoking history, is highly suggestive of **Legionella pneumonia**. - **Levofloxacin** is a **fluoroquinolone**, which is a highly effective antibiotic for treating **atypical pneumonias**, including **Legionella**, due to its excellent intracellular penetration. *Amoxicillin* - **Amoxicillin** is a **beta-lactam antibiotic** that lacks coverage for **atypical organisms** like **Legionella**, Mycoplasma, and Chlamydia. - It would not be appropriate for a suspected atypical pneumonia, especially in a patient with risk factors and characteristic extrapulmonary symptoms. *Vancomycin* - **Vancomycin** is primarily used for **Gram-positive infections**, particularly **MRSA (methicillin-resistant Staphylococcus aureus)**, and has no activity against **atypical pathogens** like **Legionella**. - There is no indication in the patient's presentation or sputum Gram stain (no organisms seen) to suggest a Gram-positive bacterial pneumonia requiring vancomycin. *Rifampin* - **Rifampin** is primarily used in the treatment of **tuberculosis** and sometimes in combination therapy for other bacterial infections, but it is not a first-line monotherapy for pneumonia. - It does not provide adequate single-agent coverage for suspected **atypical pneumonia** like **Legionella**. *Cotrimoxazole* - **Cotrimoxazole (trimethoprim-sulfamethoxazole)** is effective against a variety of bacteria, including some atypical pathogens, but it is not the preferred or most potent agent for severe **Legionella pneumonia**. - **Fluoroquinolones** or macrolides are generally considered superior for empirical or targeted treatment of **Legionella**.

Question 116: A 14-year-old boy is brought to the emergency department by his parents for joint pain following the acute onset of a diffuse, pruritic rash for the past 24 hours. A week ago, he was diagnosed with pharyngitis after returning home from summer camp and is currently taking antibiotics. There is no family history of serious illness. His temperature is 38.5°C (101.3°F), pulse is 90/min, and blood pressure is 110/70 mm Hg. Physical examination shows periorbital edema, generalized lymphadenopathy, and well-circumscribed, erythematous, confluent skin lesions of variable sizes up to several centimeters in width over his entire body. There is pain on passive movement of wrists and ankle joints bilaterally. Urine dipstick shows 1+ proteinuria. There is no hematuria. Which of the following is the most appropriate next step in management?

A. Administer diphenhydramine
B. Perform allergy testing
C. Administer prednisone
D. Switch medication to doxycycline
E. Discontinue antibiotic (Correct Answer)

Explanation: ***Discontinue antibiotic*** - The constellation of **rash, fever, joint pain, lymphadenopathy**, and **mild proteinuria** in a patient recently started on antibiotics strongly suggests **serum sickness-like reaction (SSLR)**. The most crucial initial step is to discontinue the offending agent. - SSLR is a **Type III hypersensitivity reaction** to certain drugs, particularly beta-lactam antibiotics (like cefaclor or penicillin), which manifest as immune complex deposition. *Administer diphenhydramine* - While antihistamines like diphenhydramine might help alleviate some symptoms like **pruritus**, they do not address the underlying **immune complex deposition** causing the systemic reaction. - Symptomatic treatment alone is insufficient as the primary management for SSLR, which requires removing the causative agent. *Perform allergy testing* - Allergy testing (e.g., skin prick tests) is generally performed to identify immediate **IgE-mediated hypersensitivity reactions**, not typically for delayed, immune complex-mediated reactions like SSLR. - The immediate priority is to stop the presumed causative drug, not to perform diagnostic tests that may not even be appropriate for this type of reaction. *Administer prednisone* - **Steroids (prednisone)** may be considered for severe cases of SSLR to manage systemic inflammation and immune response. - However, the initial and most critical step is to identify and **discontinue the offending antibiotic** before initiating corticosteroids, as removing the trigger is paramount to resolving the condition. *Switch medication to doxycycline* - Switching to another antibiotic, especially if the current reaction is due to antibiotics, risks **cross-reactivity** or initiating another adverse drug reaction. - Without a confirmed bacterial infection requiring immediate antibiotic therapy, continuing antibiotic treatment while an SSLR is suspected is inappropriate and potentially harmful.

Question 117: A 26-year-old female who is 12 weeks pregnant presents to her primary care physician because she is concerned about her acne. While she has struggled with acne for most of her adult life, the acne has become more severe in the past few months. She has used benzoyl peroxide, salicylic acid, and topical antibiotics in the past but these treatments have had little effect. The patient would like to try minocycline, which worked for a friend of hers. The physician responds that this drug cannot be given to pregnant women, and offers to start the patient on the drug after she delivers the baby. Minocycline may be toxic to the fetus through which mechanism?

A. Atrialization of the ventricle
B. Gray coloring of the skin
C. Formation of renal cysts
D. Inhibition of bone growth (Correct Answer)
E. Scarring of the bile ducts

Explanation: ***Inhibition of bone growth*** - **Minocycline**, a tetracycline antibiotic, can **chelate calcium** and be deposited in developing bone and teeth, leading to **inhibition of bone growth** and permanent teeth discoloration in the fetus. - This effect is particularly concerning during pregnancy and early childhood when skeletal and dental development is rapid. *Atrialization of the ventricle* - This congenital heart defect, also known as **Ebstein's anomaly**, is typically associated with exposure to **lithium** during pregnancy, not minocycline. - It involves a malformation of the tricuspid valve where portions of the right ventricle become 'atrialized'. *Gray coloring of the skin* - **Gray baby syndrome** is a rare but serious side effect seen in neonates exposed to high doses of **chloramphenicol**, not minocycline. - It is characterized by ashen-gray skin discoloration, abdominal distention, and cardiovascular collapse due to the neonate's inability to metabolize the drug. *Formation of renal cysts* - The formation of renal cysts in a fetus or newborn is usually associated with **genetic disorders** such as polycystic kidney disease or certain syndromes, or occasionally with maternal exposure to drugs like **ACE inhibitors** in late pregnancy due to their effects on renal blood flow and development. - It is not a known adverse effect of minocycline. *Scarring of the bile ducts* - **Biliary atresia**, characterized by scarring and obstruction of the bile ducts, is a congenital condition with an unknown etiology but is not linked to maternal minocycline exposure. - If untreated, it can lead to cirrhosis and liver failure.

Question 118: A 32-year-old pregnant woman presents to the clinic with complaints of cramping, abdominal pain, and severe watery diarrhea for the past 3 days. She also is nauseous and complains of fever and malaise. She was started on a 7-day course of amoxicillin after being admitted to the hospital for pyelonephritis 5 days ago. The vital signs include heart rate 98/min, respiratory rate 16/min, temperature 38.9°C (102.0°F), and blood pressure 92/56 mm Hg. Physical examination reveals abdominal distention with diffuse tenderness. Laboratory studies show a peripheral white blood cell (WBC) count of 15,000/mm3 and stool guaiac positive for occult blood. Which of the following is the best pharmacotherapy for her condition?

A. Oral nitazoxanide
B. Oral vancomycin (Correct Answer)
C. IV metronidazole plus oral vancomycin
D. Rifaximin
E. Metronidazole

Explanation: ***Oral vancomycin*** - This patient presents with **severe Clostridioides difficile infection (CDI)**: recent antibiotic use (amoxicillin), severe watery diarrhea, abdominal pain, fever, leukocytosis (WBC 15,000/mm³), and hypotension (92/56 mm Hg). - **Oral vancomycin (125 mg four times daily)** is **first-line treatment for severe CDI** per 2021 IDSA/SHEA guidelines. - It is **safe in pregnancy** due to minimal systemic absorption from the GI tract. - While hypotension raises concern, the absence of ileus or toxic megacolon means this is severe (not fulminant) CDI, making oral vancomycin monotherapy appropriate. *Oral nitazoxanide* - **Nitazoxanide** is an antiprotozoal agent used for parasitic infections like *Cryptosporidium* and *Giardia*. - It has **no role** in treating *Clostridioides difficile* infection. *IV metronidazole plus oral vancomycin* - Combination therapy with **high-dose oral vancomycin (500 mg four times daily) plus IV metronidazole** is reserved for **fulminant CDI** with hypotension/shock, ileus, or toxic megacolon. - While this patient has hypotension, the scenario does not describe ileus or megacolon, and the hypotension is relatively mild (92/56 mm Hg). - Standard-dose **oral vancomycin alone** is the appropriate initial choice for severe non-fulminant CDI. *Rifaximin* - **Rifaximin** is a non-absorbable antibiotic used to **prevent CDI recurrence** after successful treatment of an initial or recurrent episode. - It is **not recommended as initial therapy** for acute CDI. *Metronidazole* - Oral **metronidazole** was historically used for mild CDI but is **no longer recommended as first-line therapy** per current guidelines due to inferior outcomes compared to vancomycin or fidaxomicin. - It is **particularly inappropriate for severe CDI**, as in this patient with hypotension, fever, and leukocytosis.

Question 119: Five days after being admitted to the hospital for a scald wound, a 2-year-old boy is found to have a temperature of 40.2°C (104.4°F). He does not have difficulty breathing, cough, or painful urination. He initially presented one hour after spilling a pot of boiling water on his torso while his mother was cooking dinner. He was admitted for fluid resuscitation, nutritional support, pain management, and wound care, and he was progressing well until today. He has no other medical conditions. Other than analgesia during this hospital stay, he does not take any medications. He appears uncomfortable but not in acute distress. His pulse is 150/min, respirations are 41/min, and blood pressure is 90/50 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 99%. Examination shows uneven, asymmetrical scalding covering his anterior torso in arrow-like patterns with surrounding erythema and purulent discharge. The remainder of the examination shows no abnormalities. His hemoglobin is 13.4 g/dL, platelet count is 200,000/mm3, and leukocyte count is 13,900/mm3. Which of the following is the most appropriate initial pharmacological treatment for this patient?

A. Vancomycin and metronidazole
B. Amoxicillin/clavulanic acid and ceftriaxone
C. Ampicillin/sulbactam and daptomycin
D. Vancomycin and cefepime (Correct Answer)
E. Piperacillin/tazobactam and cefepime

Explanation: ***Vancomycin and cefepime*** - The patient presents with classic signs of **burn wound infection**, including fever, purulent discharge, and a rapid pulse, necessitating broad-spectrum antibiotic coverage. - **Vancomycin** provides excellent coverage against **MRSA (methicillin-resistant *Staphylococcus aureus*)**, a common pathogen in burn infections, while **cefepime** covers **gram-negative bacteria**, including *Pseudomonas aeruginosa*, which is also frequently implicated. *Vancomycin and metronidazole* - While vancomycin covers gram-positive bacteria like **MRSA**, **metronidazole** primarily targets **anaerobic bacteria**, which are less common as primary pathogens in burn wound infections. - This combination lacks adequate coverage for crucial gram-negative bacteria such as *Pseudomonas aeruginosa*. *Amoxicillin/clavulanic acid and ceftriaxone* - This combination provides coverage against some common community-acquired pathogens but is insufficient for the broad-spectrum needs of a severe **hospital-acquired burn infection**. - It lacks reliable coverage for **MRSA** and *Pseudomonas aeruginosa*, which are critical in this setting. *Ampicillin/sulbactam and daptomycin* - **Ampicillin/sulbactam** covers some gram-positive and gram-negative bacteria but would not reliably cover **MRSA** or *Pseudomonas aeruginosa*. - **Daptomycin** is effective against gram-positive bacteria, including **MRSA**, but does not cover gram-negative pathogens, leaving a significant gap in treatment. *Piperacillin/tazobactam and cefepime* - Both **piperacillin/tazobactam** and **cefepime** are excellent broad-spectrum antibiotics covering gram-negative pathogens, including *Pseudomonas aeruginosa*, but are largely redundant in this combination. - This regimen lacks specific coverage for **MRSA**, which is a significant concern in nosocomial burn wound infections.

Question 120: A 70-year-old man presents with fever, headache, and vomiting. He says that symptoms onset acutely 2 days ago and have not improved. He also reports associated weakness and chills. Past medical history is significant for occasional heartburn. His temperature is 39.4°C (103.0°F), the pulse rate is 124/min, the blood pressure is 130/84 mm Hg, and the respiratory rate is 22/min. On physical examination, there is significant nuchal rigidity. No signs of raised intracranial pressure are present. A lumbar puncture is performed and cerebrospinal fluid (CSF) analysis shows lymphocyte-dominant pleocytosis with increased CSF protein levels. Bacteriological culture of the CSF reveals the growth of Listeria monocytogenes. Which of the following antibiotics is the best choice for the treatment of this patient?

A. Ampicillin (Correct Answer)
B. Ceftriaxone
C. Ciprofloxacin
D. Chloramphenicol
E. Vancomycin

Explanation: ***Ampicillin*** - **Ampicillin** is the drug of choice for treating **Listeria monocytogenes** infections due to its excellent activity against this bacterium. - Given the patient's age (70 years old) and the serious nature of **bacterial meningitis**, prompt and appropriate antibiotic therapy with ampicillin is crucial. *Ceftriaxone* - While a broad-spectrum antibiotic often used for meningitis, **ceftriaxone lacks reliable coverage** against **Listeria monocytogenes**. - Using ceftriaxone alone in this case would lead to **treatment failure** and potentially severe outcomes. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone antibiotic that has **limited efficacy** against **Listeria monocytogenes**. - It is not recommended as a primary treatment for listerial meningitis. *Chloramphenicol* - **Chloramphenicol** has activity against Listeria but is **not a first-line agent** due to potential side effects like **bone marrow suppression** (aplastic anemia). - Its use is generally reserved for cases where other, safer options are contraindicated or ineffective. *Vancomycin* - **Vancomycin** is primarily effective against **Gram-positive bacteria**, particularly MRSA and drug-resistant pneumococci. - While Listeria is Gram-positive, **vancomycin has poor penetration into the CSF** and **limited efficacy** against Listeria monocytogenes, making it unsuitable as a primary treatment for listerial meningitis.

Question 121: A 65-year-old man with chronic obstructive lung disease, depression, and type 2 diabetes mellitus comes to the physician with fever, chills, dyspnea, and a productive cough for 5 days. His temperature is 38.8°C (101.8°F) and respirations are 30/min. An x-ray of the chest shows a right lower lobe infiltrate, and sputum culture grows bacteria that are sensitive to fluoroquinolone antibiotics. Pharmacotherapy with oral moxifloxacin is initiated. Three days later, the patient continues to have symptoms despite being compliant with the antibiotic. Serum moxifloxacin levels are undetectable. The lack of response to antibiotic therapy in this patient is most likely due to the concurrent ingestion of which of the following medications?

A. Theophylline
B. Multivitamin (Correct Answer)
C. Glimepiride
D. Prednisone
E. Amitriptyline

Explanation: ***Multivitamin*** - **Moxifloxacin is a fluoroquinolone** that undergoes chelation with **divalent and trivalent cations** (e.g., magnesium, calcium, iron, zinc), which are commonly found in multivitamins. - This chelation forms **insoluble complexes** that significantly reduce the gastrointestinal absorption of moxifloxacin, leading to undetectable serum levels and treatment failure. *Theophylline* - Theophylline is a **bronchodilator** used for COPD, but it does not interact with fluoroquinolones to reduce their absorption. - While fluoroquinolones can inhibit the metabolism of theophylline (**CYP1A2 inhibition**), leading to increased theophylline levels, this interaction would not explain undetectable moxifloxacin levels. *Glimepiride* - Glimepiride is a **sulfonylurea for type 2 diabetes** and does not interact with fluoroquinolones in a way that would decrease moxifloxacin absorption. - Fluoroquinolones can increase the risk of **hypoglycemia** when co-administered with sulfonylureas, but they do not affect each other's absorption. *Prednisone* - Prednisone is a **corticosteroid** often used for COPD exacerbations; it does not interfere with the absorption of moxifloxacin. - There are no known significant pharmacokinetic interactions between corticosteroids and fluoroquinolones that would lead to undetectable moxifloxacin levels. *Amitriptyline* - Amitriptyline is a **tricyclic antidepressant** used for depression; it does not interact with fluoroquinolones to reduce their absorption. - While fluoroquinolones can prolong the **QT interval** which could add to the **arrhythmogenic risk** of amitriptyline, this interaction does not affect moxifloxacin absorption.

Question 122: A 70-year-old Caucasian woman presents to the emergency department complaining of abdominal pain. She is oriented to person but is slow to answer questions and cannot name her location. She is afebrile on exam and endorses mild suprapubic tenderness. Her urine culture was positive for leukocyte esterase and nitrites. She was prescribed appropriate treatments. On follow-up, she complains of a new rash. In the past few days she has noticed that her skin becomes very red and more easily sunburns. Per the patient, her symptoms have resolved and her initial infection has cleared. Which of the following antibiotics was most likely prescribed to this patient?

A. Trimethoprim-sulfamethoxazole (Correct Answer)
B. Cephalexin
C. Nitrofurantoin
D. Ceftriaxone
E. Azithromycin

Explanation: ***Trimethoprim-sulfamethoxazole*** - This antibiotic is well-known for causing **photosensitivity**, which manifests as a **severe sunburn-like rash** when exposed to sunlight, consistent with the patient's new symptoms. - The **sulfonamide component** is a classic photosensitizer, making this a highly characteristic adverse effect. - It is a common and effective **first-line treatment** for **urinary tract infections (UTIs)**, especially those diagnosed with positive leukocyte esterase and nitrites. *Cephalexin* - Cephalexin is a **first-generation cephalosporin** commonly used for UTIs but is **not typically associated with photosensitivity** as a prominent side effect. - While it could treat the UTI, it does not explain the patient's subsequent **sunburn-like rash**. *Nitrofurantoin* - Nitrofurantoin is primarily used for **uncomplicated lower UTIs** and has a good safety profile. - While photosensitivity can occur with nitrofurantoin, it is **much less commonly reported and less severe** than with sulfonamide-containing antibiotics like trimethoprim-sulfamethoxazole. *Ceftriaxone* - Ceftriaxone is a **third-generation cephalosporin** administered parenterally, typically for more severe infections; it is **not associated with photosensitivity**. - It would be an unusual choice for an uncomplicated UTI in an outpatient setting and does not explain the rash. *Azithromycin* - Azithromycin is a **macrolide antibiotic** often used for respiratory or sexually transmitted infections, and while rare, can cause photosensitivity, it is **less common and severe** compared to trimethoprim-sulfamethoxazole. - It is **not a first-line agent** for UTIs, and its use would be less likely given the presentation.

Question 123: A 23-year-old woman comes to the physician because of increased urinary frequency and pain on urination for two days. She has had three similar episodes over the past year that resolved with antibiotic treatment. She has no history of serious illness. She is sexually active with one male partner; they do not use barrier contraception. Upon questioning, she reports that she always urinates and cleans herself after sexual intercourse. She drinks 2–3 liters of fluid daily. Her only medication is a combined oral contraceptive. Her temperature is 36.9°C (98.4°F), pulse is 65/min, and blood pressure is 122/65 mm Hg. Examination shows mild tenderness to palpation in the lower abdomen. The remainder of the examination shows no abnormalities. Urinalysis shows WBCs and rare gram-positive cocci. Which of the following is the most appropriate recommendation to prevent similar episodes in the future?

A. Postcoital vaginal probiotics
B. Daily intake of cranberry juice
C. Daily oral trimethoprim-sulfamethoxazole
D. Postcoital oral amoxicillin-clavulanate (Correct Answer)
E. Treatment of the partner with intramuscular ceftriaxone

Explanation: ***Postcoital oral amoxicillin-clavulanate*** - This patient presents with recurrent urinary tract infections (UTIs) that are likely linked to sexual activity, given her symptoms and history. **Postcoital antibiotic prophylaxis** is highly effective in preventing UTIs in women with this pattern. - **Amoxicillin-clavulanate** is an appropriate choice for prophylaxis, as it covers common uropathogens and can be used on an as-needed basis following intercourse. *Postcoital vaginal probiotics* - While probiotics, particularly those containing *Lactobacillus* species, can help maintain a healthy vaginal flora, there is **insufficient evidence to support their efficacy** as a standalone treatment or primary preventative measure for recurrent UTIs. - Probiotics do not directly target bacterial pathogens that ascend into the bladder, which is the mechanism of most UTIs. *Daily intake of cranberry juice* - Cranberry products contain **proanthocyanidins**, which can inhibit bacterial adhesion to the uroepithelium, potentially reducing UTI risk. However, evidence for its effectiveness in preventing recurrent UTIs is **mixed and often weak**, especially for established recurrent cases. - Its efficacy as a primary preventive strategy for a patient with a clear history of recurrent, sexually-associated UTIs is usually **less robust than antibiotic prophylaxis**. *Daily oral trimethoprim-sulfamethoxazole* - **Daily antibiotic prophylaxis** is an effective strategy for recurrent UTIs, but typically involves a low-dose antibiotic. While trimethoprim-sulfamethoxazole is a common choice, this patient's UTIs are clearly linked to sexual activity. - **Postcoital prophylaxis** is generally preferred over daily regimens for sexually associated UTIs because it reduces overall antibiotic exposure and the risk of developing antibiotic resistance by limiting antibiotic use to when it is most needed. *Treatment of the partner with intramuscular ceftriaxone* - The patient's symptoms are consistent with a **bacterial urinary tract infection**, which is not a sexually transmitted infection (STI) requiring partner treatment. **Gram-positive cocci** are seen, which could indicate *Staphylococcus saprophyticus* or *Enterococcus*, common causes of UTIs, not STIs. - **Ceftriaxone** is an antibiotic commonly used for STIs like gonorrhea or severe bacterial infections but is not indicated for the partner in this scenario, as the partner is asymptomatic and UTIs are not typically transmitted in this manner.

Question 124: A 19-year-old woman presents to the dermatology clinic for a follow-up of worsening acne. She has previously tried topical tretinoin as well as topical and oral antibiotics with no improvement. She recently moved to the area for college and says the acne has caused significant emotional distress when it comes to making new friends. She has no significant past medical or surgical history. Family and social history are also noncontributory. The patient’s blood pressure is 118/77 mm Hg, the pulse is 76/min, the respiratory rate is 17/min, and the temperature is 36.6°C (97.9°F). Physical examination reveals erythematous skin lesions including both open and closed comedones with inflammatory lesions overlying her face, neck, and upper back. The patient asks about oral isotretinoin. Which of the following is the most important step in counseling this patient prior to prescribing oral isotretinoin?

A. Wear a wide-brimmed hat outdoors
B. Apply topical retinoids in the evening before bed
C. Document 2 negative urine or blood pregnancy tests before beginning oral isotretinoin (Correct Answer)
D. Use non-comedogenic sunscreen daily with SPF of at least 45
E. Avoid direct sunlight, from 10am to 2pm

Explanation: ***Document 2 negative urine or blood pregnancy tests before beginning oral isotretinoin*** - **Oral isotretinoin** is a potent **teratogen**, meaning it can cause severe congenital disabilities if taken during pregnancy. Therefore, ensuring the patient is not pregnant is a critical safety measure. - Due to its high teratogenic risk, female patients of childbearing potential must be enrolled in the **iPLEDGE program**, which requires two negative pregnancy tests prior to starting isotretinoin and monthly negative pregnancy tests during treatment. *Wear a wide-brimmed hat outdoors* - While sun protection is important during isotretinoin treatment due to increased photosensitivity, wearing a wide-brimmed hat alone is not the *most important* counseling step, especially when considering the significant teratogenic risk. - This is a general recommendation for sun protection but does not address the primary safety concern associated with isotretinoin. *Apply topical retinoids in the evening before bed* - The patient has already tried **topical tretinoin** (a topical retinoid) with no improvement, indicating a need for a different treatment approach. - Combining oral isotretinoin with topical retinoids can increase skin irritation and dryness, and it's generally not recommended to use both simultaneously. *Use non-comedogenic sunscreen daily with SPF of at least 45* - Using **sunscreen** is important with isotretinoin due to **photosensitivity**. However, ensuring the patient is not pregnant is a more critical safety step given the severe risks of birth defects. - Sunscreen use is part of general skin care advice for isotretinoin but secondary to pregnancy prevention. *Avoid direct sunlight, from 10am to 2pm* - Avoiding direct sunlight is a good practice for anyone, and especially for those on isotretinoin due to increased **photosensitivity**. However, this is a lifestyle recommendation and not the most crucial safety prerequisite for starting the medication. - The primary concern before initiating treatment is addressing the **teratogenic** potential of the drug.

Question 125: A 25-year-old man presents with a nodule on his right foot. He says that he first noticed the nodule last week. It has not undergone any change in size and color. He denies any history of trauma or fever. Past medical history is significant for HIV, diagnosed 6 years ago. He is currently not on antiretroviral therapy. His last CD4+ T cell count was 0.19 x 109/L. He is afebrile, and his vital signs are within normal limits. On physical examination, there is a 3 cm x 4 cm nodule on the right foot, tan brown in color, non-tender, and covered with a fine scale. A biopsy of the nodule is performed and histopathological analysis reveals the proliferation of blood vessels with overgrown endothelial cells. Histological staining of the biopsy tissue reveals gram-negative bacilli. Which of the following is the best course of treatment for this patient?

A. Penicillin
B. Interferon-α
C. Cefazolin
D. Vancomycin
E. Erythromycin (Correct Answer)

Explanation: ***Erythromycin*** - The patient's history of **HIV**, recent **CD4+ count below 200 cells/µL**, and the finding of **gram-negative bacilli** in the context of vascular proliferation strongly suggest **bacillary angiomatosis**. - **Erythromycin**, a macrolide antibiotic, is **effective** for bacillary angiomatosis, which is caused by *Bartonella henselae* or *Bartonella quintana*. - While **doxycycline is the preferred first-line agent**, erythromycin is an acceptable alternative macrolide and is the **best option among those listed**. *Penicillin* - Penicillin is a **narrow-spectrum antibiotic** primarily effective against gram-positive bacteria and some spirochetes. - It is **not effective** against *Bartonella* species, which are gram-negative. *Interferon-α* - **Interferon-α** is an antiviral and immunomodulatory agent used in conditions like chronic hepatitis C or certain cancers. - It has **no direct antimicrobial activity** against bacterial infections like bacillary angiomatosis. *Cefazolin* - Cefazolin is a **first-generation cephalosporin** primarily used for gram-positive infections, particularly staphylococcal and streptococcal infections. - It is **not effective** against *Bartonella* species and would not be an appropriate choice for bacillary angiomatosis. *Vancomycin* - Vancomycin is a **glycopeptide antibiotic** used for severe gram-positive infections, especially those caused by **MRSA** or *Clostridium difficile*. - It has **no activity** against gram-negative bacteria like *Bartonella* and is therefore ineffective in treating bacillary angiomatosis.

Question 126: A 7-year-old boy is brought to the physician because of a 4-day history of fever, headache, earache, and sore throat that is worse when swallowing. He has not had a runny nose or cough. He had a similar problem 1 year ago for which he was prescribed amoxicillin, but after developing a skin rash and facial swelling he was switched to a different medication. His immunizations are up-to-date. He is at the 75th percentile for height and the 50th percentile for weight. His temperature is 38.9°C (102°F), pulse is 136/min, and respirations are 28/min. Examination of the oral cavity reveals a coated tongue, red uvula, and enlarged right tonsil covered by a whitish membrane. The deep cervical lymph nodes are enlarged and tender. A throat swab is taken for culture. What is the next most appropriate step in the management of this patient?

A. Erythromycin (Correct Answer)
B. Cefixime
C. Total tonsillectomy
D. Fluconazole
E. Penicillin V

Explanation: ***Erythromycin*** - This patient presents with symptoms highly suggestive of **Group A Streptococcus (GAS) pharyngitis** (fever, sore throat, enlarged tonsil with exudates, enlarged cervical lymph nodes, absence of cough/runny nose). - Given the history of a **skin rash and facial swelling with amoxicillin**, a **Type I hypersensitivity reaction** to penicillin is suspected. Erythromycin is an appropriate alternative antibiotic for GAS pharyngitis in penicillin-allergic patients. *Cefixime* - This is a **third-generation cephalosporin**, which carries a risk of **cross-reactivity** with penicillin in patients with Type I hypersensitivity (up to 10%), making it potentially unsafe. - While effective against some bacteria, it's not the primary alternative for GAS pharyngitis in the context of a severe penicillin allergy. *Total tonsillectomy* - **Tonsillectomy** is considered for recurrent severe tonsillitis or complications like peritonsillar abscess, but it is not the initial management for an acute infection. - Surgical intervention is not indicated before attempting antibiotic therapy for acute bacterial tonsillitis. *Fluconazole* - **Fluconazole is an antifungal medication** and would not be effective against a bacterial infection like GAS pharyngitis. - The clinical presentation clearly points towards a bacterial rather than a fungal etiology. *Penicillin V* - **Penicillin V is the drug of choice for GAS pharyngitis** in non-allergic patients, but this patient has a documented history of a severe **allergic reaction to amoxicillin**, a penicillin-class antibiotic. - Administering penicillin V would risk a severe and potentially life-threatening allergic reaction, including **anaphylaxis**.

Question 127: A 3-year-old girl is brought to the physician for a well-child visit. Her father is concerned about the color and strength of her teeth. He says that most of her teeth have had stains since the time that they erupted. She also has a limp when she walks. Examination shows brownish-gray discoloration of the teeth. She has lower limb length discrepancy; her left knee-to-ankle length is 4 cm shorter than the right. Which of the following drugs is most likely to have been taken by this child's mother when she was pregnant?

A. Tetracycline (Correct Answer)
B. Gentamicin
C. Ciprofloxacin
D. Trimethoprim
E. Chloramphenicol

Explanation: ***Tetracycline*** - **Tetracycline** exposure during tooth development (in utero or early childhood) can cause **permanent brownish-gray discoloration** and enamel hypoplasia due to its deposition in dentin and enamel. - The drug's affinity for **calcium** can also interfere with bone growth and development, potentially leading to **skeletal abnormalities** like limb length discrepancies if exposure occurs during critical periods of growth. *Gentamicin* - **Gentamicin** is an **aminoglycoside antibiotic** primarily associated with **ototoxicity** (hearing loss) and **nephrotoxicity** (kidney damage) if taken during pregnancy. - It does not typically cause dental discoloration or skeletal growth issues in the fetus. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** that, in children, has been linked to **cartilage damage** and arthropathy, thus generally avoided in pregnancy and childhood. - It is not associated with dental staining or limb length discrepancies. *Trimethoprim* - **Trimethoprim** is an **antifolate antibiotic** that, particularly when combined with sulfamethoxazole, is known to pose a risk of **neural tube defects** if taken in the first trimester. - It does not cause dental discoloration or skeletal growth abnormalities. *Chloramphenicol* - **Chloramphenicol** is primarily associated with **"Gray Baby Syndrome"** in neonates due to its effects on mitochondrial function and immature liver conjugation. - It does not cause dental discoloration or skeletal issues like the limb length discrepancy described.

Question 128: A 24-year-old man presents to the emergency department for severe abdominal pain for the past day. The patient states he has had profuse, watery diarrhea and abdominal pain that is keeping him up at night. The patient also claims that he sees blood on the toilet paper when he wipes and endorses having lost 5 pounds recently. The patient's past medical history is notable for IV drug abuse and a recent hospitalization for sepsis. His temperature is 99.5°F (37.5°C), blood pressure is 120/68 mmHg, pulse is 100/min, respirations are 14/min, and oxygen saturation is 98% on room air. On physical exam, you note a young man clutching his abdomen in pain. Abdominal exam demonstrates hyperactive bowel sounds and diffuse abdominal tenderness. Cardiopulmonary exam is within normal limits. Which of the following is the next best step in management?

A. Vancomycin (Correct Answer)
B. Mesalamine enema
C. Metronidazole
D. Clindamycin
E. Supportive therapy and ciprofloxacin if symptoms persist

Explanation: ***Vancomycin*** - The patient's history of **IV drug abuse**, recent **hospitalization for sepsis**, and severe abdominal symptoms with **bloody diarrhea** and **weight loss** are highly suggestive of **Clostridioides difficile infection (CDI)**. - **Oral vancomycin** is the recommended first-line treatment for **severe C. difficile infection**, especially with signs like systemic illness (tachycardia) and marked abdominal tenderness. *Mesalamine enema* - **Mesalamine** is an **anti-inflammatory drug** primarily used for **mild to moderate ulcerative colitis**, particularly when the disease is limited to the rectum or rectosigmoid colon. - While inflammatory bowel disease can cause bloody diarrhea, the acute presentation with recent hospitalization and IV drug use makes **infectious etiologies**, particularly CDI, much more likely. *Metronidazole* - **Metronidazole** is an antibiotic that was previously used for uncomplicated **C. difficile infection**. - However, **oral vancomycin** is now preferred for **initial CDI episodes** due to superior efficacy, especially in severe cases, and metronidazole is generally reserved for non-severe cases if vancomycin is unavailable or not tolerated. *Clindamycin* - **Clindamycin** is an antibiotic notorious for being a common cause of **antibiotic-associated C. difficile infection**. - Giving clindamycin in this scenario would likely **worsen the patient's condition** if C. difficile is indeed the cause, as it promotes C. difficile overgrowth. *Supportive therapy and ciprofloxacin if symptoms persist* - While **supportive care** (hydration, electrolyte management) is essential, it is **insufficient as the sole treatment** for severe C. difficile infection. - **Ciprofloxacin** is an antibiotic that is **ineffective against C. difficile** and could potentially exacerbate the infection by disrupting the normal gut microbiota.

Question 129: A typically healthy 27-year-old woman presents to the physician because of a 3-week history of fatigue, headache, and dry cough. She does not smoke or use illicit drugs. Her temperature is 37.8°C (100.0°F). Chest examination shows mild inspiratory crackles in both lung fields. An X-ray of the chest shows diffuse interstitial infiltrates bilaterally. A Gram stain of saline-induced sputum shows no organisms. Inoculation of the induced sputum on a cell-free medium that is enriched with yeast extract, horse serum, cholesterol, and penicillin G grows colonies that resemble fried eggs. Which of the following is the most appropriate next step in management?

A. Oral amoxicillin
B. Intravenous clindamycin
C. Oral azithromycin (Correct Answer)
D. Intravenous ceftriaxone and oral azithromycin
E. Intravenous ceftriaxone

Explanation: **Oral azithromycin** - The patient's symptoms (fatigue, headache, dry cough, bilateral interstitial infiltrates) are consistent with **atypical pneumonia**, likely caused by *Mycoplasma pneumoniae*. - The **fried egg colonies** on specialized media are characteristic of *Mycoplasma pneumoniae*, and macrolides such as **azithromycin** are the first-line treatment for this infection. *Oral amoxicillin* - **Amoxicillin** is a beta-lactam antibiotic that targets bacterial cell walls, which are **lacking in *Mycoplasma***. - Therefore, amoxicillin would be **ineffective** against *Mycoplasma pneumoniae* infections. *Intravenous clindamycin* - **Clindamycin** is primarily used for anaerobic infections and some gram-positive bacteria; it is **not active against *Mycoplasma pneumoniae***. - This antibiotic would not be an appropriate choice for atypical pneumonia. *Intravenous ceftriaxone and oral azithromycin* - While **azithromycin** is appropriate, **intravenous ceftriaxone** (a cephalosporin) is primarily used for typical bacterial pneumonia. - Adding ceftriaxone is **unnecessary** and broad-spectrum for this clear case of *Mycoplasma pneumoniae* pneumonia, and the patient does not appear severely ill to warrant IV therapy. *Intravenous ceftriaxone* - **Ceftriaxone** targets bacterial cell walls and would be **ineffective against *Mycoplasma pneumoniae*** due to its lack of a cell wall. - It is typically used for more severe or typical bacterial pneumonias, particularly when there is concern for *Streptococcus pneumoniae* or *Haemophilus influenzae*.

Question 130: A 76-year-old man comes to the physician for a follow-up examination. One week ago, he was prescribed azithromycin for acute bacterial sinusitis. He has a history of atrial fibrillation treated with warfarin and metoprolol. Physical examination shows no abnormalities. Compared to one month ago, laboratory studies show a mild increase in INR. Which of the following best explains this patient's laboratory finding?

A. Drug-induced hepatotoxicity
B. Depletion of intestinal flora
C. Inhibition of cytochrome p450 (Correct Answer)
D. Increased gastrointestinal absorption of warfarin
E. Increased non-protein bound warfarin fraction

Explanation: ***Inhibition of cytochrome p450*** - **Azithromycin**, while a weaker inhibitor compared to erythromycin and clarithromycin, **does inhibit CYP3A4 and other cytochrome P450 enzymes** to a clinically significant degree. - This inhibition **reduces warfarin metabolism**, leading to increased warfarin levels and **enhanced anticoagulant effect**, manifesting as an **increased INR**. - This pharmacokinetic interaction is well-documented and is the **primary mechanism** for azithromycin-warfarin interaction. *Depletion of intestinal flora* - The theory that antibiotics deplete **vitamin K-producing gut bacteria** leading to increased warfarin effect is a **common misconception**. - Humans obtain vitamin K primarily from **dietary sources** (leafy greens, vegetable oils), not from gut bacterial synthesis; intestinal bacteria contribute minimally to vitamin K stores. - This mechanism has been **debunked** in modern pharmacology literature and does not explain antibiotic-warfarin interactions. *Drug-induced hepatotoxicity* - While hepatotoxicity can impair **clotting factor synthesis** and increase INR, **azithromycin** rarely causes significant liver injury. - The presentation shows only a **mild INR increase** one week after starting therapy, without other signs of liver dysfunction. - This acute, mild change is more consistent with a **pharmacokinetic drug interaction** than hepatotoxicity. *Increased gastrointestinal absorption of warfarin* - **Warfarin** has high oral bioavailability (~100%) under normal conditions. - **Azithromycin** does not enhance the **gastrointestinal absorption** of warfarin. - This mechanism is not supported by pharmacological evidence for this drug interaction. *Increased non-protein bound warfarin fraction* - Displacement of warfarin from **plasma protein binding sites** can transiently increase free drug. - However, **azithromycin** does not significantly displace warfarin from **albumin**. - This mechanism does not explain the sustained INR elevation seen with azithromycin therapy.

Question 131: A 26-year-old woman comes to the physician because of a 3-day history of redness, foreign body sensation, and discharge of both eyes. She reports that her eyes feel “stuck together” with yellow crusts every morning. She has a 3-year history of nasal allergies; her sister has allergic rhinitis. She is sexually active with 2 male partners and uses an oral contraceptive; they do not use condoms. Vital signs are within normal limits. Visual acuity is 20/20 in both eyes. Ophthalmic examination shows edema of both eyelids, bilateral conjunctival injection, and a thin purulent discharge. Examination of the cornea, anterior chamber, and fundus is unremarkable. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate pharmacotherapy?

A. Topical prednisolone acetate
B. Oral erythromycin (Correct Answer)
C. Topical erythromycin
D. Topical natamycin
E. Artificial tears

Explanation: ***Oral erythromycin*** - The patient is a **sexually active young woman with multiple partners and no condom use**, presenting with **bilateral purulent conjunctivitis** – this clinical context raises concern for **sexually transmitted infections (STI)**, particularly **chlamydial conjunctivitis** (*Chlamydia trachomatis*). - In sexually active adults with conjunctivitis and risk factors for STIs, **systemic antibiotic therapy** is preferred over topical treatment alone to ensure adequate treatment of potential chlamydial or gonococcal infection. - **Oral erythromycin** provides broad-spectrum coverage including *C. trachomatis*, *S. aureus*, and *S. pneumoniae*, making it appropriate for this clinical scenario. - While the patient could also have typical bacterial conjunctivitis, the sexual history mandates consideration and empiric coverage of STI-related causes. *Topical erythromycin* - **Topical antibiotics alone** are appropriate for uncomplicated bacterial conjunctivitis in patients **without STI risk factors**. - In this sexually active patient with multiple partners and no barrier protection, topical therapy alone risks **treatment failure** if the underlying cause is chlamydial or gonococcal conjunctivitis, which require systemic antibiotics. - Topical treatment does not address potential systemic or genital reservoir of infection in STI-related cases. *Topical prednisolone acetate* - **Corticosteroids** like prednisolone reduce inflammation but are **contraindicated in infectious conjunctivitis** without concurrent antimicrobial therapy. - Steroids can worsen bacterial, viral, and fungal infections by suppressing the immune response and masking progression of disease. - Given clear signs of **purulent bacterial infection**, corticosteroids alone are inappropriate. *Topical natamycin* - **Natamycin** is an antifungal medication used primarily for **fungal keratitis** or fungal conjunctivitis. - This patient has no risk factors or clinical features suggesting fungal infection; the presentation is classic for bacterial conjunctivitis with STI risk factors. *Artificial tears* - Artificial tears provide symptomatic relief for **dry eye** or mild irritation but have no antimicrobial properties. - They do not treat the underlying **bacterial infection** and are insufficient as sole therapy for purulent conjunctivitis.

Question 132: A 24-year-old woman presents to her physician's office complaining of a worsening cough with large volumes of mucoid sputum every morning and thick, foul-smelling sputum almost every time she coughs. She says that this cough started about one month ago and has been increasing in intensity. Over-the-counter medications are ineffective. Past medical history is significant for cystic fibrosis diagnosed at the age of 6 years, and pneumonia twice in the past 2 years. Other than a cough, she has no fever or any other concerns. A sputum sample grows aerobic, non-lactose fermenting, oxidase-positive, gram-negative bacillus. Which of the following treatment regimens is the most beneficial for her at this time?

A. Postural drainage of the chest
B. Surgical therapy
C. Trimethoprim and sulfamethoxazole
D. Intravenous ciprofloxacin (Correct Answer)
E. Amoxicillin and clavulanic acid

Explanation: ***Intravenous ciprofloxacin*** - The patient's history of **cystic fibrosis** with recurrent respiratory infections and the isolation of an **aerobic, non-lactose fermenting, oxidase-positive, gram-negative bacillus** (consistent with *Pseudomonas aeruginosa*) strongly indicates the need for targeted antibiotic therapy. - **Ciprofloxacin** is a fluoroquinolone antibiotic with good activity against *Pseudomonas aeruginosa*, and intravenous administration is appropriate for pulmonary exacerbations in CF patients. - The worsening cough with large volumes of mucoid and foul-smelling sputum indicates a significant **pulmonary exacerbation** due to bacterial infection, necessitating effective antibiotic coverage. - While **combination therapy** (typically an anti-pseudomonal beta-lactam plus an aminoglycoside or fluoroquinolone) is often preferred for Pseudomonas exacerbations in CF, **ciprofloxacin is the best option among those listed** as it provides reliable Pseudomonas coverage. *Postural drainage of the chest* - **Postural drainage** is an important component of airway clearance therapy in patients with cystic fibrosis and bronchiectasis, helping to mobilize secretions. - While beneficial for symptom management and part of comprehensive CF care, it is not a primary treatment for an acute bacterial exacerbation and does not address the underlying **bacterial infection**. *Surgical therapy* - **Surgical therapy**, such as lung transplantation, is considered for end-stage lung disease in cystic fibrosis or for localized complications like severe bronchiectasis or massive hemoptysis refractory to medical management. - It is not the initial or primary treatment for an acute infectious exacerbation, especially in a patient without indications for emergent surgical intervention. *Trimethoprim and sulfamethoxazole* - **Trimethoprim-sulfamethoxazole (TMP/SMX)** is a broad-spectrum antibiotic effective against many gram-positive and gram-negative organisms. - However, it has **poor activity against Pseudomonas aeruginosa**, particularly the strains commonly found in cystic fibrosis patients, which often demonstrate intrinsic or acquired resistance to TMP/SMX. - This makes it an inappropriate choice for treating Pseudomonas pulmonary exacerbations in CF. *Amoxicillin and clavulanic acid* - **Amoxicillin-clavulanic acid** is effective against many gram-positive bacteria and some gram-negative organisms, including *Haemophilus influenzae* and *Moraxella catarrhalis*. - However, it has **minimal to no activity against Pseudomonas aeruginosa**, which is a common and highly virulent pathogen in cystic fibrosis patients, making it an unsuitable choice for this specific infection.

Question 133: A 27-year-old woman comes to the emergency room because of fever and severe left knee pain for the past week. She has not sustained any trauma or injury to the area, nor has she traveled or taken part in outdoor activities in the recent past. She is sexually active with one male partner, and they use condoms inconsistently. She appears ill. Her temperature is 38°C (100.4°F), pulse is 98/min, respirations are 17/min, and blood pressure is 106/72 mm Hg. Physical examination shows multiple painless pustular lesions on her ankles and the dorsum and soles of her feet bilaterally, as well as a swollen, erythematous, exquisitely tender left knee. Her wrists are also mildly edematous and tender, with pain on extension. X-ray of the knees shows tissue swelling. Arthrocentesis of the knee shows yellow purulent fluid. Gram stain is negative. Analysis of the synovial fluid shows a leukocyte count of 58,000/mm3 with 93% neutrophils and no crystals. Which of the following is the most appropriate pharmacotherapy?

A. Intramuscular ceftriaxone and oral azithromycin (Correct Answer)
B. Oral penicillin V
C. Oral doxycycline
D. Intramuscular ceftriaxone
E. Oral hydroxychloroquine

Explanation: ***Intramuscular ceftriaxone and oral azithromycin*** - The clinical presentation, including **fever**, **migratory polyarthralgia** (knees and wrists), **pustular skin lesions**, and **purulent synovial fluid** with **negative Gram stain**, is highly suggestive of **disseminated gonococcal infection (DGI)**. Given her inconsistent condom use and sexual activity, DGI is a strong possibility. - **Ceftriaxone** is the recommended treatment for gonococcal infections, and **azithromycin** is added to cover potential co-infection with **Chlamydia trachomatis**, which often co-occurs and can also cause a reactive arthritis presentation, or to prevent resistance of *N. gonorrhoeae* to cephalosporins. *Oral penicillin V* - **Penicillin V** is not effective against **Neisseria gonorrhoeae** due to widespread resistance, and it would not cover potential **Chlamydia co-infection**. - Its spectrum of activity is primarily against streptococcal and some staphylococcal infections, which do not match the clinical picture. *Oral doxycycline* - **Doxycycline** is effective against **Chlamydia trachomatis** but is not the primary treatment for **Neisseria gonorrhoeae** due to varying efficacy and resistance patterns, particularly in disseminated forms. - It would be inadequate as monotherapy for likely **gonococcal arthritis**. *Intramuscular ceftriaxone* - While **ceftriaxone** is the cornerstone of treatment for **gonococcal infections**, adding **azithromycin** is standard practice to cover for co-infection with **Chlamydia** and to improve treatment efficacy and prevent further resistance to cephalosporins in DGI. - Monotherapy with ceftriaxone alone is not recommended for DGI due to the high prevalence of co-infection with Chlamydia and the need to comprehensively treat both potential pathogens. *Oral hydroxychloroquine* - **Hydroxychloroquine** is an anti-malarial and immunosuppressive drug primarily used in **rheumatological conditions** like lupus or rheumatoid arthritis. - It has no role in treating **bacterial infections** like disseminated gonococcal infection.

Question 134: An 11-year-old girl is brought to the emergency department because of high-grade fever, headache, and nausea for 3 days. She avoids looking at any light source because this aggravates her headache. She has acute lymphoblastic leukemia and her last chemotherapy cycle was 2 weeks ago. She appears lethargic. Her temperature is 40.1°C (104.2°F), pulse is 131/min and blood pressure is 100/60 mm Hg. Examination shows a stiff neck. The pupils are equal and reactive to light. Neck flexion results in flexion of the knee and hip. Muscle strength is decreased in the right upper extremity. Deep tendon reflexes are 2+ bilaterally. Sensation is intact. Extraocular movements are normal. Two sets of blood cultures are obtained. Which of the following is the most appropriate next step in management?

A. Acyclovir therapy
B. Antibiotic therapy (Correct Answer)
C. MRI of the brain
D. CT scan of the head
E. Lumbar puncture

Explanation: ***Antibiotic therapy*** - This patient presents with **fever, headache, stiff neck, photophobia, and positive Brudzinski's sign (neck flexion results in flexion of the knee and hip)**, which are classic signs of **meningitis**. Given her history of **acute lymphoblastic leukemia (ALL)** and recent chemotherapy, she is **immunocompromised** and at high risk for **bacterial meningitis**, a life-threatening infection requiring immediate antibiotic treatment. - Due to the severity of symptoms and the high risk in an immunocompromised patient, immediate initiation of empiric, broad-spectrum antibiotics is crucial after obtaining blood cultures, even before definitive diagnosis from cerebrospinal fluid (CSF) analysis. *Acyclovir therapy* - **Acyclovir** is an antiviral medication used to treat herpes simplex virus (HSV) or varicella-zoster virus (VZV) encephalitis or meningitis. - While viral meningitis is a possibility, bacterial meningitis is a more urgent and severe concern in an immunocompromised patient with these neurological signs, making immediate antibiotics a higher priority. *MRI of the brain* - An **MRI of the brain** provides detailed imaging of brain structures and can detect abscesses, tumors, or inflammation. - However, in acute meningitis, especially with signs of increased intracranial pressure (which should be ruled out before LP), antibiotics are the most immediate and critical intervention, and an MRI would delay this life-saving treatment. *CT scan of the head* - A **CT scan of the head** is primarily used to rule out **mass lesions, hydrocephalus, or significant cerebral edema** before performing a **lumbar puncture (LP)** in patients with suspected meningitis who have focal neurological deficits or signs of increased intracranial pressure. - While it may be considered before LP due to the focal neurological deficit (decreased muscle strength in the right upper extremity), administering antibiotics takes precedence due to the high suspicion of bacterial meningitis in an immunocompromised patient. *Lumbar puncture* - A **lumbar puncture** is essential for diagnosing meningitis by analyzing the **cerebrospinal fluid (CSF)** for cell count, glucose, protein, and culture. - However, performing an LP can be delayed if there are signs of increased intracranial pressure (which warrants a preceding CT scan) or if the patient's condition is unstable; importantly, **empiric antibiotics should be started immediately** in a suspected bacterial meningitis case, especially in an immunocompromised patient, and not delayed for imaging or LP.

Question 135: A 62-year-old woman has been receiving amoxicillin for acute sinusitis for 12 days. She develops a macular rash on her neck, back, and torso. The amoxicillin is therefore changed to cephalexin for an additional week. The rash resolves, but she returns complaining of fatigue, flank pain, and fever that has persisted despite the resolution of the sinusitis. She has a history of essential hypertension, hyperlipidemia, and gastric reflux. She has been on a stable regimen of lisinopril, simvastatin, and omeprazole. Today, her vital signs reveal: temperature 37.9°C (100.2°F), blood pressure 145/90 mm Hg, regular pulse 75/min, and respirations 16/min. The physical examination is unremarkable. Serum urea and creatinine are elevated. Urinalysis shows leukocyturia, but urine bacterial culture is negative. A urine cytospin stained with Hansel’s solution reveals 3% binucleated cells with eosinophilic, granular cytoplasm. Which of the following is the most likely diagnosis?

A. Acute vascular injury
B. Acute glomerulonephritis
C. Acute interstitial nephritis (Correct Answer)
D. IgA nephropathy
E. Acute tubular necrosis

Explanation: ***Acute interstitial nephritis*** - The patient's presentation with **fever**, **rash**, **flank pain**, **eosinophilia** (implied by eosinophilic, granular cytoplasm in urine cytospin), and **acute kidney injury** (elevated urea and creatinine, leukocyturia with negative culture) following **amoxicillin** use is highly suggestive of drug-induced **acute interstitial nephritis (AIN)**. - The resolution of the rash and subsequent development of systemic symptoms and kidney injury after antibiotic exposure is characteristic of a **delayed hypersensitivity reaction** responsible for AIN. *Acute vascular injury* - This typically presents with acute, severe kidney failure, often in the context of an underlying systemic vasculitis or embolic event, which is not supported by the clinical picture. - While hypertension is present, the specific constellation of fever, rash, and eosinophilia strongly points away from primary vascular injury as the cause of kidney dysfunction. *Acute glomerulonephritis* - This condition often presents with hematuria, proteinuria, and sometimes edema, which are not mentioned in this case. - The presence of a prominent rash, fever, and eosinophils in the urine points more towards a tubulointerstitial process rather than a glomerular one. *IgA nephropathy* - This is an **immune complex-mediated glomerulonephritis** that commonly presents with **recurrent macroscopic hematuria** after an upper respiratory infection. - It does not typically involve a drug-induced rash, fever, or prominent eosinophiluria as seen in this patient. *Acute tubular necrosis* - This usually results from **ischemia** or **nephrotoxic agents**, causing direct damage to renal tubules and presenting with muddy brown casts in the urine. - While drug-induced, it typically does not present with a systemic rash, fever, and interstitial eosinophilia, which are critical features in this case, differentiating it from AIN.

Question 136: A 27-year-old man presents to the emergency department after a dog bite. The patient was intoxicated and pulled the dog’s tail while it was eating. The dog belongs to his friend and is back at his friend’s house currently. Physical exam is notable for a dog bite on the patient’s right arm. The wound is irrigated and explored with no retained bodies found. A tetanus vaccination is administered. Which of the following is appropriate management of this patient?

A. Administer the rabies vaccine and rabies immunoglobulin
B. Administer amoxicillin-clavulanic acid (Correct Answer)
C. Discharge the patient with outpatient follow up
D. Close the wound with sutures and discharge the patient
E. Administer trimethoprim-sulfamethoxazole

Explanation: ***Administer amoxicillin-clavulanic acid*** - Dog bite wounds are at high risk for bacterial infection, particularly from oral flora like *Pasteurella multocida* and *Capnocytophaga canimorsus*. **Amoxicillin-clavulanic acid** provides broad-spectrum coverage against these common pathogens. - Due to the nature of the wound (puncture, crush), the risk of infection is significant, warranting **prophylactic antibiotics** even after wound irrigation and exploration. *Administer the rabies vaccine and rabies immunoglobulin* - **Rabies post-exposure prophylaxis (PEP)** is indicated if the animal is high-risk, unprovoked, or cannot be observed. In this case, the dog is known and provoked, and its vaccination status can be ascertained. - The dog is owned by a friend and is presumably available for **observation** or vaccination status confirmation, which would typically negate the immediate need for rabies PEP. *Discharge the patient with outpatient follow up* - Discharging the patient without further intervention, specifically **antibiotic prophylaxis**, would be inappropriate given the high risk of infection associated with dog bites. - While follow-up is important, the immediate concern is **infection prevention**, which requires an initial intervention in the emergency department. *Close the wound with sutures and discharge the patient* - Dog bite wounds, especially **puncture or crush wounds**, are generally **not primarily closed by suturing** due to the high risk of trapping bacteria and increasing infection rates. - Instead, these wounds are typically left **open to heal by secondary intention** after thorough cleaning and antibiotic prophylaxis. *Administer trimethoprim-sulfamethoxazole* - **Trimethoprim-sulfamethoxazole** is not the antibiotic of choice for dog bite wounds. It lacks sufficient coverage against the common anaerobic and gram-negative organisms, such as *Pasteurella*, found in dog oral flora. - **Amoxicillin-clavulanic acid** is preferred due to its superior coverage for typical dog bite pathogens.

Practice by Chapter

Penicillins and beta-lactamase inhibitors

Practice Questions

Cephalosporins

Practice Questions

Carbapenems and monobactams

Practice Questions

Fluoroquinolones

Practice Questions

Aminoglycosides

Practice Questions

Macrolides, ketolides, and lincosamides

Practice Questions

Tetracyclines and glycylcyclines

Practice Questions

Sulfonamides and trimethoprim

Practice Questions

Vancomycin and other glycopeptides

Practice Questions

Oxazolidinones and streptogramins

Practice Questions

Daptomycin and lipopeptides

Practice Questions

Polymyxins

Practice Questions

Antibiotic resistance mechanisms

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free